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 REVÊTEMENT BIOACTIF AVEC POLYMÉRES DE LOW-FOULING POUR LE 
DÉVELOPMNET DES IMPLANTS VASCULAIRES BIOCOMPATIBLES 
 
Pradeep Kumar THALLA  
RÉSUMÉ 
 
  Le remplacement de vaisseaux sanguins occlus et la réparation endovasculaire des 
anévrismes de l’aorte abdominale (EVAR) effectués respectivement à l’aide de prothèses  
vasculaires synthétiques et d’endoprothèses couvertes, mènent tous deux à de fréquentes 
complications cliniques due à une problématique similaire : les matériaux utilisés 
(généralement le polyéthylène téréphthalate (PET) et le polytétrafluoroéthylène expansé 
(ePTFE) n’ont pas les propriétés de surface permettant de réduire les réactions biologiques 
indésirables tout en favorisant les interactions cellulaires requises pour la croissance des 
tissus biologiques. Par conséquent, l'objectif principal de cette thèse consistait à créer un 
revêtement bioactif sur les biomatériaux vasculaires pour réduire la thrombose tout en 
favorisant la croissance cellulaire.  
 
 Le premier objectif a consisté à mettre au point une surface empêchant l’adsorption 
des protéines (communément appelée « low-fouling ») à l’aide de polyéthylène glycol (PEG) 
à bras multiples. Un revêtement polymérisé par plasma riche en amine primaire (LP) a été 
utilisé comme substrat afin d’obtenir un revêtement polyvalent, pouvant être recréé sur 
n’importe quel type de biomatériaux ou de surface, ce qui n’est pas le cas des méthodes 
actuelles qui requièrent d’optimiser la technique de greffage pour chaque nouveau 
biomatériau. Tel que démontré par microbalance à cristal de quartz avec dissipation (QCM-
D), par mesure directe de fluorescence ainsi que lors d’essais de perfusion sanguins , les  
revêtements de PEG créés génèrent une très faible adsorption de protéine et  presque pas 
l'adhésion des plaquettes après 15 min de perfusion dans le sang total. Bien que l’adsorption 
des protéines ne soit pas empêchée à 100% et que les propriétés anti-plaquetaires ne 
permettent pas de conclure sur l’absence de thrombogénicité à long terme in vivo du 
revêtement, les propriétés de ce dernier peuvent être exploitées pour y coupler des molécules 
bioactives.  Par conséquent, le second objectif consistait à développer un revêtement bioactif 
innovant et polyvalent en utilisant la combinaison de peptide d’adhésion (KQAGDV/RGD) 
et de facteur de croissance épidermique (EGF) greffé par le biais de coils électrostatiques. Le 
dextran carboxyméthylé (CMD) a été choisi comme une alternative possible au PEG en 
raison de ses meilleures propriétés « low-fouling » et la présence de groupes terminaux 
carboxyl abondants. Bien que la technique QCM-D nous ait permis d'optimiser la 
combinaison de l'immobilisation KQAGDV / RGD et EGF, les essais cellulaire n'ont pas 
montré d'amélioration de l'adhésion des cellules musculaires lisses vasculaires (CMLV) sur 
les surfaces PEG ou CMD modifiées par les peptides. 
 
 Ce résultat met en évidence, parmi d’autres facteurs, le difficile compromis à trouver 
pour empêcher l’adsorption des protéines sans empêcher l’adhésion cellulaire. Des travaux 
VIII 
antérieurs du laboratoire suggéraient que la chondroitine sulfate (CS), un glycoaminoglycan 
sulphaté, permettait de trouver ce compromis. Pour cette raison, le dernier objectif de cette 
thèse a consisté à étudier les propriétés de revêtements de CS comparativement aux deux 
polymères « low-fouling », le PEG et le CMD.  Il a été démontré que la CS présente des 
propriétés anti-fouling sélectives puisque l’adsorption du fibrinogène est presque totalement 
supprimée tandis que d’autres protéines (et notamment certains facteurs de croissance connus 
pour interagir avec la CS) sont favorisées. La CS, comme le PEG et le CMD, diminue 
nettement l’adhésion plaquetaire en deça du niveau observé sur le PET. Par contre, alors que 
l’adhésion cellulaire sur le PEG et le CMD est très limitée, la CS favorise un attachement 
cellulaire prononcé, avec adhésion focale et résistance au cisaillement. Au contraire, les 
cellules endothéliales se détachent facilement du PET non modifié. Ainsi, les revêtements de 
CS forment une surface peu thrombogène favorisant la croissance d’une couche endothéliale 
complète et stable qui pourra agir comme surface anti-thrombotique active. Ensemble, 
l’utilisation du polymère plasma et de la CS greffée, suivie éventuellement d’immobilisation 
de facteurs de croissance, semble avoir un fort potentiel comme revêtement bioactif pour 
optimiser la biocompatibilité et les résultats cliniques des implants, en particulier des 
prothèses vasculaires.  
 
 
Mots-clés: revêtement bioactif, prothèse vasculaire, endoprothèse, low-fouling, non 
thrombogénique, adhésion de peptides, facteur de croissance épidermique, microbalance à 
cristal de quartz avec dissipation. 
 
 
 BIOACTIVE COATING WITH LOW-FOULING POLYMERS FOR THE 
DEVELOPMENT OF BIOCOMPATIBLE VASCULAR IMPLANTS 
 
Pradeep Kumar THALLA 
 
ABSTRACT 
 
 The replacement of occluded blood vessels and endovascular aneurysm repair 
(EVAR) are performed with the use of synthetic vascular grafts and stent grafts, respectively. 
Both implants lead to frequent clinical complications that are different but due to a similar 
problem, namely the inadequate surface properties of the polymeric biomaterials used 
(generally polyethylene terephthalate (PET) or expanded polytetrafluoroethylene (ePTFE)). 
Therefore the general objective of this thesis was to create a versatile bioactive coating on 
vascular biomaterials that reduce material-induced thrombosis and promote desired cell 
interactions favorable to tissue healing around implants. The use of low-fouling backgrounds 
was decided in order to reduce platelet adhesion as well as the non-specific protein 
adsorption and thus increase the bioactivity of immobilized biomolecules. 
 
 As part of the preliminary objective, a multi-arm polyethylene glycol (PEG) was 
chosen to create a versatile low-fouling surface, since the current coating methods are far 
from being versatile and rely on the availability of compatible functional groups on both PEG 
and the host surface. This PEG coating method was developed by taking advantage of novel 
primary amine-rich plasma polymerized coatings (LP). As demonstrated by quartz crystal 
microbalance with dissipation (QCM-D), fluorescence measurements and platelet adhesion 
assays, our PEG coatings exhibited low protein adsorption and almost no platelet adhesion 
after 15 min perfusion in whole blood. Although protein adsorption was not completely 
abrogated and short-term platelet adhesion assay was clearly insufficient to draw conclusions 
for long-term prevention of thrombosis in vivo, the low-fouling properties of this PEG 
coating were sufficient to be exploited for further coupling of bioactive molecules to create 
bioactive coatings. Therefore, as a part of the second objective, an innovative and versatile 
bioactive coating was developed on PEG and carboxymethylated dextran (CMD), using the 
combination of an adhesive peptide (KQAGDV/RGD) and epidermal growth factor (EGF). 
CMD was chosen as an alternative to PEG due to its better low-fouling properties and the 
presence of abundant carboxyl terminal groups. Although the QCM-D technique enabled us 
to optimize the combined immobilization of KQAGDV/RGD and EGF, cell adhesion assay 
results did not show improvement of vascular smooth muscle cell (VSMC) adhesion on 
peptide-modified PEG or CMD surfaces.  
 
 Among the reasons explaining low cell adhesion on peptides grafted low-fouling 
surfaces is the difficulty of preventing protein adsorption/platelet adhesion without 
significantly reducing cell adhesion. Preliminary data in our laboratory indicated that CS 
could be an ideal substrate to find this compromise. For that reason, the final objective of this 
PhD consisted in evaluating the potential of chondroitin sulfate (CS) coating by comparing 
its properties with well-known low-fouling polymers such as PEG and CMD. It was shown 
X 
that CS presents selective low-fouling properties, low-platelet adhesion and pro-endothelial 
cell (EC) adhesive properties As demonstrated by QCM-D and fluorescence measurements, 
CS was as effective as PEG in reducing fibrinogen adsorption, but it reduced adsorption of 
bovine serum albumin (BSA) and fetal bovine serum (FBS) to a lower extent than PEG and 
CMD surfaces. Whole blood perfusion assays indicated that all three surfaces drastically 
decreased platelet adhesion and activation to levels significantly lower than PET surfaces. 
However, while EC adhesion and growth were found to be very limited on PEG and CMD, 
cell attachment on CS was strong, with focal adhesion points and resistance to shear stress. 
CS coatings therefore form a low-thrombogenic background promoting the formation of a 
confluent endothelium layer, which may then act as an active anti-thrombogenic surface. CS 
coating can also be used to further graft biomolecules. Combination of LP, CS coating 
followed by GF immobilization shows great promise as a bioactive coating to optimize the 
biocompatibility and clinical outcome of vascular implants, in particular vascular grafts.  
 
 
Key words: bioactive coating, vascular graft, stent-graft, low-fouling, non-thrombogenic, 
adhesion peptide, epidermal growth factor, QCM-D. 
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 INTRODUCTION 
 
  Cardiovascular disease (CVD) is one of the leading causes of mortality and 
morbidity worldwide. In 2008, 17.3 million people died from cardiovascular diseases 
(CVDs), which accounted for 30% all global deaths. Of these deaths, 7.3 million deaths were 
due to coronary heart disease alone, according to the World Health Organization  
(ThomasWHO, 2013). As per recent statistics of the Heart and Stroke Foundation of Canada, 
cardiovascular diseases cause the death of one Canadian every seven minutes and cost the 
Canadian economy $ 20.9 billion every year (2011, statistics Canada). 
 
 Vascular occlusive disease is the greatest risk factor affecting the coronary arteries, 
and ultimately leads to complete heart failure. To date the standard clinical approach involves 
angioplasty, stenting, and bypass graft surgery depending on the degree of occlusion. More 
than 70% of patients with occluded arteries require treatment with bypass grafts. Autografts 
(such as saphenous vein, arm vein, mammalian artery, or radial artery) are preferred for 
primary revascularisation to replace small diameter vessels (Desai, Seifalian et Hamilton, 
2011). However, 3–30% patients presented with no autologous vessels due to previous 
disease conditions or previous organ harvesting (L'Heureux et al., 2007; Rathore et al., 
2012).  
 
 Synthetic vascular grafts (VG), made of polyethylene terephthalate (PET) and 
expanded polytetrafluoroethylene (ePTFE), are successfully used for the replacement of 
medium or large diameter blood vessels (> 6mm). However, the use of PET and ePTFE 
based vascular grafts for small diameter vessels (<6 mm) have been restricted due to 
unacceptable patency rates in the long term. This could be due to the fact that small diameter 
vascular grafts encounter low blood flow and high shear rate conditions that lead to several 
complications such as acute thrombosis (leads to early failure; within 30 days after the 
implantation), intimal hyperplasia (leads to midterm failure; 3 months to 2 years after the 
implantation), and atherosclerosis (leads to late failure after 2 years) (Conte et al., 2002). 
Similarly, the use of PET and ePTFE based stent grafts (SG) for the treatment of 
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endovascular aneurysm repair (EVAR) is limited by risk of thrombosis, undesirable blood-
material interactions and most importantly inadequate healing around implants. Therefore, 
there is an urgent clinical need for developing improved vascular implants (Zhang et al., 
2007). Current VGs and SGs made of PET and e PTFE tend to fail because they are 
ineffective in preventing surface-induced thrombosis and lack favorable surface properties 
that promote confluent cell adhesion growth and survival.  
 
 Several attempts were already made to improve surface properties and thereby 
enhance the patency rates of vascular implants. However, two main issues still need to be 
addressed. The first is that current bioactive coating methods fail to find a good compromise 
between preventing thrombus formation and promoting desirable cell-adhesive properties. 
The second is that most techniques lack versatility, which compromises their commercial use 
since the coating process must be optimized for each material and application. Therefore, the 
multidisciplinary work of this PhD thesis involves the growing field of surface modification 
in biomaterial research. More specifically, it aims to develop an innovative and versatile 
bioactive coating for vascular grafts and stent grafts that can induce desired cell interactions 
while preventing undesirable protein and blood-material interactions.  
 
 Chapter 1 of this thesis includes a literature review, detailing the current vascular 
implants, blood-material interactions and the scientific approach leading to the design of 
bioactive coatings. More specifically, this section describes the structure and function of 
arteries, vascular disease, the uses of current vascular implants and limitations, protein-
surface interactions and their consequences such as thrombosis and blood coagulation. 
Surface modifications with low-fouling coatings and anticoagulants that reduce protein 
adsorption and thrombosis, and finally bioactive coatings using peptides and growth factors 
that improve cell interactions with the material surface are also presented. The potential 
advantage of using low-fouling backgrounds or spacers for biomolecules immobilization is 
explained, as well as the use of the hydrophilic polymers polyethyleneglycol (PEG) and 
carboxymethylated dextran (CMD) to obtain such low-fouling background. 
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Based on the literature review, several hypotheses were made and three main objectives were 
defined for this thesis. In addition, the most promising bioactive molecules were chosen to 
create a low-fouling and non-thrombogenic bioactive coating that promotes cell growth. The 
specific objectives and their rationale are presented in Chapter 2, while Chapter 3 covers the 
materials and methods used for the project. Chapter 4 comprises the results and discussion 
section of PhD thesis, which was divided into three subsections based on the specific 
objectives. The general discussion and the resulting recommendations and limitations are 
presented in Chapter 5 followed by the conclusions. 
 

 CHAPTER 1 
 
 
LITERATURE REVIEW 
1.1 Clinical problematic 
 
1.1.1 Morphology of arteries 
 
 The walls of large vessels such as arteries consist of three concentric layers: an inner 
intima, an intermediate media and an outer adventitia (Figure 1.1). Regardless of the 
organization of these layers, the main constituents of blood vessel walls are endothelial cells 
(ECs), smooth muscle cells (SMCs) and the extracellular matrix (ECM). The intimal layer is 
attached to the basement membrane rich in collagen IV and laminin. This layer consists of a 
monolayer of specialized ECs, which forms a tight non-thrombogenic/anti-thrombogenic 
barrier between the lumen and the rest of the vessel wall. Vascular ECs experience shear 
stress in vivo, which ranges between 10 and 20 dynes/cm2 for straight arteries of uniform 
geometry. For non-uniform geometries (branches and arches), the shear stress can be as high 
as 50 dynes/cm2 with pulsatile flow (Papaioannou et Stefanadis, 2005). The intimal layer 
plays a role not only in preventing unwanted clot formation, but also prevents infection and 
inflammation of the underlying tissue.  
 
 The acellular and dense elastin layer, also known as the internal elastic lamina, 
separates the intimal layer from the medial layer. This muscular layer of the artery consists 
mainly of SMCs, collagen Type I and III, and a lesser amount of other proteins and 
proteoglycans. The collagen matrix and the SMCs in the intermediate media are aligned 
circumferentially along the axis of the blood vessel. Vessel contraction or dilation is caused 
by the stimulation of SMCs by signals from ECs of the lumen or directly by cytokines. 
Another dense elastin layer, the external elastic lamina, separates the intermediate media 
from the outermost layer of the vessel wall, i.e. the outer adventitia. The adventitia consists 
of a loose collagen matrix with embedded fibroblasts and vasa vasorum, which serves to 
anchor the blood vessel to the surrounding tissue and to provide additional structural support. 
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Figure 1.1. Schematic view of the organization of the three 
layers (intima, media and adventitia) of an artery. Taken from 
(Muscle anatomy of the body, 2014). 
 
 
1.1.2 Vascular injury 
 
 The most common reason for vessel failure is atherosclerosis, which is an 
inflammatory disease that causes plaque build-up beneath the intimal layer of the vessel wall. 
This plaque is formed by the infiltration of monocytes into the intima, and a resulting 
increase in the migration, proliferation, and secretary activity of the vascular SMCs. The 
blood vessel lumen narrows as the plaque grows (see Figure 1.2) and calcifies, leading to a 
decrease in blood flow to the downstream tissues. Plaque rupture and subsequent clot 
formation can eventually lead to infarction of the downstream tissue (Stary et al., 1995).  
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Figure 1.2. Schematic view of narrowing artery due to 
atherosclerotic plaque. Taken from (Merck, 2014). 
 
 Another possible result of atherosclerosis is the abnormal permanent dilation of the 
aorta, which leads to the formation of an aneurysm (Sakalihasan, Limet et Defawe, 2005; 
Zankl et al., 2007). Aortic aneurysms commonly occurred in three different locations, which 
are classified as abdominal aortic aneurysm (AAA), thoracic aneurysm and thoracic 
abdominal aneurysm. Of those aneurysms, AAA is leading cause of death in the aging 
population. It is typically either fusiform or saccular. Fusiform aneurysms present as a fairly 
uniform shape with symmetrical dilation that involves the full circumference of the aortic 
wall while saccular aneurysms present as localized dilation that appear as an outpouching of 
only a portion of the aortic wall (Adam van der Vliet et Boll, 1997). 
 
 There are three main pathophysiological mechanisms, such as inflammation, 
proteolysis and apoptosis, involved in the development of abdominal aortic aneurysms. AAA 
is mostly associated with severe atherosclerosis, which is characterized by the presence of 
inflammatory cells (Jonasson et al., 1986) that are recruited from blood and 
neovascularization processes in the media layer forming a lymphomonocytic infiltrate 
(Herron et al., 1991; Holmes et al.; Shah, 1997). The second mechanism for the development 
of AAA involves proteolytic degradation of elastin fibers and collagen by matrix 
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metalloproteinases (MMPs) that are either activated by other MMPs or plasmin (Carrell et 
al., 2002; Defawe et al., 2003; Rao, Reddy et Cohen, 1996; Thompson et Parks, 1996). The 
third and most significant mechanism leading to AAA involves the reduction of the density 
of smooth muscle cells in the media layer by the apoptotic process (Lopez-Candales et al., 
1997). Altogether, the mechanisms leading to AAA suggest that the presence of a smooth 
muscle cell layer in the aortic wall is important, since VSMCs protect against inflammatory 
and proteolytic processes and also play a key role in repair processes of the aneurysms 
through localized expression of numerous extracellular matrix proteins and protease 
inhibitors (Allaire et al., 2002).  
 
1.1.3 Vascular prostheses and their limitations 
 
 When stenting is not an option, the use of autologous vessels, including saphenous 
veins and mammary arteries, remains the standard procedure for the replacement of coronary 
arteries. However, one third of patients do not have veins suitable for grafting due to pre-
existing vascular disease and vein stripping or vein harvesting for prior vascular procedures 
(Edwards, Holdefer et Mohtashemi, 1966; Veith et al., 1979). Finally, the harvest of 
autologous vessels causes significant morbidity and surgical costs. All of these factors 
contribute to a clinical requirement for readily available and functional synthetic small-
diameter vascular grafts. Therefore, there is an increasing need to develop small-diameter 
vascular vessels for bypass surgery and other vascular reconstructive procedures. In addition, 
vascular grafts are needed for surgery performed for vascular trauma, aneurysms, and organ 
transplantation. 
 
 The most common method for the treatment of AAA involves traditional open 
surgery and endovascular aneurysm repair (EVAR). Surgical procedure involves the 
replacement of the walls of the aneurysm with a synthetic graft, whereas EVAR using stent 
grafts is an alternative to surgical procedure (see Figure 1.3 B). SGs, also called covered 
stents, are made of a polymeric tubular structure supported by metallic struts and are inserted 
by catheter to exclude blood flow from the aneurysmal sac and therefore prevent further 
enlargement or aneurysm rupture. EVAR is increasingly being used due to several 
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advantages such as its minimally invasive nature, reduced expense compared to conventional 
surgery and reduced recovery time and morbidity. However, this procedure is not free of 
complications that potentially occur during and after the EVAR procedure, which are mainly 
due to poor healing around the SG and lack of fixation into the surrounding vessel. 
 
 
Figure 1.3. Schematic of (A) commercially available ePTFE vascular 
grafts (GORE-TEX) for coronary artery bypass and (B) stent graft 
placement for the repair of EVAR (Biotextiles, 2014). 
 
 Current vascular grafts and stent grafts are generally made of woven polyethylene 
terephthalate (PET, Dacron) or expanded polytetrafluoroethylene (ePTFE) (see Figure 1.3). 
 
PET: Poly (ethylene terephthalate), chemical structure represented as [O-C=O-C6H6-O-
C=O-CH2CH2]n, is a semi-crystalline polymer from the family of polyesters patented by 
DuPont (Dacron ®) in 1950; (Chlupac, Filova et Bacakova, 2009)). PET's long chains are 
obtained from polycondensation of terephthalic acid and ethylene glycol. When PET is made 
into fibers, it is referred to commercially as Dacron. Dacron can be manufactured in either 
knitted or woven designs. Woven grafts have small pores, while knitted grafts have larger 
pores that promote greater tissue ingrowth and are more compliant. This polymer is generally 
strong, with a tensile strength of 170 MPa-180 MPa and a tensile modulus of 14,000 MPa. 
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These properties confer non-biodegradability and are stable for up to 30 years. However, 
Dacron grafts have been found to dilate over time (Boss et Stierli, 1993; Sporn et al., 2008). 
 
PTFE: ePTFE, or Teflon, is a crystalline polymer composed of saturated carbon and fluorine 
atoms (-CF2-CF2-) patented by Gore (Gore-Tex) in 1969 (Chlupac, Filova et Bacakova, 
2009). ePTFE is an expanded polymer that is obtained by a heating, stretching, and extruding 
process resulting in a non-textile porous tube composed of random-shaped solid membranes 
(nodes). This polymer is considered to be chemically inert and hydrophobic. ePTFE has a 
very low coefficient of friction, medium stiffness with a tensile strength of 21 MPa and 
tensile modulus of 413 MPa, and is much less flexible than PET (Palmaz, 1998; Ruben Y. 
Kannan et al., 2005). This polymer is relatively less prone to deterioration in biological 
environments compared to PET (Guidoin et al., 1993). The electronegative character of 
ePTFE is known to be helpful in minimizing its reaction with blood components (Palmaz, 
1998; Ruben Y. Kannan et al., 2005). 
 
 These two materials were chosen for designing vascular prostheses due to their 
mechanical properties and relatively good hemocompatibility, which help to prevent 
thrombus formation. The current VG perform well as large-caliber substitutes, but their long-
term patency is not satisfactory for small-caliber applications (<6 mm) such as in coronary 
and microvessel surgery (Hoenig et al., 2005; Kakisis et al., 2005; Kannan et al., 2005; 
Salacinski et al., 2001). This failure is mainly the result of an unfavorable healing process, 
surface thrombogenicity, lack of endothelial cells and anastomotic intimal hyperplasia caused 
by hemodynamic disturbances. Therefore, the use of synthetic small-diameter vascular grafts 
made of PET and ePTFE remain unsuccessful (Burkel, 1988; Greisler, 1990; Yeager et 
Callow, 1988; Zilla, von Oppell et Deutsch, 1993). Similarly, the use of current stent grafts 
for EVAR is limited by postoperative complications, which mainly arises due to surface-
induced thrombosis, incomplete healing and lack of vascular tissue growth around the 
implant. These complications are mainly related to lack of favorable surface properties of 
implants for promoting VSMC adhesion, growth and resistance to apoptosis. 
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 The comparison of Dacron vs. ePTFE by systematic evaluation and meta analysis of 
randomized controlled trials showed no evidence of an advantage of one material over the 
other (Roll et al., 2008). Host reactions to the synthetic vascular prosthesis start immediately 
after contact with blood circulation. The physico-chemical properties of the material surface, 
such as charge, energy, wettability and roughness, play a key role for the graft’s patency. It 
was demonstrated that the first event is the plasma protein adsorption/desorption process 
typical for any blood/material interface (Vroman et Adams, 1969). This process is followed 
by platelet recruitment, white blood cell and erythrocyte adhesion, and eventually endothelial 
and smooth muscle cell migration. Fibrin deposits (containing platelets and blood cells) 
usually form during the first few hours to days after implantation and are stabilized for 18 
months with the formation of an inner compacted fibrin layer. Furthermore, fibrin is known 
to fill the interstices within the graft wall. Unfortunately, these steps are not followed by 
spontaneous endothelialisation, which would be required to reproduce the anti-thrombotic 
properties as described above. Only a few dispersed small islands of endothelialisation 
appeared on woven excised Dacron grafts (Wu et al., 1995) and knitted Dacron grafts during 
1-11 years after implantation (Shi et al., 1997). ePTFE-based grafts face the same 
complications as Dacron when used for small-diameter blood vessels (Wu et al., 1995). 
 
 The presence of adsorbed proteins from blood plasma greatly influences cell 
attachment to synthetic surfaces. Proteins bind to surfaces depending on surface physico-
chemical properties (Roach, Farrar et Perry, 2006) such as wettability, chemical composition 
and surface charge. These properties can determine the composition, surface density and 
conformation of the adsorbed protein layers. A combination of interactions such as 
hydrophobic forces, electrostatic forces, hydrogen bonding and van der Waals forces is 
responsible for protein adsorption on material surfaces (Brash, 1996). Changing surface 
properties, for example increasing surface hydrophilicity, results in quantitative and 
qualitative variation in the composition of the adsorbed protein layer. Proteins usually adhere 
irreversibly on hydrophobic surfaces since such surfaces exert strong interaction with 
hydrophobic parts of the protein. This interaction causes protein deformation or denaturation 
or disruption of native conformation and therefore the exposition of cell-binding regions on 
proteins is altered. It has been recognized that albumin and fibrinogen (Wu et al., 2005) 
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adsorbs to hydrophobic surfaces, while adhesive proteins (Fn and Vn) preferentially adsorb 
to hydrophilic surfaces when surfaces are exposed to blood plasma or serum (Koenig, 
Gambillara et Grainger, 2003a; Kottke-Marchant, Veenstra et Marchant, 1996). It is 
generally observed that ECs adhere and spread moderately on hydrophilic surfaces, whereas 
EC adhesion is reduced or even absent on hydrophobic surfaces (Absolom, Hawthorn et 
Chang, 1988; van Wachem et al., 1987). Both Dacron and ePTFE grafts are hydrophobic, 
however ePTFE is more hydrophobic than PET (Chlupac, Filova et Bacakova, 2009). 
Therefore, these materials are prone to adsorb fibrinogen and albumin and unfavorable for 
the adsorption of cell-adhesive proteins, which may lead to platelet adhesion and activation 
with poor or no EC adhesion. Therefore it is important to improve surface chemical and 
biological properties to reduce thrombosis and promote desired cell adhesion and growth 
(ECs for vascular grafts and VSMCs for sent grafts). In the following sections various 
surface modification methods will be described. 
 
1.2 Blood-material interactions 
 
 The majority of biomaterials used in blood-contacting devices are associated with 
many complications due to the interactions between blood and the material surface. Such 
interactions can ultimately lead to the failure of the device. This section will describe the 
mechanisms implicated in thrombus formation on biomaterials surfaces. As mentioned 
earlier, the introduction of foreign material into the body or blood causes immediate 
adsorption of blood proteins onto the surface and usually form a monolayer within seconds 
(Brash et Ten Hove, 1993; Courtney et Forbes, 1994). These interactions usually followed by 
platelet adhesion and activation, leukocyte adhesion, activation of the complement system, 
activation of blood coagulation and therefore thrombus formation (Eckmann et al., 2013; 
Gorbet et Sefton, 2004; Ratner et Bryant, 2004). As shown in Figure 1.4 (Courtney et Forbes, 
1994), the body reacts to the layer of adsorbed proteins rather than the surface itself. Since 
the protein adsorption is the initial step of blood-material interactions, the protein adsorption 
phenomen is also described in the following sections. 
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Figure 1.4. Schematic shows a simplified view of the 
interaction of blood elements with biomaterial 
surface. Taken from (Courtney et Forbes, 1994). 
 
1.2.1 Protein-surface interactions and their influence on protein adsorption 
 
 Proteins consist of long chain amino acids that are linked together by peptide bonds 
formed between the amino and carboxyl groups of adjacent amino acid residues. Proteins are 
also referred to as polypeptides, since amino acids polymerize to form protein through 
peptide bonds. The net charge on proteins can be positive, negative or neutral, depending on 
the composition of amino acids, pH of the solution and protein's isoelectric point. Protein 
adsorption can be described as the "accumulation” of protein at the material interface. 
Normally, protein adsorption on the surface takes place in a non-specific way, which means 
that the proteins are only "physically" attached to the surface. The amount of adsorbed 
protein on the surface depends on its concentration as well as protein-surface affinity 
(Barnthip et al., 2008).  
 
 Both the affinity and the rate of transport to the surface influence protein adsorption 
kinetics. The rate of protein diffusion is influenced by the size of proteins, with smaller 
proteins diffusing faster than larger ones. The size of the protein also determines the affinity 
of protein molecules. For example, larger proteins may readily adsorb to the material surface 
since they have more binding sites to interact with the surface. A number of other factors 
come into play to influence the affinity of protein adsorption, since proteins are composed of 
sequences of amino acids and they exhibit different properties. Protein properties such as 
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charge (depending on the pH of their environment), hydrophilicity, hydrophobicity and 
internal structure influence protein-surface affinity (David Richard Schmidt, 2009). For 
example, larger "soft" proteins (e.g. immunoglobulin (IgG), α-lactalbumin, β-casein and 
hemoglobin) that have a low structural stability are known to interact with higher affinity 
than smaller "hard" ones (α-chymotrypsin, ribonuclease, lysozyme and β-lactoglobulin) that 
have greater structural stability (Norde, 1996).  
 
 The structure of a protein also plays a key role in protein adsorption because specific 
conformation may expose specific binding domains to interaction with the surfaces. Protein 
may lose its specific activity when it undergoes a conformational change upon adsorption to 
a material surface; over a period of time pertinent protein unfolding and changes in protein 
activity may also occur as shown Figure 1.5. This schematic illustrates that; (a) the protein 
has a binding site that requires a specific structure, (c) upon protein adsorption, these 
conformational epitopes are no longer functional as they are far apart, (d) over a period of 
time, the adsorbed protein may continue to unfold, thereby exposing additional binding sites. 
and (b) the hidden biding site of protein may have been revealed but it becomes available for 
binding to another molecule once the protein has unfolded upon adsorption on the material 
surface (David Richard Schmidt, 2009). 
 In a multi-protein system, for example blood plasma, many proteins compete for the 
adsorption sites on the material surface. Initially, protein adsorption is controlled by protein 
diffusion. Therefore, in the early stages, the protein concentration and size play a critical role 
(Barnthip et al., 2009; Krishnan, Siedlecki et Vogler, 2004; Noh et Vogler, 2007); smaller 
proteins present at higher concentration adsorb more than larger ones at lower concentration. 
However, over a period of time, proteins of higher surface affinity will displace those of 
lower affinity regardless of protein concentration and size. This exchange phenomena is 
known as the Vroman effect (Leonard et Vroman, 1991; Noh et Vogler, 2007). For example, 
when this phenomenon was verified for plasma proteins containing albumin, IgG and 
fibrinogen (Fg) (Brash, 1996; Jung et al., 2009; Noh et Vogler, 2007), it was noticed that 
initially adsorbed Fg had been displaced over time by other higher affinity and low 
concentration proteins such as high molecular weight kininogen (Brash et Ten Hove, 1993). 
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Figure 1.5. Schematic view of protein conformational 
changes upon adsorption on the material surfaces. Taken 
from (David Richard Schmidt, 2009). 
 
 
  While the properties of individual proteins are important for protein 
adsorption, material surface properties such as hydrophilicity, hydrophobicity, topography, 
surface charge and chemistry (Andrade et Hlady, 1986) also decide the fate of protein 
adsorption. Figure 1.6 shows the interactions between a protein and the surface that have 
different binding domains. It is worth noting that water molecules adsorb to the material 
surface prior to protein adsorption. In the case of hydrophobic surfaces, a shell of water 
molecules forms in which water molecules prefer to interact with each other rather than 
interacting with the hydrophobic surface. One hypothesis postulates that the shell of these 
surrounding water molecules represents a fairly ordered scenario with a decreased level of 
entropy; disruption of this layer with proteins is energetically favorable due to a concomitant 
increase in entropy (David Richard Schmidt, 2009). The increase in entropy is the primary 
driving force for protein adsorption on hydrophobic surfaces. Although it is difficult to 
predict how surface hydrophobicity affects protein adsorption for a specific system, in 
general, enhanced protein adsorption and conformational changes are observed as surface 
hydrophobicity increases (Gray, 2004). Depending on the charged areas of both the surface 
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and the protein, surface charge has an effect of either attracting or repelling proteins. For 
example, a net negative charge on the material surface reduces the adsorption of serum 
proteins, since the majority of blood serum proteins are negatively charged (in physiological 
condition).  
 
 
Figure 1.6. A schematic view of protein-surface 
interactions. Both the surface and the protein have a 
number of interacting domains with charged, 
hydrophobic and polar character. Image taken from 
(Andrade et Hlady, 1986). 
 
 Protein adsorption is also strongly influenced by topographical features on a material 
surface. Increased surface roughness may lead to a net increase in protein absorption on the 
material surface, since roughness provides more surface area for protein adsorption 
(Rechendorff et al., 2006). Finally, changes in surface chemistry dictate the types of bonds 
between protein and material surface and thus affect protein adsorption. In the literature, the 
impact of several surface functional groups on protein adsorption was mentioned. Non-polar 
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and hydrophobic groups such as methyl (CH3) groups are known to tightly bind fibrinogen (a 
key protein involved in platelet adhesion and thrombus formation) and immunoglobin (IgG; 
an antibody protein involved in the immune response). A material surface that functionalized 
with -OH groups is known to increase surface hydrophilicity and thus reduce the affinity of 
plasma proteins. Amine (NH2) groups are found to strongly bind fibronectin and other 
proteins and induce adhesion of platelets and several cell types. These functional groups are 
also known to trigger acute inflammatory reactions in vivo. (Wang et al., 2004). Carboxyl (–
COOH) groups are negatively charged in the presence of blood serum and aqueous protein 
solutions and are hydrophilic. These groups are known to interact preferentially with 
vitronectin and albumin (Wang et al., 2004; Weis et al., 2004). It is important to note that 
these generalized observations may not be true for all cases and may vary depending on 
experimental conditions and the type of protein solutions. For example, a surface that is 
activated with multiple functional groups may have a different effect on protein adsorption 
compared to individual functional groups. In the case of mixed SAMs of –NH2 and –COOH 
functional groups (at equal molar fractions), reduced fibrinogen adsorption (Chuang et Lin, 
2007) and therefore the lowest platelet adhesion was observed (Thevenot, Hu et Tang, 2008; 
Wang et al., 2004). It is also important to note that, over time, the presence of water and 
other molecules in the surrounding environment may modify the activity of functional groups 
on the material surface (Wang et al., 2004; Weis et al., 2004). 
 
 The environment in which protein adsorption occurs is also an important factor that 
may alter protein adsorption and conformation. Temperature significantly above room 
temperature can increase protein adsorption. Another important factor is pH condition, which 
can affect protein adsorption because changes in the charge of both the material surface and 
the protein molecule may lead to variations in electrostatic interactions (Brash et Ten Hove, 
1993). 
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1.2.1.1 Adsorption of serum proteins 
 
 The adsorption of serum proteins plays a critical role in promoting platelet and cell 
adhesion and other biological functions. There are more than 150 varieties of proteins found 
in human blood serum. The most widely studied proteins and their biological function are 
listed in the following Table 1.1. Some studies in the literature reported that serum protein 
adsorption on glass surfaces follows the sequence as albumin first, followed by IgG, 
fibrinogen, fibronectin, factor XII, and high molecular weight kininogen (Boland et Weigel, 
2006; Ellis et al., 1999). Since albumin is the smallest protein and present in high 
concentration in serum, it adsorbs first on the material surface. Albumin, however, has a 
relatively low affinity compared to other proteins present in the serum, therefore, over a 
period of time, it is partially replaced by larger and higher-affinity proteins such as 
fibrinogen (which is a key molecule in promoting platelet recruitment) (Boland et Weigel, 
2006; Ellis et al., 1999). 
 
Table 1.1. Major constituents of human blood serum and their biological functions. 
Taken from (David Richard Schmidt, 2009). 
 
 
1.2.2 Thrombus formation 
 
 The blood circulatory system is a closed-loop system and it is responsible for the 
distribution of essential nutrients throughout the body. Injury to the healthy blood vessel 
leads to immediate thrombus formation to seal the damaged site and therefore to prevent 
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blood leakage. This process is an essential mechanism to maintain circulation integrity. The 
accumulation of circulating platelets will take place at the site of injury during thrombus 
formation and the coagulation system produces thrombin and fibrin to stabilize the clot. 
 
 In the native vasculature, after vessel injury, platelet aggregation occurs by the 
adhesion of exposed collagen in the sub-endothelial matrix. The initial platelet adhesion is 
mediated by membrane receptors, such as glycoprotein VI and glycoprotein Ib, that bind to 
collagen and von Willebrand factor, respectively (Fressinaud et al., 1994; Mackman, 2008; 
Ruggeri, 1997). Platelet adhesion is also known to be mediated by integrin receptors α2β1 
and αIIbβ3, which bind to collagen and fibrinogen/fibrin, respectively (Bennett, Berger et 
Billings, 2009; Mackman, 2008; McCarty et al., 2004). The adsorption of these proteins to 
blood-contacting devices or materials initiates platelet adhesion and therefore platelet 
activation will occur. Alternatively, soluble factors can activate platelets through binding to 
its receptors. For example, the tissue factor (TF) pathway leads to thrombin production, and 
subsequently thrombin cleaves protease-activated receptor 1 (Par-1) on the platelet surface 
and ultimately activates platelets. Another example is that thromboxane A2 (TXA2) and 
ADP can bind to their respective receptors on platelets and activate platelets (Davie, 
Fujikawa et Kisiel, 1991; Furie et Furie, 2008; Mackman, 2008). Both mechanisms (platelet 
adhesion and the exposure to soluble agonists) are known to be capable of initiating platelet 
activation individually. However, the relative contribution of each mechanism is still 
unknown. In general, platelet activation can be recognized by a rapid change in platelet 
geometry and the release of platelet granules containing a variety of strong chemical agonists 
that amplify the activation and aggregation of platelets (Blockmans, Deckmyn et Vermylen, 
1995; Ruggeri, 2009). The activation of platelets leads to thrombus formation as well as 
inflammatory responses. 
 
1.2.3 Blood coagulation 
 
 Blood coagulation involves a series of cascading events that leads to formation of 
thrombin and therefore fibrin clot. Blood coagulation follows two separate pathways, 
namely, the intrinsic pathway (or contact phase pathways) and the extrinsic pathway. Both 
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pathways lead to a common pathway for thrombin generation (as shown in Figure 1.7). The 
intrinsic pathway is a series of cascading events that occurs immediately (within 100-200 s) 
after the surface comes into contact with blood. The Factor XII, kallikrein, high-molecular-
weight kininogen, and Factor XI are known as primary components for the intrinsic pathway 
(Davie, Fujikawa et Kisiel, 1991; Schmaier, 1997). However, it was found that patients 
deficient in activated Factor XII still produce elevated levels of thrombin during vascular 
bypass procedures. Therefore it was suggested that the intrinsic pathway may not be required 
for thrombus formation on implantable material surfaces (Burman et al., 1994). 
 
 The extrinsic pathway of blood coagulation, also referred to as the TF dependent 
pathway, is initiated by the exposure of TF to blood. The physiological coagulation process 
involves the expression of TF to damaged cells at the site of vascular injury. Initially it was 
believed that TF resides on the adventitial and medial tissue layers of blood vessels (Wilcox 
et al., 1989). However, a significant amount of evidence from several research groups 
suggests that TF presents in the circulating blood secreted by monocytes and neutrophils 
(Coughlin, 2000; Furie et Furie, 2008; Giesen et al., 1999). Thus TF in blood plays a key role 
in biomaterial-induced thrombus formation (Jensen et al., 2007; Tomizawa, 1995). Once 
exposed, plasma Factor VII (FVII) binds to TF on the cell membranes and forms TF-VIIa 
complex, which is also known as the tenase complex. This tenase complex cleaves Factor X 
to produce activated Factor Xa and then Factor Xa is able to activate and interact with Factor 
V. This process leads to the formation of Factor Xa–Factor Va complex, which is also known 
as the prothrombinase complex. Finally, prothrombinase complex coverts prothrombin to 
thrombin (Coughlin, 2000; Davie, Fujikawa et Kisiel, 1991; Furie et Furie, 2008). 
 
 Thrombosis is necessary for the maintenance of hemostasis, but to maintain the 
function of cardiovascular implants (such as vascular and stent grafts) it is important to 
prevent thrombosis on implant surfaces. Endothelium is known to be an effective cellular 
layer that inhibits the adhesion and activation of platelets and also inhibits thrombin 
generation by expressing several thrombin inhibitors, and therefore blocks the coagulation 
process and mediates clot dissolution, which is described in the following section. With the 
21 
understanding of these molecular mechanisms, one can design bioactive surfaces that mimic 
natural antithrombogenic properties locally or systemically. 
 
 
Figure 1.7. Schematic diagram of a simplified view of the blood 
coagulation cascade that includes intrinsic and extrinsic pathways. 
Taken from (Gorbet et Sefton, 2004). 
 
1.2.4 Regulation of thrombosis by endothelium 
 
 The endothelium acts as a physical barrier that separates circulating blood from 
thrombogenic tissue components within the vascular wall. Moreover, the endothelium is 
known to play a multifaceted role in hemostasis and actively regulates thrombotic events. 
Therefore, biomaterial research has largely focused on achieving EC coverage and/or 
mimicking specific antithrombotic elements inherent to ECs. Here we give a brief overview 
of the key mechanisms of EC regulation of thrombus formation.  
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 ECs synthesize several key molecules that inhibit blood coagulation events and act as 
an antithrombotic layer. The EC layer expresses heparan sulfate proteoglycan (HSPG) that 
serves as a cofactor of antithrombin-III (AT-III) to facilitate thrombin inhibition (Bernfield et 
al., 1999; Bernfield et al., 1992). Additionally, ECs express thrombomodulin (TM), which 
binds to thrombin and converts protein C to its active form (activated protein C; APC), which 
in turn inhibits Factor Va and Factor VIIa (Stearns-Kurosawa et al., 1996). ECs are also 
known to be responsible for synthesizing TF pathway inhibitor (TFPI), which binds to both 
Factor VIIa and Factor Xa. Therefore, TFPI limits TF-induced activation of the extrinsic 
coagulation pathway (Hackeng et al., 2009) (Figure 1.8). 
 
 The endothelium also plays a key role in inhibiting or regulating thrombus formation. 
ECs synthesize and release nitric oxide (NO) and prostacyclin (PGI2), both known to 
suppress platelet adhesion and activation (Figure 1.8 b) (Best et al., 1977; de Graaf et al., 
1992). The level of expression of NO and prostacyclin is modulated by ECs in response to 
fluid shear stress and chemical stimuli (Knudsen et Frangos, 1997; Radomski et al., 1993). 
The ECs also bind to ectonucleotidases that hydrolyze ADP, which is an agonist of platelet 
activation (Michiels, 2003; Pearson, Carleton et Gordon, 1980). The EC surface has a brush-
like glycocalyx layer (0.4–0.5 μm in thickness), which consists of proteoglycans with 
glycosaminoglycan (GAG) side chains and glycoproteins bearing acidic oligosaccharides. 
The GAGs, such as chondroitin/dermatan sulfate proteoglycans and hyaluronic 
acid/hyaluronan (HA), are expressed by ECs, with heparan sulfate accounting for 50%– 90% 
of side chains. These molecules are negatively charged and effectively retain water and form 
a lubrication layer on the EC surface. There is evidence that heparin sulfate proteoglycans 
(HSPGs) can resist platelet adhesion (Hashi et al., 2007). Overall, the literature suggests that 
the healthy ECs exert antithrombotic activity by inhibiting coagulation and suppressing 
platelet aggregation. 
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Figure 1.8. (a) EC regulation of coagulation 
and (b) platelet adhesion and activation. Taken 
from (Li et Henry, 2011b). 
 
1.3 Surface modification for blood compatibility 
 
1.3.1 Low-fouling coatings 
 
 Biological "inertness" is a desired feature for designing implantable devices used in 
research and clinical applications (Boland et Weigel, 2006). The main principle of biological 
inertness is to reduce unfavorable immune responses to the foreign body or implantable 
device to the absolute minimum. Since surface-induced thrombosis continues to be a major 
problem, biomedical materials that prevent non-specific protein adsorption and cellular 
interactions are considered to be advantageous. Protein adsorption is the initial event that 
occurs when the material surface comes into contact with the biological environment and 
plays a critical role leading to thrombus formation. Therefore it is important to passivate the 
surface to reduce non-specific protein adsorption. Such protein-resistant surfaces also 
referred to as low-fouling or non-fouling surfaces. 
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 As mentioned in the previous section, protein adsorption to synthetic materials is 
largely dependent on the material’s surface chemistry. Over the past decades, various efforts 
were made to develop protein-resistant properties by chemical modification of the material 
surface (Kingshott et Griesser, 1999; Lee, Lee et Andrade, 1995; Roach, Farrar et Perry, 
2005; Shen et al., 2003). Whiteside's group and others extensively investigated the effect of 
surface functional groups on protein adsorption using self-assembled monolayers (SAMs). 
They described that the surface should possess four different surface characteristics to 
prevent protein adsorption: the surface should (1) be polar, (2) have hydrogen-bond 
acceptors, (3) have no hydrogen-bond donors and (4) be electrically neutral (Chapman et al., 
2000; Love et al., 2005; Ostuni et al., 2001). Although all the inert surfaces that they 
examined match these characteristics, not all inert surfaces do (Love et al., 2005). Since the 
interactions between protein and material surface are diversified, various methods have been 
developed to design protein-repellent surfaces (Higuchi et al., 2002; Zhao et al., 2003; Zhou 
et al., 2005). The most common strategy involves producing well-solvated polymer brushes 
on the surface and thus creating a high activation barrier for protein adsorption (Leckband, 
Sheth et Halperin, 1999). Several protein-resistant polymers were identified, including: 
Polyethylene glycol (PEG) (also referred as polyethylene oxide (PEO)) (Lee, Lee et Andrade, 
1995), poly 2-hydroxyethylmethacrylate (PHEMA), poly sulfobetaine and poly 
carboxybetaine methacrylate (Zhang et al., 2006), poly 2-methoxyethylacrylate (poly(MEA)) 
(Jin et al., 2009), polyacrylic acid (PAA) (Vermette et Meagher, 2002), polysaccharides 
(Osterberg et al., 1995), and poly(methacrylates) (Zhang et al., 2006). Of those polymers, 
PEG is the most widely used and investigated polymer for developing non-fouling or low-
fouling surfaces. Moreover, depending on surface charge and functional groups, PEG is 
known to possess most of the characteristics described by Whiteside's group (as described 
above). Since we use this polymer for creating low-fouling surfaces in this PhD thesis, PEG 
and its low-fouling mechanism is described in the following section. 
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1.3.1.1 Polyethylene glycol (PEG)  
 
 Polyethylene glycol (PEG) is crystalline, water-soluble (in room temperature), non-
toxic and a synthetic polymer and is available in a wide range of molecular weights. It is 
available in both linear and branched conformations, with a repeat unit of -CH2-CH2-O- and 
usually terminated on each end of the molecule by an -OH group. However, PEG is also 
synthesized with several other terminal groups, for example -OCH3, -OCH2, -NHS, and –
COOH. These terminal groups are helpful and important for covalent grafting onto 
biomaterial surface or conjugating with other molecules. Since PEG is highly water-soluble, 
it has a good structural fit with water molecules. As shown Figure 1.9, a strong hydrogen 
bonding exists between the ether oxygen atoms of PEG and hydrogen atoms of two water 
molecules. 
 
 
Figure 1.9. Schematic shows hydrogen 
bonding between ether oxygen atoms. 
Image adapted and modified from 
(Andrade et Hlady, 1986). 
 
PEG low-fouling mechanism 
 
 As explained earlier, surface modification with hydrophilic polymers, such as PEG, is 
a widely used method to reduce protein adsorption. Although several factors have been 
hypothesized for protein-resistant properties, two main mechanisms are described more often 
in the literature to explain PEG non-fouling properties. 
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Figure 1.10. Schematic view of (a) protein repulsion on hydrated polymer 
chains and (b) prevention of protein adsorption on PEG layer by excluded 
volume-steric repulsion. Image adapted from (Andrade et Hlady, 1986). 
 
 The first mechanism involves steric repulsion, especially for long chain polymers, 
which arises due to conformational freedom of the -C-C-O backbone of PEG and unrestricted 
rotation around the C-O bonds. When protein approaches the PEG-modified surface, the 
compression of the polymer chains causes an entropy loss and generates steric repulsion 
against proteins, and therefore polymer chains, effectively pushing proteins away from the 
surface (see Figure 1.10 b) (Jeon et Andrade, 1991; Jeon et al., 1991). The second 
mechanism is related to the hydration layer near the surface and the low interfacial energy at 
the PEG-water interface (Chen et al., 2000; Herrwerth et al., 2003; Zheng et al., 2005). The 
tightly bound water layer around polymer chains forms a physical and energetic barrier to 
protein adsorption. Expulsion of the water molecules from the polymer chain is the 
obligatory step to allow protein adsorption by reducing the free energy barrier arising from 
dehydration entropic effects (Chen et al., 2000). Although most of hydrophilic polymers are 
able to reduce protein adsorption, the best non-fouling ability can only be achieved when 
surface hydration and steric repulsion work together. It was speculated that both the steric 
repulsion and the hydration properties of PEG make it ideal for creating a non-fouling 
surface. 
 
 However, many other parameters influence protein adsorption on PEG-modified 
surfaces, such as polymer chain density, chain length, chain terminal groups-protein 
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interaction, protein-surface interaction and so on (Currie, Norde et Cohen Stuart, 2003). 
Among these, both PEG chain length and surface coverage are considered to be very 
important parameters affecting protein resistance (Currie, Norde et Cohen Stuart, 2003). 
Therefore, a surface modified with sufficiently high density and long PEG chains is able to 
resist protein adsorption very effectively. 
 
1.3.1.2 PEG immobilization 
 
 Several strategies have been proposed for PEG immobilization on material surfaces, 
including simple direct adsorption (Davis et Illum, 1988), radiation and chemical cross-
linking approaches (Graham et McNeill, 1984), and self-assembled monolayers (Yang, 
Galloway et Yu, 1999). Of those methods, the simple adsorption method is flexible and 
convenient, but its efficacy is limited by the tendency of PEG to elute off the surface 
(Gombotz et al., 1991). It has been demonstrated that a stable and efficient PEG coating can 
be achieved by covalent chemical grafting onto substrates (Demming et al., 2011). When 
PEG is covalently grafted onto the substrate through its terminal groups, depending on PEG 
density, three surface "regimes" may be distinguished (Gasteier et al., 2007), as shown in 
Figure 1.11. If the PEG grafting density is too low, the PEG will be grafted and displayed in 
a random coil conformation, known as the "mushroom regime”, where the PEG chains do not 
overlap. In this case, empty spaces exist between PEG molecules and therefore protein will 
adsorb on these open spaces. As the density increases, random coil conformation no longer 
exists, and PEG molecules must stretch to be accommodated in a given space. At a higher 
PEG grafting density, the distance between the chains is smaller than the radius of gyration 
and PEG chains will be completely stretched, and therefore the surface will be displayed in 
the "brush regime" (Figure 1.11). In this case, protein adsorption is prevented more 
effectively. However, it depends on the type of PEG used for grafting. For example, if the 
PEG is a homobifunctional polymer, there are great chances of both terminal groups 
interacting with the substrate. 
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Figure 1.11. Schematic shows three different PEG regimes, depending on the PEG 
chain density. The PEG conformation on the surface changes from non-overlapping 
"mushrooms" to fully extended "brushes" at different grafting densities. Image 
adapted and slightly modified from (Unsworth et al., 2005). 
 
 
1.3.1.3 Linear vs. branched polymers 
 
 As mentioned earlier, PEG can be synthesized in both linear and branched 
conformations or star-shaped structures (Irvine et al., 1998). Star-shaped molecules are 
defined as species consisting of a central core region with linear "arms" that are radiating 
outward from that core (Sofia, Premnath et Merrill, 1998). Star-shaped structures usually 
form at the junction of various linear molecules, which are referred to as the star arms (see 
Figure 1.12b). This junction forms the star core with arms extending out from the higher-
density core and the number and length of these arms can vary. Various groups synthesized a 
wide range of molecular weight star PEGs, with a great variety of arms per molecule (ranges 
from 4 arms to 70 arms/molecule) (Groll et Moeller, 2010; Irvine et al., 1998; Keys, 
Andreopoulos et Peppas, 1998; Kuhl et Griffith-Cima, 1996; Sofia Susan et Merrill Edward, 
1997). The structural variation of star PEG compared to linear PEG is advantageous for low-
fouling and bioactive coating on biomaterial surfaces. 
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Figure 1.12. Schematic diagram of a) a linear PEG molecule 
and b) an end-functionalized 4-arm star PEG. The circles 
represent end functional groups by which the molecules may 
tether to surfaces. Image adapted from (Irvine et al., 1998). 
 
 The presence of greater number of chains or arms, terminal groups and long chain 
length on star PEG enable higher surface grafting density compared to linear PEG. (Groll et 
Moeller, 2010; Kuhl et Griffith-Cima, 1996; Sofia Susan et Merrill Edward, 1997). Irvine 
and coworkers compared the effect of polymer architecture on surface concentration and 
protein adsorption using different molecular weights of star-shaped and linear PEGs. The 
grafting density for star PEG was found to be significantly higher than that of linear 
molecules (Irvine, Mayes et Griffith-Cima, 1996). It was also noted that, for similar chain 
lengths and molecular weights, star-shaped polymers possess higher grafting density 
compared to linear PEGs. Star PEGs are known to prevent the adsorption of large proteins 
(for example fibrinogen and albumin) more effectively compared to linear PEGs, which is 
due to greater steric repulsion arising from the large number of arms in star PEG (Sofia, 
Premnath et Merrill, 1998). However, star PEGs were also shown to allow a small amount of 
protein adsorption, especially smaller size proteins (for example cytochrome-c) (Sofia, 
Premnath et Merrill, 1998). It was suspected that this was due to lack of overlapping between 
star molecules, creating open spaces between star molecules that allowed the adsorption of 
smaller size proteins in small amounts (Sofia, Premnath et Merrill, 1998). It was suggested 
that increasing star PEG coupling concentrations during grafting would overcome steric 
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repulsion between star molecules and help to achieve tight packing of star PEG molecules on 
the surface and therefore achieve complete prevention of protein adsorption (Groll et al., 
2004a; Irvine et al., 2002; Satulovsky, Carignano et Szleifer, 2000). It was also demonstrated 
that a monolayer coverage of star PEG polymers with sufficient grafting density on the 
surface is able to prevent complete protein adsorption (Groll et al., 2004a; Groll et al., 
2005c), which may not be possible using linear PEG as most systems are using PEG SAMs 
to create complete low-fouling surfaces.  
 
1.3.1.4 Low-fouling polymers for bioactive coatings 
 
 In the last few years, there has been increasing interest in using low-fouling polymer 
as a spacer for the immobilization of small peptide sequences, growth factors and other 
biomolecules. The bioactivity of immobilized biomolecules can be increased on low-fouling 
surfaces compared to those immobilized on fouling surfaces. This is due to several reasons 
(see Figure 1.13): (i) It prevents non-specific adsorption of biomolecules and of proteins 
which would cover and hide the bioactive molecule. (ii) It prevents interaction of the other 
end of tethered biomolecule with the substrate. (iii) Tethered biomolecules stand out from the 
surface and are accessible for receptor binding due to the sterical hindrance effect of low-
fouling polymers (for example star PEG as shown in Figure 1.13). (iv) It offers 
conformational flexibility to the tethered biomolecules and makes them accessible to the 
receptors. As shown in Figure 1.13, the arms of star PEG always emanate outward from the 
core of the molecule due to the steric hindrance effect. Therefore the terminal groups are still 
available for further coupling with other molecules. This makes it possible to tether a greater 
number of biomolecules per star molecule (Groll et Moeller, 2010; Kuhl et Griffith-Cima, 
1996), which is not possible using linear PEG as it has only one end group available for 
coupling. Moreover, if the linear PEG is a homobifunctional polymer, it is possible that both 
the terminal groups would interact with the surface, leaving no available groups for further 
coupling. 
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Figure 1.13. Schematic view of the possible interactions and orientations of 
biomolecules when they are immobilized on (a) an amine-functionalized surface vs. 
(b) a 4-arm star PEG modified surface  
 
 Several studies have demonstrated improved bioactivity of immobilized biomolecules 
on PEG coated surfaces. Kim and co-workers immobilized heparin on a PEG spacer and 
showed improved bioactivity of heparin in terms of antithrombin binding compared to those 
surfaces prepared by direct immobilization of heparin (Byun, Jacobs et Kim, 1994). Others 
also showed high antithrombin binding of heparin and reduced fibrinogen adsorption when it 
is immobilized through a PEG spacer (Chen et al., 2005a; Xu et al., 2005). In another studies, 
a PEG spacer was used to improve the bioactivity of antibodies to detect antigens for 
biosensor applications (Sebra et al., 2005) and similarly for DNA hybridization in 
microarrays (Del Campo et Bruce, 2005). Several other studies also used PEG coatings to 
promote specific cell adhesion (Groll et al., 2005b; Hoffmann et al., 2006) and investigate 
cell interactions (Maheshwari et al., 2000) by immobilizing small peptide sequences such as 
RGD peptides and growth factors (Klenkler et al., 2008). Overall, the literature suggests that 
PEG coatings are useful for preparation of bioactive surfaces, which are helpful in 
developing biocompatible biomaterials for vascular graft applications.  
 
1.3.1.5 Limitations of PEG coatings 
 
 There are some limitations using PEG surfaces for low-fouling and bioactive 
coatings, which include: (i) PEG is very expensive to synthesize (ii) PEG coatings exhibit 
poor stability due to the rapid oxidization of PEG in the presence of oxygen and transition 
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metal ions. (iii) Some studies have shown that despite low protein adsorption on PEG 
surfaces, blood coagulation still occurs on these surfaces (Hansson et al., 2005a; Zhang et al., 
2008a). In vitro and in vivo studies by several groups have proved that PEG-coated 
cardiovascular materials significantly reduce platelet adhesion (Bernacca et al., 1998; Deible 
et al., 1999; Park et al., 2000; Ritter et al., 1998). However, most in vivo studies of PEG-
modified implants have been unsuccessful in limiting blood clot formation (Hansson et al., 
2005b; Nojiri et al., 1990a; Park et al., 2000). One explanation is that the PEG layers limit 
only individual platelet adhesion but not platelet aggregates that might form in blood away 
from the material surface (Park et al., 2000). Moreover, PEG coatings do not prevent material 
induced complement activation and blood coagulation (Andersen et al., 2013b). (iv) The non-
adhesive nature of high-density PEG coatings may be unfavorable for promoting confluent 
cell growth on the biomaterial surface (Klenkler et al., 2008). Altogether these limitations 
suggest that PEG coatings alone are not enough to improve patency of vascular implants; 
they must combine with biomolecules that promote desired cell adhesion and prevent blood 
clotting. 
 
1.3.1.6 Dextran for low-fouling coatings 
 
 Among low-fouling coatings, PEG polymers have attracted particularly strong 
attention because of their hydrophilic nature as well as their steric repulsion properties. 
Another class of molecules, such as polysaccharides (alginic acid, dextran and  chondroitin 
sulphate, etc), was also found to be highly wettable and able to produce low-fouling coatings 
(McArthur et al., 2000). These polymers are heavily hydrated, and hydrogels like structure 
and mobile molecular chains that offer a steric repulsion towards protein adsorption. Among 
polysaccharides, dextran coatings were found to be a good alternative to PEG coatings and 
its low-fouling properties were as good as PEG (Dubois, Gaudreault et Vermette, 2009; 
Michel et al., 2014; Monchaux et Vermette, 2007). These coatings have been investigated for 
a variety of biomaterials and biosensor applications (Marchant, Yuan et Szakalas-Gratzl, 
1994; Österberg et al., 1993; Toufik et al., 1995). The low-fouling mechanisms for dextran 
polymers are similar to the mechanisms described for PEG. Carboxymethylated dextrans 
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(CMDs) have been widely studied as their carboxylic terminal groups enable reaction either 
with surfaces or with bioactive molecules (Dubois, Gaudreault et Vermette, 2009; Liberelle 
et al., 2010; Massia, Stark et Letbetter, 2000). The most common methods of CMD grafting 
include covalent immobilization of carboxyl terminal groups onto the surface. This strategy 
was found to be efficient against protein adsorption and cell adhesion (Massia, Stark et 
Letbetter, 2000). Surface-bound CMD is known to provide more sites than PEG for further 
immobilization of biomolecules (for example small peptide sequences). However, CMD has 
random polymer chains, unlike star PEG (see Figure 1.14). Several studies used CMD as a 
spacer for the immobilization of RGD  (to enhance HUVEC adhesion) (Hadjizadeh et 
Doillon, 2010; Hadjizadeh, Doillon et Vermette, 2007), antibodies  (for ELISA test) 
(Liberelle, Merzouki et Crescenzo, 2013) and fibronectin (Dubiel et Vermette, 2012). 
 
 
Figure 1.14. Schematic shows (a) the chemical structure of dextran and (b) 
the configuration of surface-bound dextran polymer. Image adapted from 
(Massia, Stark et Letbetter, 2000). 
 
1.3.2 Surface modification with anticoagulants 
 
 While the low-fouling polymers such as PEG, CMD and other hydrophilic polymers 
are known to prevent protein adsorption and therefore reduce platelet adhesion and 
activation, they clearly do not reproduce the anti-thrombotic activity of EC. Alternatively, 
surface coating with anticoagulant molecules became a popular choice for inhibiting 
biomaterial-induced thrombosis and blood clotting. In particular, in the last few decades, 
heparin-coated surfaces have been widely investigated for the development of biomedical 
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materials with anticoagulant function. Therefore, here we focussed on surface modification 
using heparin molecules and other thrombin inhibitors.  
 Heparin sulfate is a linear polysaccharide with repeating units of alpha-D-
glucosamine and uronic acid (Mulloy, Mourão et Gray, 2000) containing clusters of O- and 
N-sulphated groups. Heparin is able to bind AT-III and causes a conformational change in 
the reactive center of AT-III to allow the inhibition of thrombin (see Figure 1.15). To some 
extent, heparin-AT-III complexes are also known to inhibit other coagulation factors such as 
Factors XIa, Xa, and IXa (Holmer, Kurachi et Soderstrom, 1981).  
 
 Several studies showed that surface modification with heparin could substantially 
reduce thrombus formation, both in vitro and in vivo (Huynh et al., 1999; Ritter et al., 1998; 
Walpoth et al., 1998). The heparinized vascular implants generally showed improved 
anticoagulant properties compared to unmodified implants. Several studies also showed 
prolonged blood clotting on heparin-modified synthetic polymers (e.g. poly(hydroxyethyl 
methacrylate) (PHEMA) and vinyl copolymers) (Baldwin et Kiick, 2010; Jao et al., 2010; 
Marconi, Benvenuti et Piozzi, 1997; Wang et al., 2011a). Heparin coatings are also currently 
being used for commercially available medical devices such as stents, oxygenators and 
vascular grafts, and many of these devices have been developed using the coating method 
developed by Larm et al. (Larm, Larsson et Olsson, 1983) (for example Carmeda® 
BioActive Surfaces (CBAS)). 
 
 Although the above-mentioned heparinized surfaces have been found to prolong 
clotting time, they do not prevent clotting completely, and it was also demonstrated that 
clinical success of heparin-coated surfaces has been rather limited (Gorman et al., 1996; Jain 
et al., 2009; Palatianos et al., 1983). These mitigated results for heparin could be explained 
by two reasons; (i) The antithrombotic action of heparin is based on its ability to bind 
antithrombin and its strong stimulatory effect on the neutralization of thrombin and Factor 
Xa (E. Niklason et S. Langer, 1997; Sacks, Schoen et Mayer, 2009). Therefore, maintaining 
the biological activity of heparin (i.e. the AT-III binding should remain accessible) is an 
important concern. Variations in heparin immobilization strategies may result in different 
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efficacy and clinical outcomes. (ii) The anticoagulant response to heparin is unpredictable, 
since the heparin–antithrombin complex is not able to inhibit fibrin-bound thrombin (Lytle et 
al., 1985). 
 
 Other sulfated glycoaminoglycans have also shown to exhibit anticoagulant 
properties. It is the case of chondroitin sulfate (CS) and sulfated hyaluronic acid which were 
shown to prevent thrombosis. (Keuren et al., 2003). Little is known about this question and 
the mechanism of action is not completely known, but it was found that the removal of 
sulfated groups decreased their anticoagulant activity (Mulloy, Mourão et Gray, 2000). It is 
thus suspected that the negative charge induced by sulfated groups causes electrostatic 
repulsion towards negatively charged blood components while wettability diminishes protein 
adsorption.  
 
 Several different strategies have been used for the immobilization of anticoagulant on 
biomaterials surfaces. They include ionic bonding, physical adsorption, bulk material 
incorporation, and covalent linkage. Stability of heparin coatings were found to be much 
higher for a covalent immobilization compared to other immobilization strategies. Covalent 
grafting can be achieved on a biomaterial surface by cross-linking reactions involving one of 
several functional groups (such as hydroxyls, carboxyls, or amines) that reside on the heparin 
chain. Covalent immobilization of heparin using a PEG spacer was shown to enhance the 
AT-III binding activity of heparin (Park et al., 2000; Tay et al., 1989) and maintain the 
patency of vascular grafts for 3 months in a canine model (Nojiri et al., 1990b). The 
improved biological activity of heparin when using a PEG spacer is most probably due to the 
reduction of non-specific protein adsorption and conformational flexibility. Therefore, the 
use of low-fouling spacers such as PEG or other polymers seems to be a more promising 
strategy for heparin immobilization and thus reducing blood clotting. 
 
 Despite widespread use of heparin to coat blood-contacting materials, it has a few 
limitations; (i) Heparin is unable to inhibit fibrin-bound thrombin. (ii) Heparin relies on the 
local presence of AT-III to exert its activity. (iii) Heparin has the ability to bind a wide range 
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of biomolecules that includes growth factors and matrix proteins, which could lead to other 
side effects and adverse immune reactions (Fairbrother et al., 1998; Neufeld et al., 1999a; 
Sakiyama-Elbert et Hubbell, 2000). It was thus demonstrated that heparin-coated stents could 
induce neointima formation due to the inflammatory response caused by heparin coating (De 
Scheerder et al., 1997; Goodwin et al., 2003).  
 
 
Figure 1.15. Schematic view of mechanism of action of 
immobilized heparin, hirudin, thrombomodulin (TM) and tissue 
factor pathway inhibitor (TFPI) to inhibit coagulation. Taken 
from (Li et Henry, 2011b). 
 
 In order to overcome the limitations of heparin, many groups have explored surface 
modifications using factors that directly inhibit thrombin or thrombin production. Among 
direct thrombin inhibitors, hirudin was found to be the most potent natural inhibitor. Hirudin 
is a small protein consisting of only 65 amino acids and originally derived from the 
medicinal leech. It forms a tight bivalent complex with thrombin, and this complex blocks 
both the active site and the fibrinogen-binding exosite of thrombin (Grutter et al., 1990; 
Schmitz, Rothe et Dodt, 1991). Furthermore, it is capable of inhibiting soluble thrombin as 
well as fibrin-bound thrombin (Figure 1.15). Several studies covalently attached recombinant 
hirudin (r-hirudin) to biomaterial surfaces and succeeded in significantly reducing thrombus 
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formation in vitro (Phaneuf et al., 1997; Seifert, Romaniuk et Groth, 1997; Wyers et al., 
1999). However, direct immobilization (without using any spacer) of hirudin through its N 
terminus has resulted in significantly reduced bioactivity compared to soluble hirudin. 
Selective attachment using the ε-amino acids was shown to be a good alternative to preserve 
the bioactivity of immobilized hirudin (Lahann et al., 2001). Again, the use of a PEG spacer 
and covalent immobilization through the C-terminus showed improved bioactivity of r-
hirudin and overall reduction of adherent and activated platelets. In vivo performance of the 
PEG-hirudin-treated vascular graft was shown to increase in patency at 6 months after 
implantation into rat carotid arteries (Hashi et al., 2010). The effect of immobilized hirudin 
on late stent thrombosis still needs to be investigated. Although hirudin coatings through the 
use of a PEG spacer seems to be a promising strategy, the complete prevention of blood clot 
formation has not yet been achieved. Alternatively, some groups are investigating (Sun et al., 
2001; Tseng et al., 2006) the use of TM and TFPI coatings to limit thrombin production 
(Figure 1.15) and further enhance the antithrombogenic properties of tissue-engineered 
implants  
 
 Overall the literature shows an interesting development towards bioactive anti-
thrombogenic surfaces and suggests that the use of a low-fouling spacer could help to 
improve the biological activity of anticoagulants such as heparin and hirudin. However, these 
surfaces do not reproduce the complete set of bioactivity observed with the native 
endothelium, as described in section 1.2.4. Moreover their long term efficiency is a concern. 
An alternative approach is to directly promote the growth of an endothelial layer for 
achieving perfect antithrombogenic surfaces because endothelium has the advantage of 
multifaceted activity in regulating thrombus formation and blood clotting. 
 
1.4 Modifying surface physico-chemical properties to promote cell adhesion 
 
 In order to improve surface properties of vascular materials, several research groups 
focussed on increasing surface hydrophilicity either by chemical (UV exposition or alkaline 
hydrolysis) (Mikulikova et al., 2005) or plasma treatments (ammonia or oxygen plasma 
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treatment) (Gigout et al., 2011; Lerouge et al., 2007; Pompe et al., 2007; Pu et al., 2002b; 
Ratner, 1995). These treatments introduce polar groups and charges on the surface. For 
example, TCPS and Primaria (routinely used for cell culture) are made by plasma treatments 
in order to create cell-adhesive surfaces. Such plasma-modified surfaces are hydrophilic and 
allow adsorption of adhesive proteins and can promote cell adhesion, spreading and growth 
(Gigout et al., 2011; Qu et al., 2005; Steele et al., 1994). Oxygen-rich surfaces exhibit 
negatively charged groups, while nitrogen-rich surfaces are positively charged at any 
physiological pH. In the presence of serum or blood plasma, the adsorption of Fn is 
responsible for initial cell attachment on nitrogen-rich surfaces (e.g, Primaria), whereas cell 
adhesion on oxygen-rich surfaces (e.g. TCPS) is mediated by Vn adsorption alone, because 
Fn is a negatively charged acidic protein that can abundantly adsorb on positively charged 
surfaces (Boura et al., 2005; Ertel, Ratner et Horbett, 1990; Steele et al., 1994).  
 
 Plasma treatments, particularly amine plasma polymerization, are widely used to alter 
biomaterial surface properties. In general, plasma depositions can change a variety of surface 
characteristics, including chemical, electrical, and mechanical properties (Siow et al., 2006). 
These treatments can provide sterile surfaces and can be scaled up to industrial productions 
(Ohl et Schröder, 1999). Nitrogen- and oxygen-based plasma depositions are commonly used 
to introduce a variety of functional groups such as hydroxyl, carboxyl, amine and aldehyde. 
There are two main advantages to using these techniques in the context of vascular graft 
applications: (i) improved cell-adhesive properties due to alteration of surface charge and 
increase in surface hydrophilicity; (ii) introduction of functional groups allowing chemical 
coupling of a variety of molecules such as hydrophilic polymers and biomolecules. 
 
 More recently, the team of professor Wertheimer (École Polytechnique) and Lerouge 
has developed a new range of primary amine-rich organic coatings via polymerization of 
ethylene (C2H2) and ammonia (NH3) operating at low-pressure (L-PPE: N) or atmospheric-
pressures (“high”, “HPPE:N”) (Truica-Marasescu et al., 2008). These coatings possess 
several advantages compared to simple plasma functionalization techniques; i) very versatile 
i.e. coatings can be deposited on any biomaterial surface, (ii) high nitrogen and primary 
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amine concentration (about 7%), iii) relatively low aging and iv) very good surface 
uniformity (Ruiz et al., 2010; Truica-Marasescu et al., 2008). L-PPE: N or H-PPE: N 
coatings on biomaterial surfaces, such as PET and ePTFE, were shown to promote HUVEC 
adhesion and retention for vascular graft applications (Gigout et al., 2011). These coatings 
were also used to promote VSMC adhesion and growth for stent graft applications (Lerouge 
et al., 2007). However such physico-chemical modifications of the surfaces promote non-
specific interactions through the adsorbed protein layer, leading to uncontrolled and 
unwanted interactions with blood and biological compounds. Therefore, many attempts are 
now made to promote more specific surface modification using bioactive biomolecules 
known to directly interact with cells and promote specific behavior. Thus, in Lerouge’s lab, 
the primary amine-rich L-PPE:N was used for the covalent immobilization of anti-apoptotic 
molecules, namely CS and Epidermal Growth Factor (EGF). These coatings showed 
enhanced VSMC adhesion, growth and resistance to apoptosis (Charbonneau et al., 2012). 
Other experiments showed that, interestingly, CS promotes VSMC adhesion while 
preventing EGF non-specific adsorption during grafting, indicating probable low-fouling 
properties (Lequoy et al. 2014). 
 
 More generally, there is a clear trend towards bioactive coatings to foster specific 
cell-surface interactions. In the following section, we discuss in detail the possibilities of 
improving surface biocompatibility using bioactive coatings. These can be combined with 
low-fouling coatings to help improving the biocompatibility of materials used for vascular 
implants. 
 
1.5 Bioactive coatings to promote cell adhesion and growth 
 
1.5.1 Coatings made of ECM proteins 
 
1.5.1.1 ECM and cell interactions 
 
 The ECM provides mechanical support and biochemical cues for cell adhesion and 
influences major cellular events such as migration, proliferation, differentiation and 
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apoptosis. The composition of the ECM ultimately determines which program will be 
selected for cellular events. ECM proteins, more particularly cell adhesive proteins 
(fibronectin (Fn), laminin (Ln) and vitronectin (Vn)), have many binding domains that can 
interact with cell surface receptors (see Figure 1.16) as well as with other ECM proteins. The 
specific amino acid sequence present within ECM molecules is responsible for binding with 
cell surface receptors and triggering intracellular pathways. Cell-ECM adhesions are 
mediated primarily by heterodimer proteins, known as integrins, which consist of α and β 
subunits. To date 18 α and 8 β subunits are known, which can associate to form 24 different 
heterodimers. The formation of different heterodimers from these complexes depends on the 
signals found on the ECM. However, each amino sequence present on the ECM is a signal 
for a specific integrin complex attachment site. For example endothelial cells (ECs) are found 
to interact with fibronectin through αvβ3 and α5β1 integrins (Brooks, Clark et Cheresh, 
1994; Stupack et Cheresh, 2004) whereas collagen type 1 and IV interact through α1β1 and 
α2β1 integrins (Panetti et al., 2004; Plow et al., 2000). 
 
 Once the ligand interacts with its specific receptor on the cell, it begins to spread or 
flatten on the interface. Integrins then form adhesion structures and relay signals to the cell 
nucleus by bridging proteins and actin fibres. If these signals are positive, integrin molecules 
that are attached to both the ligand outside of the cell and the cytoskeleton inside the cells 
(stress fibers and a number of other cell proteins, such as focal adhesion kinase, vinculin, 
talin, and tensin) cluster together in the plasma membrane and thus increase the area of cell 
adhesion to the substrate. The cascade of events finally leads to formation of focal adhesion 
contacts (Geiger et Bershadsky, 2001b; Petit et Thiery, 2000; Zamir et Geiger, 2001b). It is 
worth noting that the interaction between peptide ligands and integrins not only ensures the 
structural integrity of living cells, but also influences many aspects of cell responses such as 
migration, growth, differentiation and survival (Petit et Thiery, 2000). The coordination 
between integrin receptors and other receptors and their synergistic effects is further 
discussed in the combined immobilization section. 
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Figure 1.16. Schematic view of progression of anchorage 
dependent cell adhesion. (A) Initial contact of cell with solid 
substrate that has multiple binding domains. (B) Formation of 
bonds between cell surface receptors and ligands. (C) 
Cytoskeletal reorganization for increased adhesion strength. 
Taken from (Massia, 1999). 
 
1.5.1.2  Surface coating with cell adhesive proteins 
 
 Surface coating with the adsorption of several ECM proteins may promote cell 
adhesion, but it is an exceedingly complex phenomenon, the exact composition is not known 
and it is very difficult to control or reproduce (Ratner, 1993). Moreover, the adsorbed protein 
layer can undergo denaturation and proteolysis, which may affect the long-term performance 
of implanted biomaterials (Andrade et Hlady, 1986; Thomas et John, 1987). Hence, the use 
of individual components of the ECM such as Fn, collagen type I and IV would be more 
controllable and beneficial in designing or developing biocompatible materials. Surface 
coating with such individual proteins may be adequate enough to mimic physico-chemical 
features of tissue ECM and to promote cell interactions with the material surface. Since ECM 
proteins are large molecules and have several binding domains to interact with the surface, 
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surface coatings are usually performed via direct adsorption. Although covalent binding 
allows stable coupling, most systems rely on direct adsorption of ECM proteins. This might 
be due to the fact that it is difficult to control the orientation of proteins through covalent 
bonding (due to the presence of several binding groups on ECM proteins for coupling) 
(Petersen, Gattermayer et Biesalski, 2011), which leaves a significant fraction of binding 
sites inaccessible to cells and therefore loss of protein biological activity. Several ECM 
protein coatings on a different variety of surfaces and their influence on promoting cellular 
interactions are thus discussed in the following paragraph. 
  
 Fn is a widely used and investigated ECM protein for surface coating that was shown 
to enhance several types of cell adhesion, spreading and proliferation (Koenig, Gambillara et 
Grainger, 2003b). Such Fn coating was shown to promote the formation of focal adhesions 
and the organization of actin filaments into stress fibers through the interaction of integrin 
receptors such as α5β1 and αvβ3 (Underwood et Bennett, 1993). Similarly, collagen type I 
and type IV coating on PTFE was shown to promote EC adhesion and retention (Feugier et 
al., 2005; Ludwig et al., 2006) and induce EC migration to a higher extent than Fn (van 
Horssen et al., 2006), which is known to interact with integrin receptors α1β1 and α2β1 
(Underwood et Bennett, 1993). Another ECM protein, Laminin, was also shown to support 
EC adhesion and spreading, but to a lesser extent than Fn and collagen (Underwood et 
Bennett, 1993), with no formation of focal or even fibrillar adhesions (Vainionpaa et al., 
2006). 
 
 Although these proteins enhance the cell interactions with the surface, the underlying 
surface chemistry is known to influence protein density, conformation and spatial 
organization, which in turn affect cell attachment and subsequent cell behavior. Fn adsorbed 
on a hydrophilic surface supports higher EC adhesion and retention than when adsorbed on a 
hydrophobic surface. It has been reported that the protein exposes to a higher density of cell 
binding sites when bound to a hydrophilic substrate, therefore cells may form more bonds 
with the surface and lead to a higher cell adhesion strength (Burmeister et al., 1999; Iuliano, 
Saavedra et Truskey, 1993; Ugarova et al., 1995). Cell adhesion studies on Fn coating using 
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various surface chemistries (such as neutral, positive and negatively charged surfaces) 
showed that it can alter Fn conformation and influences subsequent integrin binding and its 
ability to support cell adhesion (Keselowsky, Collard et García, 2003). Changes in Fn 
conformation showed different binding affinity levels with α5β1 and/or αvβ3 integrins 
(Garcia, Vega et Boettiger, 1999; Keselowsky, Collard et García, 2005). Fn was found to be 
weakly bound and can be rearranged when it is adsorbed on hydrophylic negatively charged 
surfaces, which in turn allowed the N-terminal domain of Fn to interact with α5β1 integrins 
on EC and therefore increased focal adhesion. On the contrary, Fn was found to strongly 
interact with the surface and  could not be rearranged when it was covalently attached or 
adsorbed onto a hydrophobic surface (Pompe et al., 2003). EC attached on strongly bound Fn 
presented fewer focal adhesions than on weakly bound Fn (Pompe et al., 2007; Pompe et al., 
2003). The integrin binding ability of Fn and resulting cell behavior depended on surface 
pliability (Katz et al., 2000). For example, fibroblasts were attached to Fn through α5β1 
integrin when they were exposed to strongly bound Fn, whereas in the case of weakly bound 
Fn, cells were attached through αvβ3 integrin (Faucheux et al., 2006; Katz et al., 2000). 
Altogether, these studies suggest that it may be possible to improve cell interactions on ECM 
protein coated surfaces compared to unmodified biomaterial surfaces, but it is difficult to 
control and predict their orientation and their interactions with the cells.  
 
Limitations of using ECM proteins  
 
 Fibronectin coatings on ePTFE or Dacron were shown to be effective in enhancing 
endothelialization (Assmann et al., 2013; De Visscher et al., 2012). However, EC seeding 
should be performed in vitro before conduit implantation due to concerns regarding increased 
thrombogenicity (Parikh et Edelman, 2000). Similarly, collagen coatings were also shown to 
enhance EC attachment to ePTFE or Dacron (Kapadia, Popowich et Kibbe, 2008; Wissink et 
al., 2000b), but native collagen is intrinsically thrombogenic and it was shown to increase 
platelet attachment compared to uncoated ePTFE (Badimon et al., 1987). The other main 
limitation of ECM protein coatings is that it is difficult to reproduce surface coatings because 
their orientation and conformation is not predictable. Fibronectin or other ECM protein 
coating on biomaterials surfaces through the use of low-fouling polymers or spacers may 
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help to solve the issue of protein denaturation and nonspecific protein adsorption. However, 
it is not clear whether these immobilized proteins (via chemical coupling) are biologically 
active or not, since ECM proteins are large in size and posses multiple binding sites for 
chemical coupling that may lead to multiple interactions with low-fouling polymers or 
spacers (which may ultimately lead to abrogated biological activity) (Hersel, Dahmen et 
Kessler, 2003; Li et Henry, 2011b). 
 
 There are other limitations to using ECM proteins for vascular graft surface coatings. 
Since proteins have to be isolated and purified from other organisms, they may cause 
immune responses and infection risks. Proteins can undergo proteolytic degradation, which 
makes them impossible to use for long-term applications. The surface charge, wettability and 
topography may influence the conformation and orientation of the proteins, which causes a 
different presentation of cell reorganisation motifs (Altankov, Grinnell et Groth, 1996; Fields 
et al., 1998; Hlady et Buijs, 1996; Hyman, 1985; Iuliano, Saavedra et Truskey, 1993; 
Lewandowska et al., 1992; Lhoest et al., 1998; Underwood, Steele et Dalton, 1993). It was 
also recognized that the stochastic orientation of proteins on the surface means that only a 
part of the proteins have the proper orientation for cell adhesion (Elbert et Hubbell, 2001). 
 
1.5.2 Surface modification with peptides 
 
 Due to the limitations of protein immobilization on biomaterial surfaces, the use of 
smaller biomolecules, namely peptides and growth factors, has been proposed in order to 
elicit desired and defined cell interactions. Therefore, this section and the next section 
describes the rationale and methods for grafting peptides and growth factors on biomaterial 
surfaces. 
 
 Since the discovery that short peptide sequences within ECM protein are specifically 
recognized by cell receptors, small peptide fragments have been used for surface 
modification in several studies (Ferris et al., 1999; Ito, Kajihara et Imanishi, 1991; Mann et 
West, 2002; Patel et al., 2007; Petrie et al., 2008) in order to control elicited signals and 
subsequent cell behavior. In addition to providing binding specificity, the use of short peptide 
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fragments has several advantages over the use of native ECM proteins. Unlike native ECM 
proteins, the short peptide fragments are relatively more conformationally stable and they can 
be synthesized massively in laboratories more economically (Neff, Caldwell et Tresco, 
1998). Moreover, the short peptide fragments exhibit higher stability under sterilization 
conditions (Weiß, Klee et Höcker, 2001), heat treatment, pH-variation (Ito, Kajihara et 
Imanishi, 1991) and storage conditions (Boxus et al., 1998). Small peptide fragments are 
known to be stable against enzymatic degradation and therefore they can be used for long-
term applications. Since the peptide fragments need less space than ECM proteins, they can 
be packed with higher density on surfaces. Small peptide sequences represent only one motif 
that can selectively address a specific type of cell adhesion receptor, whereas ECM proteins 
have several binding domains that can address adhesion of several cell types. 
 
 As an alternative to whole ECM protein, the small peptide sequence Arg-Gly-Asp 
(RGD) was used in numerous studies to promote cell interactions on biomaterial surfaces. 
This peptide sequence is present in various adhesive proteins such as fibronectin (FN), 
vitronectin (VN) and laminin (LN). It has been recognized that about half of the 24 integrins 
(α3β1; α5β1; α8β1; αIIbβ3; αvβ1; αvβ3; αvβ5; αvβ6; αvβ8; and to some extent α2β1 and 
α4β1) can bind with RGD sequences (Pfaff, 1997). Therefore RGD is known to promote 
adhesion of almost all cell types (Hersel, Dahmen et Kessler, 2003). Several other cell-
adhesive motifs such as Tyr-Ile-Gly-Ser-Arg (YIGSR), Arg-Glu-Asp-Val (REDV), Lys-Gln-
Ala-Gly-Asp-Va (KQAGDV) and Ile-Lys-Val-Ala-Val (IKVAV) are also able to stimulate 
adhesion of several cell types when immobilized on biomaterial surfaces (Ranieri et al., 
1995). Interestingly, some of them are recognized to promote selective cell adhesion. For 
example, KQAGDV, used in this PhD thesis, is known to interact specifically with VSMC 
(Dong et al., 2012b; Mann et West, 2002). This is due to the fact that the cell adhesion of 
KQAGDV is mediated through the single motif, α2bβ3 integrin and it may be specific for the 
receptor of VSMCs (Dong et al., 2012a). Similarly, there are several other peptide sequences 
that promote selective cell adhesion. The selective synthetic peptide sequences and their 
specificity for cell adhesion are listed in Table 1.2. 
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 Although small peptide sequences are known to promote cell adhesion, their 
presentation on biomaterials surface is an important factor in making them accessible for cell 
adhesion receptors. Therefore different immobilization methods are discussed in the 
following section. 
 
Table 1.2. Selective synthetic peptide sequences of extracellular matrix proteins and 
their functions. Taken from (Shin, Jo et Mikos, 2003). 
 
 
1.5.2.1 Peptide immobilization or coupling methods 
 
 A variety of materials such as glass (Dee, Andersen et Bizios, 1998; Dee, Anderson et 
Bizios, 1999; Mann et West, 2002), quartz, metal oxide (De Giglio et al., 2000; Dong et al., 
2012a; Rezania et al., 1999), and polymers (Massia et Hubbell, 1990b; Sabra et Vermette, 
2011; Tugulu et al., 2007) have been modified with small synthetic peptides and 
characterized to determine their interaction with cells. The covalent chemical coupling 
method is known to offer stable coating and is the most widely used method for modifying 
surfaces with peptides. It was also recognized that cell attachment on covalently linked RGD 
peptide leads to an increase in expression of integrins and focal contact formation 
(Cavalcanti-Adam et al., 2002; Grigoriou et al., 2005). 
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 In the literature, several different coupling techniques have been employed. However, 
the most common approach involves stable covalent amide bonding between COOH 
functional groups on the material surface and the NH2 functional group (N-terminus of the 
peptide) on peptides. This type of reaction is usually performed by either the single step or 
the two step method. The single step method involves activation of carboxylic groups using a 
water-soluble coupling reagent such as 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide 
(EDC). However, there are two problems using this method. Firstly, multiple reactive groups 
are present on the peptide, which leads to multiple binding with the surface, and the peptide 
may lose its biological activity. For example, as shown in Figure 1.17, RGD peptide has 
COOH functional groups on C- terminus as well as in the aspartic acid side chain. Similarly, 
it has NH2 functional groups in the N-terminus as well as in the arginine side chain. The 
second problem is that the activated carboxylic groups (by EDC) can be deactivated quickly 
by hydrolysis. In order to overcome this problem, some studies proposed blocking the 
reactive amino acid side chains using protecting groups (which can be done prior to coupling 
with the substrate). This method was used successfully to bind RGD peptides on polymers 
(Lin et al., 1994; Lin et al., 1992; Quirk et al., 2001), as shown in Figure 1.18. However, the 
major drawback of using this method is that it requires harsh conditions for deprotection of 
blocking groups, which may hamper the biological activity of the peptide.  
 
 
Figure 1.17. The chemical structure and 
nomenclature of RGD peptide. Image adapted 
from (Hersel, Dahmen et Kessler, 2003). 
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Figure 1.18. Coupling of a protected RGD peptide 
through its N-terminus to a surface carboxyl group 
and deprotection of the blocking groups. Image 
adapted from (Hersel, Dahmen et Kessler, 2003). 
 
 As an alternative to this method, a two-step method was proposed. This method 
involves the activation of carboxylic groups using DCC or EDC and subsequent reaction 
with NHS (Jo, Engel et Mikos, 2000). It prevents quick hydrolysis of activated carboxylic 
groups, since the half-life time of NHS active esters ranges between several minutes and  an 
hour at neutral pH (Besselink, Beugeling et Bantjes, 1993; Morpurgo, Bayer et Wilchek, 
1999). Such NHS-activated surfaces can also be stored (not in the presence of solution or 
exposure to air but in specific conditions) for several months and the best conditions for 
peptide coupling to this ester are at pH 8-9 using sodium bicarbonate or phosphate buffer 
(Hern et Hubbell, 1998; Morpurgo, Bayer et Wilchek, 1999). The peptide coupling using this 
procedure is usually for 1-2 h, however, more elevated pH conditions and high concentration 
buffers (or salts) can reduce the half-life time of NHS-activated ester to less than several 
minutes or even less than 1 minute (Morpurgo, Bayer et Wilchek, 1999). The advantage of 
using this method is that it does not require protecting groups when using COOH displaying 
surfaces. Since it is a two step procedure, the surface is activated with NHS/EDC prior to 
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RGD coupling. Therefore, in this procedure, the aspartate side chain carboxyl group is not 
activated for coupling and the nucleophilicity of the arginine side chain is nearly abolished 
due to protonation in water (Hermanson, 2008). In order to increase the yield of peptide 
bonding, in some studies coupling was performed at low pH conditions and long coupling 
times (Beer, Springer et Coller, 1992; Dai, Belt et Saltzman, 1994; Hirano et al., 1993; Jo, 
Engel et Mikos, 2000) and using excess peptide (Hern et Hubbell, 1998). 
 
Peptide immobilization using a spacer or linker 
 
 The use of spacers became a popular method for peptide immobilization, as it offers 
flexibility to the immobilized peptide in the biological environment (Rezania et al., 1999) 
and helps the cells to access the peptides. This method involves exploiting the 
heterobifunctional cross linker. In this approach, the thiol group (-SH) on peptide is usually 
linked to a maleimide functionalized surface (as shown in Figure 1.19) via a 
heterobifunctional linker (for example sulfosuccinimidyl 4-(N-maleinimidomethyl) 
cyclohexane-1-carboxylate (Sulfo-SMCC)) (Lateef et al., 2002; Stile et Healy, 2001), which 
enables peptide coupling through disulfide bonding. The major advantage of using this 
method is that it does not interrupt either N- or C-terminus of the peptide.  
 
 
Figure 1.19. Reaction scheme between maleimide group on the 
surface and thiol functional group on peptide. Image adapted from 
(Hersel, Dahmen et Kessler, 2003; Lateef et al., 2002). 
 
 When peptides are directly grafted on biomaterials, peptides may be covered by a 
layer of adsorbed proteins, the same as for a normal surface. Thus minimizing non-specific 
protein adsorption is an important criterion while immobilizing a peptide or any other 
biomolecules in order to elicit the desired signals and subsequent cell responses. In such 
cases, peptides can usually be immobilized using low-fouling spacers that can limit non-
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specific protein adsorption and enable peptide sequences to freely extend outward from the 
network. In order to achieve this, several studies performed peptide immobilization using 
various low-fouling polymers such as PEG (Fittkau et al., 2005; Hern et Hubbell, 1998), 
polysaccharides (Massia et Stark, 2001; Murugesan et al., 2002; Sagnella et al., 2004), and 
phospholipid bilayers (Dillow et al., 2001; Pakalns et al., 1999b). Again, covalent 
immobilization is the method of choice for peptide immobilization on low-fouling polymers. 
This is usually achieved by linking carboxyl groups or maleimide groups on low-fouling 
polymer and amine-displaying groups on the N-terminus of the peptide (as described above).  
 
1.5.2.2 The effect of peptide density and presentation on cell adhesion 
 
 The peptide surface concentration may be related to the number of cells attached to 
the surface. Cell adhesion as a function of RGD peptide density showed a sigmoidal increase 
(Danilov et Juliano, 1989; Jeschke et al., 2002; Kantlehner et al., 2000; Neff, Tresco et 
Caldwell, 1999). It was also demonstrated that a higher peptide density is also related to cell 
spreading, focal contact formation, survival and to some extent cell proliferation (Kantlehner 
et al., 2000; Mann et West, 2002; Massia et Hubbell, 1990a; Neff, Tresco et Caldwell, 1999). 
Some studies showed the required minimum peptide concentration to induce cell attachment, 
cell spreading and focal contact formation by using substrates of covalently grafted peptides 
(Drumheller et Hubbell, 1994; Hubbell, Massia et Drumheller, 1992; Massia et Hubbell, 
1991). One study indicated that at least 1 fmol/cm2 of peptide density is necessary for 
fibroblast spreading and 10 fmol/cm2 of surface density is required for cytoskeleton 
formation (Massia et Hubbell, 1991). However, the required concentrations were higher 
when RGD peptide was grafted on poly (acrylic acid) hydrogel via a PEG spacer, which was 
12 fmol/cm2 for cell spreading and 66 fmol/cm2 for focal contact formation (Drumheller, 
Elbert et Hubbell, 1994). These results indicate that high peptide density is required when 
using low-fouling coatings. Some other study also investigated the relation between peptide 
density and cellular response using PEG-based hydrogels. These results showed that the 
intermediate concentrations (2.8-7 µmol/mL) of incorporated peptide promoted cell adhesion 
and spreading without hampering  migration, proliferation and matrix production of smooth 
muscle cells (Mann et West, 2002). It seems a dose-dependent increase in cell response may 
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depend on the type of cell line and polymer used for peptide immobilization. Moreover, 
using low-fouling polymers may be unpredictable due to sterical hindrance effect of low-
fouling polymers. 
  
 Surfaces with high peptide density may enhance cell adhesion, but they may impede 
cell migration and proliferation. EC adhesion, spreading and focal adhesion formation were 
shown to increase with RGD peptide density. However, EC migration was maximum at 
intermediate concentration of RGD (Hern et Hubbell, 1998; Lin et al., 2001; Mann et West, 
2002; Murugesan et al., 2002; Pakalns et al., 1999a; Smith, Elkin et Reichert, 2006). This 
might be due to the fact that at low-peptide/ligand density cells cannot form new focal 
adhesion at leading edge efficiently, while at high density cells cannot break focal adhesion. 
Overall these observations suggest that it is not possible to generalize the impact of peptide 
density on promoting cell adhesion, but in general, high peptide density may be 
advantageous for cell attachment but not for cell migration and proliferation. It seems 
surfaces need to be activated with other factors such as growth factors, since GFs are known 
to promote cell migration and proliferation (Neufeld et al., 1999b; Nolan et al., 2004). 
 
  As mentioned earlier, low-fouling coatings help to improve the bioactivity of 
immobilized biomolecules. In addition, when using star shaped low-fouling polymers for 
peptide immobilization, they have been shown to promote integrin clustering. Before 
describing this advantage, it is important to understand the mechanism of integrin-mediated 
cell adhesion, which is explained in the following paragraph.  
 
 A cascade of four different overlapping events such as cell adhesion, organisation of 
cytoskeleton and focal contact formation are involved in the process of integrin-mediated cell 
adhesion (LeBaron et Athanasiou, 2000): (i) The initial cell attachment to the surface through 
ligand binding allows cells to withstand gentle shear forces. (ii) Then, the cell body begins to 
flatten and spread over the substrate. (iii) Cell spreading leads to actin organisation into 
microfilament bundles, also referred to as stress fibers. (iv) Finally, focal contact formation 
will occur, which will link ECM molecules of the actin cytoskeleton. The clustered integrins 
and more than 50 other transmembrane associated molecules are involved in focal adhesion 
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(see Figure 1.20), in which tetraspanins, growth factor receptors, syndecans, lipids, tensin, 
talin, vinculin, paxillin, and focal adhesion kinase (FAK) were identified (Geiger et 
Bershadsky, 2001a; Pande, 2000; Petit et Thiery, 2000; Zamir et Geiger, 2001a). These 
events describe the importance of integrin clustering for focal contact formation and 
therefore strong cell attachment on the surface.  
 
 
Figure 1.20. Schematic representation of how integrin-
mediated activation regulates the cell/substrate interaction 
(Owen et al., 2005). 
 
 Therefore, integrin-mediated cell adhesion not only depends on receptor occupancy, 
but also depends on integrin clustering. The linked fibrils of the ECM account for a complex 
network conducive to receptor occupancy as well as integrin clustering. It was demonstrated 
that different cell responses on peptide-modified surfaces are not only due to different 
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surface concentrations, but also depend on the method of presentation (Irvine, Mayes et 
Griffith, 2000). Maheshwari et al. compared fibroblast cell response when peptides presented 
in a clustered versus random individual fashion (Maheshwari et al., 2000). In order to 
achieve controlled peptide density and controlled spatial ligand distribution, RGD peptides 
were functionalized on branched/star PEG polymer. An average of 1, 5 and 9 peptides per 
star molecule were immobilized to achieve an overall surface concentration range of 0.15-
20.5 nmol/cm2. A significant fraction of fibroblasts showed enhanced shear stress resistance, 
well-formed stress fibers and focal contact formation on RGD clusters compared to the 
individual format. Few other studies also showed a similar trend when RGD was 
immobilized on embedded PPMA latex or comb polymers (Irvine, Mayes et Griffith, 2000; 
Irvine et al., 2001; Koo et al., 2002). 
 
 
 
Figure 1.21. Schematic illustration of RGD 
presentation on star polymers. (A) The same amount 
of ligands presented in homogeneous (top) versus 
ligands presented in discrete clusters (bottom).Image 
adapted from (Maheshwari et al., 2000). 
 
 Overall the literature suggests that the presentation of peptide on the surface and its 
concentration are important factors for eliciting desired cell interactions. However, it is not 
clear whether high grafting densities have a negative impact on other cellular events such as 
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cell migration and proliferation. When using low-fouling surfaces, it is important to cover the 
surface with high peptide densities, otherwise complete cell coverage may not be achieved on 
these surfaces. If high peptide densities are problematic for promoting other cellular events 
such as cell migration and proliferation, co-immobilization of peptides and growth factors 
may help to achieve optimal cell interactions on biomaterial surfaces. 
 
1.5.3 Surface modification with growth factors 
 
 Growth factors are soluble polypeptides, produced naturally by many cell types, that 
are capable of instructing specific cellular responses in a biological environment. Growth 
factor signaling can result in a very wide range of cell actions such as cell survival, control 
over migration, and differentiation or proliferation of a specific subset of cells. These actions 
may occur through autocrine (produced by and acts on the same cell type) and juxtacrine 
(acts on neighbouring cells) or paracrine (produced by and acts on different cell types) 
mechanisms (Douglas A. Lauffenburger, 1993). The biological functions and roles of growth 
factors will be altered when they are present in the ECM, since ECM contain numerous 
components such as adhesive molecules, notch signaling molecules, and proteoglycan 
molecules, which can modulate the activity of a number of growth factors (Cao et al., 2009; 
Discher, Janmey et Wang, 2005; Ramirez et Rifkin, 2003). As shown in Figure 1.22, the 
producer cell secretes growth factors and initiates the signal transmission mechanism. The 
growth factor binds to specific transmembrane receptors (which are referred as 
transmembrane glycoproteins, belonging to either the receptor tyrosine kinase (RTK) or G-
protein-coupled receptor (GPCR) families (Sorkin et Von Zastrow, 2002)) of the target cell 
and translates instructions to the cell nucleus through the cascade of events involving 
cytoskeleton protein phosphorylation, ion fluxes, changes in metabolism, gene expression, 
protein synthesis and ultimately an integrated biological response (Cohen, Ren et Baltimore). 
 
 The receptor activation may also lead to phosphorylation of Akt, a kinase involved in 
antiapoptotic signaling (Yanai et al., 2002), and alteration of cell morphology and motility 
through association with the actin cytoskeleton. Binding of growth factors to the ECM leads 
to sequestration or controlled release of growth factors and may regulate or enhance their 
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effect on cellular interactions (Dinbergs, Brown et Edelman, 1996). The growth factor 
stimulation induces cells to produce or alter the surrounding matrix, and promotes migration 
on the ECM through enhanced integrin expression or cytoskeletal interactions (Maldonado et 
Furcht, 1995).  
 
 
 
Figure 1.22. Cross talk between cells mediated by growth factors and ECM. 
Insert illustrates how ECM can control growth factor presentation in a 
temporal and spatial fashion. Taken from (Lee, Silva et Mooney, 2011). 
  
 The relationship between growth factor signaling and specific cellular response is not 
yet well understood. On the one hand, the same growth factor can convey different 
instructions, depending on the receptor type and cell type to which it binds. On the other 
hand, the same receptor can translate different messages depending on the intracellular 
transduction pathways, which can differ from one cell type to another (Lamalice, Le Boeuf et 
Huot, 2007; Lee, Silva et Mooney, 2011). 
 
 It was recognized that two waves of growth factor-dependent signaling events were 
required for a proliferative response, one occurring immediately after growth factor 
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stimulation and the other post stimulation (Jones et Kazlauskas, 2000). The former is known 
as acute burst signalling, which does not persist longer than 60 minutes. It was noted that the 
cell silences this signalling cascade in different ways, such as receptor internalization and 
degradation, as well as the appearance of enzymes (which antagonize the signaling enzyme). 
After completion of acute burst signaling, the post stimulation triggers the cell cycle program 
through the exposure of growth factor to the receptor for 8-10 h, which involves activation of 
cyclin-dependent kinases (Cdks). It was shown that fibroblasts require at least 8 h continuous 
exposure to growth factor to engage the cell cycle program (Pardee, 1989). It seems that 
early burst signaling is insufficient for cell cycle progression, and there must be additional 
inputs made by growth factor at later time points. Therefore it is important to note that cells 
require continuous exposure of growth factors at least for 8-10 h in order to complete cell 
cycle progression. 
 
1.5.3.1 Epidermal Growth Factor (EGF)  
 
 Among the various growth factors involved in vascular repair, epidermal growth 
factor (EGF) is of particular interest, since it was known as a potent mitogenic and 
chemotactic factor for VSMC (Miyagawa et al., 1995; Raab et Klagsbrun, 1997; Reape et al., 
1997) and was previously shown to enhance VSMC growth (Major et Keiser, 1997; 
Reynolds et al., 2002). It is worth noting that promoting VSMC growth and resistance to 
apoptosis is prerequisite for developing stent grafts that are used to repair EVAR.  
 
 EGF is one of the most stable and biologically potent growth factors known to date. It 
is a globular, water-soluble and 6 kDa polypeptide comprised of a single chain consisting of 
53 amino acids (Carpenter et Cohen, 1979; Holladay et al., 1976; Lee et Park, 2002). The 
primary structure of human EGF as shown in Figure 1.23. EGF has an isoelectric point of 4.6 
and it is known to be negatively charged under physiological pH conditions (Taylor, Mitchell 
et Cohen, 1972). 
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Figure 1.23. Primary structure of human epidermal growth factor (EGF). 
Adapted from (Carpenter et Cohen, 1979). 
 
EGF receptor binding and signaling pathways 
 
 EGF binds to both low and high affinity sites on cells expressing the EGF receptor 
(EGFR) (Jorissen et al., 2003). This receptor consists of the intracellular domain as well as 
the extracellular domain, which are linked in the native protein by a single membrane-
spanning segment (Jorissen et al., 2003; Lax et al., 1991). The former is for expressing its 
protein tyrosine kinase activity and the latter is for binding its ligand (EGF). Signal 
transduction is initiated through the binding of EGF to the extracellular domain of the 
receptor that contains a two-cysteine-rich region (see Figure 1.24). The EGF receptor (ErbB) 
family consists of four closely related tyrosine kinase transmembrane receptors such as 
ErbB1/ EGFR, ErbB2/HER2/neu, ErbB3/HER3, and ErbB4/HER4 (Normanno et al., 2005). 
However, EGF binds exclusively with ErbB1 whereas ErbB2 acts as a co-receptor. Binding 
EGF to corresponding receptors leads to formation of a ligand-receptor complex and 
therefore leads to hetero-dimerization of the receptor. 
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Figure 1.24. (A) Schematic representation of EGFR domain structure of 
the extracellular and intracellular regions. (B) Hetero-dimerization of the 
EGFR and Erb B2 upon receptor activation. Image adapted and redrawn 
from (McInnes et Sykes, 1997). 
 
 This results in the activation of the intracellular kinase domain leads to 
autophosphorylation of tyrosine residues (Sherrill et Kyte, 1996). These (tyrosine 
phosphorylated) sites allow the binding of proteins containing the Src Homology 2 (SH2) 
domain, which consists of intracellular docking proteins or adaptor proteins such as Grb2, 
Nck and Shc. These proteins associate with other proteins, resulting in the activation of 
serine–threonine kinases that phosphorylates serine or threonine residues on transcription 
factors (Olayioye et al., 2000). This resulting kinase cascade leads to amplification of a 
network of signaling pathways, which eventually leads to changes in protein functions and 
activation of gene transcription. These changes also interact with the apoptotic signaling 
pathways (see Figure 1.25) preventing cell death. This cascade of events is crucial to a 
variety of cellular responses, such as cell proliferation, migration, and differentiation 
(Carpenter et Cohen, 1990; Earp et al., 1995). 
 
59 
 
Figure 1.25. Schematic representing the pathways which lead 
to the activation of anti-apoptotic proteins (white) and the 
inactivation of pro-apoptotic proteins (black). Taken from 
(Srokowski et Woodhouse, 2013). 
 
1.5.3.2 EGF tethering to implant surface 
 
 A suitable method is required to deliver EGF to the surrounding cells and therefore 
direct cellular response to a biomaterial surface. The delivery of growth factor can be 
achieved through different methods including from solution, by controlled release, simple 
adsorption and chemical immobilization to the biomaterial surface. The mechanism of 
delivery must allow the growth factor to occupy the receptor for a sufficient length of time to 
effect cell cycle progression (Douglas A. Lauffenburger, 1993; Jones et Kazlauskas, 2000), 
as mentioned above. Immobilization of growth factor is expected to result in improved 
control of its concentration and delivery compared to its soluble form because the 
immobilization procedure inhibits the internalization of growth factor as shown in Figure 
1.26 (Ito, Kajihara et Imanishi, 1991). Normally cells decompose the biosignal molecules to 
reduce their stimulation. This phenomenon is called down-regulation. The immobilization 
method was considered to inhibit this down-regulation and therefore the stimulation 
continues for a long time.  
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 It is worth noting that the simple adsorption method is convenient but not preferable, 
since it leads to changes in growth factor conformation and is therefore inaccessible to the 
receptors present on cells. 
 
 
Figure 1.26. Schematic illustration of the interaction between cells and native (a) 
and immobilized (b) growth factors (Ito, Kajihara et Imanishi, 1991). 
 
 Growth factor attachment must be performed in a manner such that the receptor 
binding and resulting biological activity of the growth factor is preserved. This may be 
accomplished by the covalent immobilization method, which involves the creation of one or 
more covalent bonds between the growth factor and the surface, with or without using a 
polymer linker. Immobilization of growth factor on solid substrate via a polymer linker is 
known as tethering. Kuhl and Griffith-Cima showed that EGF retained its activity in 
promoting DNA synthesis in rat hepatocytes when EGF was tethered to glass substrates 
using a PEG spacer (Kuhl et Griffith-Cima, 1996). Other studies also showed enhanced 
growth factor activity when they immobilized on PEG hydrogels compared to growth factors 
in soluble form (Bentz, Schroeder et Estridge, 1998; Gobin et West, 2003a; Mann, 
Schmedlen et West, 2001). The use of a PEG spacer is believed to enhance the flexibility and 
therefore accessibility of the growth factor to the cellular receptor (as shown in Figure 1.27). 
However, PEG’s steric hindrance effect and non-adhesive nature may hamper cell growth, as 
observed by Klenkler et al. studies (Klenkler et al., 2008). 
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Figure 1.27. Schematic illustration of EGF accessibility to the 
cellular receptor when it is tethered to a substrate material via 
flexible polyethylene glycol chains. Taken from (Ito, 1998). 
 
 In the literature, the most common approach for covalent immobilization involves 
bonding though carbodiimide chemistry between carboxyl groups on the substrate and amine 
groups displayed on N-terminus or on the side chains of lysine residues of EGF. Although 
this approach is convenient, it causes improper orientation of EGF due to the presence of 
multiple amine-displaying groups (Carpenter et Cohen, 1990). This type of immobilization, 
also known as non-oriented or random immobilization, leads to heterogeneous ligand 
populations, poorly reproducible and therefore inefficient, and optimal cell interactions could 
not be achieved.  
 
 Other covalent immobilization alternatives involve exploiting thiol groups and 
disulfide bonding between ligand and surface functional groups (O'Shannessy, Brigham-
Burke et Peck, 1992). This method is more common for the immobilization of small peptide 
sequences, where an engineered cysteine is added to the original peptide sequence during 
synthesis and the surface is activated with the cross linker that contains maleimide groups. 
However, this method is not appropriate for EGF tethering because it has a negative impact 
on bioactivity due to a wrong disulfide bridge during folding. 
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 Another method of choice is exploiting the specific interaction between streptavidin 
and biotin reactive linkers. This strategy involves biotinilation of the protein and subsequent 
immobilization onto spretavidin coated surfaces. This method, also referred to as ligand 
affinity capture, is not strictly covalent, but high affinity interaction between biotin and 
streptavidin is irreversible (Blackburn et Shoko, 2011; De et al., 2000). This method is 
becoming a popular choice because it offers oriented and stable immobilization and 
homogeneity of ligand population . 
 
 The concept of oriented immobilization was also investigated by our team in De 
Crescenzo's lab, by taking advantage of a de novo designed coiled-coil system. The coiled-
coil system is composed of two distinct peptides, namely E and K coils, that were originally 
designed by Hodges and Co-workers (Chao et al., 1998; Chao et al., 1996). The K peptide is 
made of a unique repeating heptad with the sequence K-V-S-A-L-K-E, and similarly the E 
peptide consists of repeating heptad with the sequence E–V–S–A–L–E–K. When the E and K 
peptides associate, they specifically heterodimerize to form a well-defined coiled-coil 
structure. The E and K coils were shown to interact through hydrophobic and electrostatic 
interactions with high affinity, and the resulting coiled-coil complex is stable at wide range 
of pH and salt concentrations. The hydrophobic residues V and L (at positions a, a', d and d') 
of E/K coils are responsible for hydrophobic interactions, which tend to favor a dimeric 
conformation and therefore formation of a stable coiled-coil complex. Electrostatic attraction 
(at positions g-e' or g'–e) further stabilizes the E/K coiled-coil through E and K interchain salt 
bridge formation as shown in Figure 1.28. 
 
 The main advantage of the coiled-coil system is that it is ideal for immobilizing 
proteins or growth factors in an oriented manner at the biomaterial surface. In order to 
achieve this, one E/K coil peptide should be chemically conjugated to growth factor or 
protein and subsequently immobilized onto the surface that is previously activated (via 
covalent immobilization using a cross-linker) with the other coil peptide. More recently, our 
team in De Crescenzo's lab has tested and successfully demonstrated EGF immobilization 
onto amine- and carboxyl-displaying surfaces using the coiled-coil system. To accomplish 
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this, E coil EGF was produced in human embryonic kidney (HEK) 293 cells and its 
bioactivity was confirmed on human epidermoid carcinoma (A-431) cell lines (Boucher et 
al., 2008a) and Cysteine tagged K coil (Cys-Gly-Gly-K coil) produced as described in (De 
Crescenzo et al., 2003) and was demonstrated to be efficient for the stable and oriented 
capture of coil tagged proteins. Thiol groups on the cysteine molecule of K coil were 
exploited for immobilization onto amine-displaying or carboxyl-displaying surfaces using an 
LC-SPDP or EMCH cross-linker. Therefore, E/K coiled-coil was achieved through high 
affinity interaction between K coil and E coil EGF (See Figure 1.29). 
 
 
Figure 1.28. Helical wheel representation of the heterodimeric parallel E/K 
coiled-coil, which shows hydrophobic interaction between V and L residues 
(at positions a, a', d and d') and electrostatic interchain interactions between E 
and K residues (at positions e-g' and g-e') that forms E/K salt bridge. Taken 
from (Chao et al., 1998). 
 
 EGF oriented immobilization via coiled-coil interactions led to a strong and sustained 
EGFR autophosphorylation as compared to that observed on randomly immobilized 
(covalent immobilization via the reactive amine groups present at the EGF N-terminus or on 
its lysine side chain (at position 28 and 48 for human EGF)) or soluble EGF (Boucher et al., 
2009). More recently, in our lab this strategy was applied to immobilize EGF on a CS 
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surface. This study showed that EGF bioactivity and therefore VSMC survival and resistance 
to apoptosis (in a serum-deprived environment) were enhanced when using the coiled-coil 
strategy as compared to random immobilization of EGF (Lequoy et al., 2014). As mentioned 
above, the coiled-coil capture system could also be applied to other growth factors or 
proteins. As an example, recently this system was successfully used for hVEGF capture on 
amine-displaying surfaces and confirmed its bioactivity (Murschel et al., 2013).  
 
 
Figure 1.29. Schematic diagram of an oriented immobilization of EGF onto an 
amine-displaying surface through coiled-coil interaction (Boucher et al., 2009). 
 
1.5.4 Combination of peptide and growth factor 
 
 Achieving optimal cell interactions on a low-fouling background is a challenging task 
due to the non-adhesive nature of low-fouling polymers. Klenkler et al. observed poor cell 
coverage and growth when EGF immobilized on PEGylated surfaces (Klenkler et al., 2008). 
Similarly, poor VSMC response was observed when EGF tethered on CMD surface in 
oriented fashion (Lequoy et al., 2014). Klenkler concluded that additional factors that would 
promote initial cell adhesion on PEG surfaces were required. These concerns encouraged us 
to search in the literature for combined immobilization of growth factors and/or cell adhesive 
molecules and their possible synergistic effects. 
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Figure 1.30. Schematic diagram of 
collaborative signaling of growth factor 
and integrin receptors. Taken from 
(Yamada et Even-Ram, 2002). 
 
 The cell adhesion receptors such as integrin and growth factor receptors are known to 
share common signaling pathways, and the mutual activation of both the receptors through 
their association results in signaling synergism and reciprocal potentiation (Comoglio, 
Boccaccio et Trusolino, 2003; Yamada et Even-Ram, 2002). The synergy between integrin 
and growth factor receptors is known to regulate cell differentiation, proliferation, and 
survival. A classic example of sharing common signaling pathways is the ability of integrins 
to engage ligands and subsequent activation of the Shc-Ras-Mitogen activated protein kinase 
pathway in a manner similar to growth factor receptors (Wary et al., 1996; Wary et al., 
1998). The mechanism of synergy between integrin and growth factor signaling can be 
explained by collaborative signaling as shown in Figure 1.30. Integrin clustering takes place 
when ligands bind to integrins and the clustered integrins can associate with other surface 
receptors, including growth factor receptors (Yamada et Even-Ram, 2002). Signals triggered 
by growth factor and integrin binding to their respective receptors will follow parallel but 
superimposable pathways, with additive activation of signaling cascades that converge on 
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common downstream effectors. This type of collaboration is also known to exploit 
membrane proximal proteins to mediate (directly or indirectly) the formation of integrin-
growth-factor-receptor complexes. For example, as shown in Figure 1.31, a membrane-
proximal transducer such as FAK is able to integrate cytoplasmic tails of growth factor and 
integrin receptors through its amino and carboxyl termini, respectively (Sieg et al., 2000). 
This coordinated activity can be explained by the observation that fibroblasts lacking FAK 
are refractory to motility signals from platelet-derived growth factor (PDGF) and epidermal 
growth factor (EGF), and rescue of this defect was achieved by stable expression of FAK that 
is able to interact with the sites of kinase and integrin receptor clustering (Sieg et al., 2000). 
An increase in VEGFR-2 activation and EC proliferation was observed when VEGF receptor 
((VEGFR)-2) physically associates with the αvβ3 integrin (Soldi et al., 1999). 
 
 A question remains whether growth factor covalently/firmly linked to the surface 
promotes collaborative association with integrins. This can be explained by comparing the 
mechanism of action for soluble and immobilized growth factor. Soluble growth factors bind 
receptors on the apical side of the cell and form collaborative associations with integrins, but 
they are internalized and therefore immediately terminate the stimulated cell growth. 
However, immobilized growth factors are exposed to the basal side of the cell and can 
directly bind integrins. Due to increased local concentrations, immobilized growth factors 
may induce formation of integrin-growth factor-receptor complexes that do not form in the 
presence of soluble growth factors (Vlahakis et al., 2007). Moreover, immobilized growth 
factors are known to offer sustained activity since they are not internalized.  
 
 Very few studies to date have examined combined immobilization of growth factors 
and cell adhesion peptides or ECM proteins and their effect on cell growth. Ito and 
coworkers observed enhanced insulin growth factor activity and cell growth when it co-
immobilized with ECM proteins or RGD peptides on a polymer surface (Ito, 1998). De Long 
et al (DeLong, Moon et West, 2005) noted enhanced fibroblast proliferation and migration 
when EGF tethered on RGD containing hydrogels. Similarly, Gobin et al (Gobin et West, 
2003b) observed increased VSMC proliferation and migration when FGF co-immobilized 
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with RGD peptide. More recently Christopher M et al. developed a surface that presents both 
cell-adhesion factors (RGD) and growth factors (bFGF) at subcellular-length scales using 
PEG hydrogels. The results from this work showed enhanced HUVECs adhesion, spreading 
and formed focal adhesion assemblies through synergistic effects of integrin, and growth 
factor receptor signaling (Murray et Lopez, 1997). 
 
 
 
Figure 1.31. Schematic diagram of FAK function that 
integrates growth factor and integrin signals to promote 
cell migration (Sieg et al., 2000). 
 
 Overall, based on the literature, integrin receptor seems to collaboratively associate 
with other integrin receptors or growth factor receptors to potentiate their signals. There is a 
strong interest in developing methods that allow combined immobilization of an adhesive 
peptide with a growth factor to enhance cell proliferation and migration and therefore to 
achieve optimal cell interactions. However, several factors may need to be optimized, such as 
grafting density and required ratios of these biomolecules on the surface. The coiled-coil 
tethering method developed in De Crescenzo’s lab may be helpful for combined 
immobilization of peptides and GFs and therefore modulate the ratios of these biomolecules. 
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In addition, the Quartz Crystal Microbalande (QCM-D) technique, which will be detailed in 
the next section, may help to achieve an interesting study of combined immobilization. 
1.6 QCMD- technique 
 
1.6.1 Introduction 
 
 The quartz crystal microbalance (QCM) was used for a long time as a weighting 
device to measure thin film deposition in vacuum as well as gas phases. In 1980, it was 
recognized that the QCM technique could be used in the liquid phase (Nomura et Hattori, 
1980). Later, Hook constructed an experimental setup to follow frequency and dissipation of 
energy simultaneously in all three phases (vacuum, air and liquid) (Höök et al., 2002). 
Hook’s technique was named quartz crystal microbalance with monitoring of dissipation 
(QCM-D), which is an extension of the traditional QCM method. Among others, QCM-D 
enables to study the kinetics of protein adsorption. Unlike QCM, the QCM-D technique can 
provide the unique and quantitative information of the viscoelastic properties of adsorbed 
protein layers (Hook et al., 2001). Thus this technique is known to allow a reliable protein 
adsorption study in biomaterial research (Andersson et al., 2005; Thompson, Arthur et 
Dhaliwal, 1986). 
 
1.6.2 Fundamental principles of the QCM-D technique 
 
 The QCM system consists of a piezoelectric quartz crystal sensor that is used to 
measure very small masses. This thin crystal is covered with gold electrodes on its two faces. 
When an AC voltage is applied across the electrodes, it causes the crystal to oscillate at a 
specific resonant frequency (f). A change in frequency of the oscillating crystal will occur if 
the mass is adsorbed on the crystal and the resonant frequency will decrease proportionally to 
the mass of the film. This linear relation between increase in mass (∆m) and decrease in 
resonance frequency (∆f) was described in 1959 by Sauerbrey (Hemmersam et al., 2005; 
Höök et al., 1998; Sauerbrey, 1959), which can be explained as follows.The resonant 
frequency (f) is given by the following Eq.1.1 (taken from (Sauerbrey, 1959)). 
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                                                           f = n . Vq/2 tq = n. f0                                                   (1.1) 
 
 Where "vq" is the wave velocity and "tq" is the thickness of the quartz plate (Höök et 
Biophysics, 1997; Sauerbrey, 1959) and "n" is the overtone number (n=1, 2, 3 etc.). The 
resonant frequency for n=1 is called the fundamental resonant frequency (f0 (=vq/2·tq)), and 
n=3 for the third overtone and so on. 
 
 An increase in mass (∆m) bound to the quartz crystal surface causes the oscillation 
frequency to decrease, obtaining a negative shift of the resonance frequency (-∆f). It is 
described by the following Eq.1.2. (taken from (Sauerbrey, 1959) 
 
                            df = ∆f = − f/ tq ρq . ∆m = -n . 2.f02/vq ρq = -n . 1/C . ∆m                        (1.2) 
 
Where C is the mass sensitivity constant (C=17,7 ng·cm-2·Hz-1 at 5MHz). 
 
 The Sauerbrey equation (Eq.1.2) is valid if: (i) the adsorbed layer is rigid, (ii) the 
added mass is smaller than the weight of the crystal, (iii) there is no slip in the metal/layer 
interface, and (iv) the layer is homogeneously distributed on the surface. Thus, for the 
Sauerbrey relation, it was concluded that the change in resonance frequency is proportional 
to the change in the adsorbed mass if the adsorbed mass is much smaller than the mass of the 
crystal (Hemmersam et al., 2005; Sauerbrey, 1959). 
 
1.6.2.1 The dissipation factor 
 
 The QCM technique is a very sensitive tool that determines the mass of the analyte 
adsorbed, with sensitivity in the ng/cm2 regime (Rodahl et al., 1995; Thompson, Arthur et 
Dhaliwal, 1986; Weber, Wendel et Kohn, 2005a). However, it is not applicable to inelastic 
subjects such as cells and bimolecular systems, because there is an energy loss due to 
hydrated and viscous layers. In the case of protein solutions, the protein layer is not rigid and 
does not couple completely with the oscillating crystal, which leads to underestimation of the 
real mass when using the Sauerbrey relation. Therefore, in those cases, in addition to 
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resonant frequency, the dissipation factor (D) must be taken into consideration (Hemmersam 
et al., 2005; Rodahl et al., 1995). The dissipation factor is inversely proportional to the Q-
factor of the oscillator (Höök et al., 2002), which is a dimensionless parameter that compares 
the time constant for decay of an oscillating physical system's amplitude to its oscillation 
period. This relation is described by the following Eq.1 3 (taken from (Voinova et al., 1999): 
 
                                                 D = 1/Q = Edissipated/ 2 π Estored                                           (1.3) 
 
Where Edissipated refers to the energy dissipated during one period of oscillation, and Estored 
refers to the energy stored in the oscillating system.  
 
 The QCM-D technique measures the dissipation factor (D) based on the fact that the 
voltage over the crystal (A(t)) decays exponentially as a damped sinusoidal with the time (t) 
when the driving power of a piezoelectric oscillator is switched off (Voinova et al., 1999) (as 
shown in Figure 1.32). This relation is described by the following Eq.1.4.  
 
                                                  A (t) = A0 . et/τ . sin (2πft + ɸ)                                             (1.4) 
 
Where "A0" is the amplitude of oscillation before switching off the driving power, τ is the 
decay time constant, f the frequency and ɸ is the phase angle.  
 
 The dissipation factor is related to the decay time constant and therefore it can be 
calculated using the following equation Eq.1.5 
 
 
                                                                    D = 1/πfτ                                                           (1.5) 
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Figure 1.32. Schematic illustration of relative changes in the 
crystal oscillation upon adsorption of mass (m). Initially, the 
frequency is constant at its fundamental overtone. When the mass 
is added to the crystal, the frequency decreases but remains 
constant. Finally, when the driving power is switched off, the 
frequency decays and the dissipation can be calculated (image 
adapted from Q-Sense reported data). 
 
 The loss of energy in the system depends on the medium surrounding the crystal and 
the properties of adsorbed mass onto the crystal. The possibilities of determining dissipation 
shift in real time gives additional valuable information about the adsorbed protein layer 
(when using protein solutions) on the surface. Since the dissipation is caused by the loss of 
energy within the protein layer, the changes in dissipation are believed to arise from protein 
conformational changes and/or the amount of liquid trapped inside the protein layer (Rodahl 
et al., 1997b). 
 
 QCM-D allows frequency (∆f) and dissipation shift (∆D) to be recorded 
simultaneously by applying alternating current (AC) across the quartz crystals. This 
technique can provide unique and quantitative information on the viscoelastic properties of 
adsorbed protein layers, which includes density, shear elastic modulus, and shear viscosity 
(Hook et al., 2001). As explained above, since the protein layer is not rigid, may slip on the 
moving electrodes surface and is not fully coupled to the crystal surface, the Sauerbrey 
relation underestimates the adsorbed mass. Therefore, when using protein solution the 
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Sauerbrey equation must be used cautiously. For viscoelastic films, the Sauerbrey equation 
can be applied if the protein layer has the following characteristics: (i) The dissipation shift 
should be less than 1×10-6 or dissipation should be less than 5% of a frequency shift of 
respective surface (Brewer et al., 2005). (ii) The film thickness should be less than 250nm, 
which is the extinction depth into the aqueous protein solution of the shear waves excited by 
the QCM-D crystal (Höök et al., 1998). Although Sauerbrey mass is not real for viscoelastic 
films, the calculated mass allows comparison between different surfaces.  
 
 If the protein layer possesses high dissipation values (>1×10-6; as mentioned above), 
it is necessary to consider dissipation changes to calculate the adsorbed mass and to 
determine viscoelastic properties. In order to calculate adsorbed mass for such protein layers, 
theoretical modeling of QCM-D response is necessary. This can be achieved by introducing a 
shear viscosity coefficient (η) and a shear elasticity modulus (μ) using either one of these two 
basic models: (i) Maxwell and (ii) Kelvin-Voigt. Polymer solutions can exhibit purely liquid-
like behavior, at least for low shear rates, and therefore the Maxwell model is usually 
applicable. For polymers that conserve their shape and do not flow, however, the Voigt 
model is applied. (Voinova et al., 1999).The Voigt model was applied in this PhD thesis, 
since we used protein solutions and were unsure about purely liquid-like behavior for protein 
solutions. Moreover, in the literature, it is very common that protein adsorption studies were 
performed applying Voigt model.  
 
 The Voigt viscoelastic model is a mechanical model that uses a parallel combination 
of a spring and a dashpot to represent the elastic (storage) and inelastic (damping) part of a 
material. In the Voigt model, as shown in Eq 1.6, the viscoelastic element is described by a 
complex shear modulus (G) in which the real part (storage modulus (G')) is independent of 
frequency while the imaginary one (loss modulus (G'')) increases linearly with frequency 
(Voinova et al., 1999). 
 
                                                     G = G' + iG" = µf + i2πfnf                                             (1.6) 
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where " μf "  is the elastic shear modulus," ηf " is the shear viscosity and "f "is the oscillation 
frequency 
 
 Based on this approach, Voinova et al. analytically solved the wave equation 
describing the shear oscillation of a quartz crystal surface covered by a viscoelastic film 
(uniform thickness and density) that is in contact with a semi-infinite Newtonian liquid under 
no-slip conditions (Voinova et al., 1999). The general solution of this wave equation was 
referred to as the β-function. The change in resonance frequency (Δf) and dissipation factor 
(ΔD) of the adsorbed film can be obtained from the imaginary and the real part of the β-
function (referred in Eq. 1.7 and 1.8) (Hook et al., 2001; Voinova et al., 1999). 
 
                                                           ∆f = Im (β)/ πfρQtQ                                                    (1.7) 
 
                                                          ∆D = Re (β)/πfρQtQ                                                    (1.8) 
 
 In the Voigt model, each protein film is represented by four unknown parameters 
(Figure 1.33), which includes density (rf), shear viscosity (hf), shear elastic modulus (μf), and 
the thickness (tf). Since viscous layers exhibit different penetration depths of harmonic 
acoustic frequencies, changes in frequency and dissipation can be measured simultaneously 
by considering several different overtones. It was suggested that frequency and dissipation 
changes be measured by considering the maximum number of overtones (there are 13 
overtones in total; f=5MHz, 15 MHz, 25 MHz.etc.), which allows the Voigt model to better 
fit the data and to calculate the unknown parameters (hf, μf, tf).  
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Figure 1.33. Schematic diagram of the geometry of a quartz crystal covered with 
a viscoelastic protein film. The film is represented by various parameters such as 
density (rf), viscosity (hf), elastic shear modulus (μf), and thickness (tf). The 
parameters for bulk liquid are represented by a density (rl), and a viscosity (hl) 
and for the crystal are represented by density (rQ), elastic shear modulus (mQ), 
and thickness (tQ). Taken from (Höök et al., 2001). 
 
 
 CHAPTER 2 
 
 
OBJECTIVES AND HYPOTHESIS 
 As seen in the literature review, small vascular implants made of PET and ePTFE fail 
due to thrombosis and neointima formation. These materials also show their limitations when 
used for the design of stent grafts, where they do not promote the tissue encapsulating the 
implant and ensuring its fixation into the vessel wall. Both cases show that those polymeric 
materials lack favorable properties for promoting cell adhesion and growth. A potential way 
to limit vascular graft failure would be to provide rapid, uniform, stable and complete 
endothelial cell coverage for vascular grafts. Similarly, it is essential to promote vascular 
smooth muscle cell growth around endovascular stent-graft materials to ensure better fixation 
into the vessel wall. Therefore the general aim of this PhD thesis is to develop bioactive 
coatings on PET-based vascular grafts and stent grafts to promote confluent cell 
adhesion, survival and growth. 
 
 Altering surface physical, chemical and biological properties of PET or ePTFE has 
shown some success, but the formation of a stable and confluent endothelial layer on the 
lumen side of vascular graft is still a challenge. Moreover, several strategies such as 
fibronectin or primary amine-rich plasma polymerized coatings previously developed by our 
team in Wertheimer and Lerouge's lab (Ruiz et al., 2010; Truica-Marasescu et al., 2008) do 
not only promote endothelial cell adhesion and retention (Gigout et al., 2011), but also 
platelet adhesion. Such thrombogenic underlayers could be problematic in case of cell 
detachment under blood flow. In contrast, it is known from the literature that low-fouling 
underlayers can reduce platelet adhesion as well as the non-specific protein adsorption and 
could increase the bioactivity of immobilized biomolecules (Chen et al., 2005b; Groll et al., 
2004b; Sebra et al., 2005). General hypothesis: Based on the literature, we hypothesize that 
low-fouling coating combined with adequate immobilized biomolecule(s) allows to create a 
non-thrombogenic coating promoting cell and tissue growth on synthetic vascular 
prostheses. 
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Rationale 1: Minimizing non-specific protein adsorption and platelet adhesion could help to 
reduce surface thrombogenicity. PEG coatings have previously been reported to exhibit a low 
degree of protein adsorption (Jeon et Andrade, 1991) and platelet and cell adhesion (Zhang, 
Desai et Ferrari, 1998). Multi-arm PEG coatings are known to offer relatively high grafting 
densities and better low-fouling properties compared to linear PEG (Groll et al., 2005a; Sofia 
Susan et Merrill Edward, 1997). Several studies have already proposed methods for PEG 
coatings (Davis et Illum, 1988; Demming et al., 2011; Gombotz et al., 1991; Graham et 
McNeill, 1984). However, current coating methods are far from being versatile since they 
rely on the availability of compatible functional groups on both PEG and the host surface. 
 
We hypothesize that the combination of LP coating and subsequent star PEG coating can 
offer low-protein adsorption and low-thrombogenic properties on any biomaterial surface. 
 
Objective 1. Develop low-fouling and low-thrombogenic coatings that can be applicable to a 
wide variety of biomaterial surfaces.  
 
Rationale 2: The terminal groups of star PEG or CMD coatings enable subsequent coupling 
of peptide and/or growth factors at higher densities. Low-fouling polymers (PEG or CMD) 
offer conformational flexibility and minimize non-specific protein adsorption and therefore 
enhance the bioactivity of immobilized biomolecules (peptides or growth factors) (Groll et 
al., 2005b; Tugulu et al., 2007). However, based on the literature and previous studies in our 
lab (Lequoy et al., 2014), it was recognized that immobilization of growth factor alone is not 
sufficient to achieve cell confluence due to the non-adhesive nature and sterical hindrance 
effect of high density low-fouling underlayers (Klenkler et al., 2008). More generally, the 
literature (Crombez et al., 2005; Klenkler et al., 2008; Kolodziej et al., 2011) suggests that 
immobilization of EGF with the combination of cell-adhesive peptide (for example RGD or 
KQAGDV) on low-fouling background could help to increase VSMC adhesion and growth 
and optimal cell interactions could be achieved through positive synergistic effects. The 
coiled-coil technique for EGF immobilization, previously developed in De Crescenzo's lab 
(Boucher et al., 2008b) using K coil and E coil tags, was shown to enhance the bioactivity of 
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EGF and offers an interesting approach to combine EGF with adhesive peptides on low-
fouling substrates. 
 
We hypothesize that the bioactivity of KQAGDV peptide and / or EGF is increased when 
they are immobilized on low-fouling polymers (PEG or CMD) and together they produce 
an additive or synergistic effect. This could aid to significantly enhance biological 
activities such as VSMC adhesion, survival and growth. 
 
Objective 2: Develop immobilization protocols allowing for the subsequent decoration of 
KQAGDV peptide and/or EGF (individually or combined) on low-fouling surfaces and 
evaluate their effect on vascular smooth muscle cells. 
 
Rationale 3: CS coating has previously been developed in our lab (Charbonneau et al., 
2012), and this polymer was shown to promote VSMC growth and resistance to apoptosis. 
CS exhibited a good cell growth when recent studies (from our lab) compared VSMC 
behavior on CS and CMD surfaces on which EGF had been grafted (Lequoy et al., 2014). 
Moreover, CS prevented EGF non-specific adsorption as effectively as CMD (Lequoy et al., 
2014). It was also shown that sulfated polysaccharides can improve hemocompatibility by 
means of electrostatic repulsion toward negatively charged blood components (Keuren et al., 
2003).  
 
Based on the literature and observations from previous studies in our lab, we hypothesize 
that CS exhibits selective low-fouling, low-thrombogenicity and pro-cell adhesive 
properties which could create an interesting compromise as a luminal surface for vascular 
grafts endothelialization. 
 
Objective 3: Evaluate the low-thrombogenic and low-fouling properties of various coatings 
(PEG, CMD and CS) and evaluate the advantages and limitations of using CS coating for the 
creation of low-thrombogenic surfaces for vascular graft applications. 
 

 CHAPTER 3 
 
 
MATERIALS AND METHODS 
3.1 Surface preparation and coating methods 
 
 During this PhD thesis, various substrates were used for surface coatings. The 
nitrogen-rich plasma polymerized ethylene coatings (LP) were performed on microscope 
glass slides, PET films (Goodfellow, Huntingdon, England) and gold-plated QCM-D crystal 
surfaces (Q-Sense AB, Sweden). Such primary amine-rich coatings were used as an 
underlayer for covalent immobilization of multi-arm polyethyleneglycol (star PEG), 
carboxymethylated dextran (CMD) and chondroitine-4-sulfate (CS) polymers. However, 
amino-coated glass surfaces (10 × 10 mm2; Erie Scientific Co, Portsmouth, NH, USA) were 
also used for same purpose, in particular for specific experiments such as X-ray 
photoelectron spectroscopy (XPS) analysis and complementary protein adsorption studies 
using fluorescence measurements. For the second objective of this thesis, adhesive peptides 
and epidermal growth factor (EGF) molecules were further immobilized on PEG and CMD 
surfaces, as described in 3.1.4. 
 
3.1.1 Cleaning samples 
 
 The substrates were cleaned before and after surface coatings, as described in the 
following paragraphs. 
 
Before LP deposition:  PET films and microscope glass slides were cleaned with ethanol in 
an ultrasonic bath for few minutes and dried with a stream of nitrogen gas. Gold-plated 
sensor surfaces were cleaned using the cleaning protocol described below in the QCM-D 
section. 
 
Cleaning amino-coated glass surfaces: Prior to chemical grafting, the glass slides were 
cleaned with chloroform (99% purity, Fisher Scientific) for 2 min using an ultrasonic bath 
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followed by rinsing twice with Milli-Q water, and finally drying with a stream of nitrogen 
gas.  
 
After chemical grafting of PEG, CMD and CS: After completion of the reaction, the 
excess solution was removed from the surfaces, and the slides were rinsed for 2 min with 
PBS, followed by Milli-Q water (2 times) in an ultrasonic bath. Finally, the slides were dried 
with nitrogen gas stream. 
 
3.1.2 Plasma polymerization 
 
 The low-pressure plasma polymerized (LP) coatings were deposited using a low-
pressure radio-frequency (r.f.) glow-discharge plasma reactor developed by Wertheimer and 
Lerouge. LP deposition was performed as already described in (Ruiz et al., 2010; Truica-
Marasescu et al., 2008). The coating was deposited in a cylindrical aluminium/steel vacuum 
chamber approximately 20 cm in diameter and 20 cm in height (Figure 3.1). A turbo-
molecular pump, backed by a two-stage rotary vane pump, was used to evacuate the chamber 
and to maintain a base pressure of <104 Pa (measured by an ionisation gauge). A mixture of 
anhydrous ammonia (NH3) and ethylene (C2H4) (99.9% and 99.5% purity, respectively; Air 
Liquide Canada Ltd., Montreal, QC, Canada) was admitted into a reactor chamber using 
electronic flow meter/controllers (Vacuum General Inc.) and a 'shower head' gas distributor 
at flow rates of 15 and 20 standard cubic centimeters per minute (sccm), respectively. 
 
This gas ratio (R = FNH3 / FC2H4 = 0.75) was chosen since it was previously found to create 
coatings with the best compromise in terms of primary amine concentration and stability in 
aqueous media. XPS analysis showed a high concentration of nitrogen ([N] = 14 %) and 
primary amines ([NH2] = 7.5%, determined by chemical derivatization using 4-
[trifluoromethyl] benzaldehyde [TFBA] followed by F content measurement) in the resulting 
coating, as detailed previously (Ruiz et al., 2010). Moreover, these coatings were found to be 
very stable in aqueous solutions, with less than 10% decrease in thickness when immersed in 
Milli-Q water or PBS solution for up to one week, as assessed by Dektak profilometry. (Ruiz 
et al., 2010). LP deposition using these conditions led to a smooth and homogeneous layer, 
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without detectable porosity and with a roughness (Rq) of 0.2-0.3 nm, as observed by scanning 
electron microscopy (SEM) and atomic force microscopy (AFM) (Ruiz et al., 2010), 
respectively. In the present study, a plasma deposition time of 10 min was chosen for all 
experiments, leading to 80 to 90 nm-thick LP coatings. 
 
 
Figure 3.1. Schematic views of the low-pressure, capacitively coupled radio-
frequency plasma reactor. Taken from (Truica-Marasescu et al., 2008). 
 
3.1.3 Chemical grafting of PEG, CMD and CS 
 
 Three different macromolecules were covalently grafted on LP as well as on amino-
coated glass surfaces to create low-fouling surfaces, namely star PEG, CMD and CS. The 
chemical structures of these molecules are presented in Figure 3.2. The PEG grafting method 
was first optimized by estimating low-fouling properties of various PEG coupling 
concentrations (for objective 1). A 4-arm PEG with N-hydroxy succinimide (NHS) terminal 
functional groups (PEG-NHS; Mw = 10 kDa, Creative PEG Works Inc., Winston Salem, NC, 
USA) was chosen for this work. The terminal NHS groups allow simple reaction with 
primary amine groups (on LP or amino-coated glass) to form stable amide bonds as shown in 
Figure 3.3. The optimized PEG coating method was then compared with the CMD coating 
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for their ability to immobilize KQAGDV peptide and/or EGF (for objective 2). Finally, the 
low-fouling, non-thrombogenic and cell-adhesive properties of PEG, CMD and CS coatings 
were compared (for objective 3). Therefore, CMD and CS coating methods are also 
described in this section.  
 
 CMD is a highly flexible polysaccharide, an anionic derivative of dextran, which 
contains various carboxyl groups on the chain as shown in Figure 3.2. CMD chains were 
generated from commercially available dextran (Pharmacosmos, Holbaek, Denmark), and the 
carboxymethylation degree of the dextran chains (70 kDa) was previously estimated as 
approximately 60% (Liberelle et al., 2010). Similarly, CS (Sigma-Aldrich Canada Ltd., 
Oakville, ON, Canada) contains carboxyl terminal groups as shown in Figure 3.2. This 
polymer is a member of the glycosaminoglycan (GAG) family and a sulfated polysaccharide 
containing repetitive units of glucuronic acid and galactosamine. 
 
 Both CMD and CS polymers were covalently grafted on amine-functionalized 
surfaces (LP-coated or amino-coated glass surfaces) via NHS/EDC chemistry by following 
protocols that were previously developed in Lerouge's and De Crescenzo's laboratories 
(Charbonneau et al., 2011; Liberelle et al., 2010). In this procedure, EDC reacts with 
carboxyl terminal groups on the polymer to form an O-acylisourea intermediate and, 
followed by NHS reaction, forms a stable amine-reactive NHS ester, which enables stable 
amide bonding. 
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Figure 3.2. Chemical structure of polyethyleneglycol (PEG), 
carboxymethyl dextran (CMD) and chondroitin-4-sulfate (CS). 
 
3.1.3.1 Optimizing star PEG Grafting 
 
 Star PEG-NHS reaction scheme is presented in Figure 3.3. PEG-NHS solutions at 
different concentrations (0.55, 1.66, 5, and 15% w/v) were prepared by dissolving in 25 mM 
phosphate buffer (25 mM NaH2PO4 + 25 mM Na2HPO4, with drops of 0.01 M NaOH to 
adjust to pH 8.5) (Nakajima et Ikada, 1995). In order to prevent hydrolysis of NHS terminal 
groups, the PEG solution was immediately deposited on aminated surfaces for 2 h at room 
temperature (RT). The surfaces were then rinsed and dried as described in the cleaning 
samples section. Since there is no significant improvement in low-fouling properties by 
increasing PEG coupling concentration (See results section 4.1.2), 5 % (w/v) PEG was used 
for comparing low-fouling properties of PEG, CMD and CS surfaces. 
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Figure 3.3. Schematic diagram of star PEG covalent binding reaction. Either one or 
two N- hydroxyl succinamide (NHS) terminal groups of star PEG react directly with 
primary amines through ester-amine reactions to form stable amide bonds; the 
remaining terminal groups do not participate in coupling, due to steric constraints 
(Park, Mao et Park, 1990) and hydrolyze to carboxylic acid groups during the reaction. 
 
3.1.3.2  CMD grafting 
 
 The CMD solution was prepared in Milli-Q water (2 mg/mL). Once dissolved, CMD 
was activated by preparation of a solution containing (for a total volume of 1 mL) 800 μl of 
CMD solution, 100 μL of 0.4 M EDC in Milli-Q water and 100 μL of 0.1 M NHS in Milli-Q 
water. The NHS-activated CMD solution was allowed to react with NH2 displaying surface 
for 1h at RT. The surfaces were finally rinsed and dried as described above.  
 
3.1.3.3 CS grafting 
 
 The CS solution was prepared by dissolving 0.1 g in 1 mL of Milli-Q water, and was 
filtered (0.2 μm PTFE filter) to remove aggregates. CS was then activated by preparation of a 
solution containing (for 1 mL) 400 μL of EtOH, 347 μL of Milli-Q water, 50 μL of 1 M 
MES, 57 μL of 0.4 M EDC, 46 μL of 0.1 M NHS, and 100 μL of CS solution. These 
conditions were shown to provide the best CS-covered surface as assessed by contact angle, 
XPS and ellipsometry, detailed in (Charbonneau et al., 2011). The NHS-activated solution 
was reacted with NH2 displaying surfaces for 1 h at RT. Rinsing steps and drying were 
performed as described above. 
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3.1.4 Covalent immobilization of peptides and epidermal growth factor (EGF)  
 
 Immobilization of peptide and tethering of EGF was performed on low-fouling 
surfaces (PEG or CMD) to investigate the possibilities of improving VSMC adhesion, 
growth and survival on biomaterial surfaces. Therefore, the immobilization procedure for 
these biomolecules is described in this section. 
Peptide immobilization: The adhesive peptides such as KQAGDV (CGG-KQAGDV; Mw = 
876 Da) and RGD (CGG-RGD; Mw = 563 Da) were produced with three additional residues 
at their C terminus, i.e. CGG, in order to immobilize them by taking advantage of the unique 
thiol (R-SH) group in their sequence. These peptides were synthesized by the peptide facility 
at the University of Colorado (Denver, CO, USA).  
 
 Peptides were immobilized on carboxyl terminal groups of PEG or CMD using a 
heterobifunctional cross linker, i.e., 3,3'-N-[є-Maleimidocaproic acid] hydrazide, 
trifluoroacetic acid salt (EMCH; Fisher Scientific Co., Ottawa, ON, Canada), as shown in 
Figure 3.4 (b --> d1). This linker readily reacts with cysteine containing molecules through 
sulfyhydril bonding (Trail et al., 1993). The carboxyl terminal groups of PEG or CMD were 
reacted with EMCH for 2.5 h using a solution containing (for a total volume of 1 mL) 100 μL 
of EMCH (3.4 mg/mL in DMSO) and 400 μL of PBS and 500 μL of 0.4 M EDC. The same 
protocol was used for PDPH (3-[2-Pyridyldithio] propionyl hydrazide; Fisher Scientific Co., 
Ottawa, ON, Canada) linker grafting, which was an alternative to EMCH. Surfaces were then 
rinsed once with PBS and twice with Milli-Q water and finally air-dried at RT. Various 
concentrations (38, 12.6, 4.2, 1.4 and 0.46 µM) of peptide solutions were prepared in PBS 
and reacted with linker-activated surfaces for 2 h, and finally surfaces were rinsed as 
described above. 
EGF tethering: EGF tethering was performed on low-fouling surfaces by taking advantage 
of the innovative oriented immobilization strategy based on the interactions of two high-
affinity peptides: the E coil and the K coil. These peptides heterodimerize with high 
specificity and affinity through coiled-coil interactions, as detailed in the literature review 
section and as shown in Figure 3.4 (d2 --> e). This technique was previously developed by 
De Crescenzo's team at Ecole polytechnique (Boucher et al., 2008b; De Crescenzo et al., 
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2003). In order to allow such oriented immobilization of EGF on a low-fouling surface, E 
coil tagged EGF ((EVSALEK)5-EGF, produced in human embryonic kidney (HEK293) cells 
as described in (Boucher et al., 2008a)) and K coil (CGG-(KVSALKE)5; Mw = 4 kDa, 
chemically synthesized and purified by the peptide facility at the University of Colorado 
(Denver, CO, USA) ) were used. First, K coil (2 µM) solution in PBS was reacted with an 
EMCH-grafted surface for 2h (Figure 3.4 (c-->d2)). After 2h, the surface was rinsed with 
PBS and then directly incubated with E coil EGF (160 nM) solution in PBS for 1 h, which 
allows EGF capture via coiled-coil interactions (Figure 3.4 (d2 --> e)). Finally, surfaces were 
rinsed with PBS as well as Milli-Q water to remove an unbound E coil EGF protein.The 
combined immobilization of peptides and EGF was optimized using the QCM-D technique, 
which will be described in the QCM-D measurement section. 
 
 
Figure 3.4. Schematic of KQAGDV and K coil peptide grafting using EMCH linker 
and E coil EGF tethering through coiled-coil interaction. 
87 
3.2 Surface characterization 
 
3.2.1 X-ray photoelectron spectroscopy (XPS) 
 
 XPS is the most commonly used technique to analyze the composition of biomaterial 
surface coatings. In brief, it is accomplished by irradiating a sample with monoenergetic soft 
x-rays and analyzing the emitted electrons that have kinetic energies specific to the elements 
present as well as to their chemical state. Photons from the energy source have limited 
penetrating power in a solid on the order of 1-10 µM and they interact with the atoms in the 
surface region, causing electrons to be emitted by the photoelectric effect (Hofmann, 2013). 
The emitted electrons can be measured in kinetic energies using the following equation 
Eq.2.1. 
                                                           KE = hγ - BE - ɸs         (Swingle, 1975)                    (2.1) 
Where hγ is the energy of the photon, BE is the binding energy, and ɸs is the spectrometer 
work function. 
 
 Since each element has a unique set of binding energies, XPS can enable to determine 
the atomic concentration of elements on the surface, except hydrogen or helium, with a 
sensitivity of approximately 0.1 atom percent (Swingle, 1975). Variations in the elemental 
binding energies, also known as chemical shifts, arise from differences in the chemical 
potential and polarizability of the compounds. These changes can be used to identify the 
chemical state of the material being analyzed. 
 
 The chemical composition of PEG-modified surfaces was characterized by XPS using 
a VG ESCALAB 3MkII instrument with non-monochromatic Mg Kα radiation. The surface 
elemental composition was detected using survey scans and the chemical state of each 
element was evaluated by high-resolution scans. The curve fitting was applied to the peaks in 
the high-resolution scan for precise determination of binding energies. For each sample, 
survey (0-1200 eV) and high-resolution spectra for C1s and O1s were recorded at a pass 
energy of 100 eV and 20 eV, respectively. The take-off angle, defined as the angle between 
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the sample surface and the electron path to the analyzer, was adjusted to 70° in order to 
minimize the effect of the substrate. Charging was corrected by referencing all peaks with 
respect to the carbon (C1s) C-C, C-H peak at 285.0 eV. The Avantage v4.12 software 
(Thermo Electron Corporation, Waltham) was used to quantify the constituent elements after 
Shirley-type background subtraction by integrating the areas under relevant peaks. High 
resolution spectra of C1s and O1s were deconvoluted by full width half maximum (FWHM) 
factors of 1.6 and 1.8 respectively. Deconvoluted peak positions of chemical bonds such as 
C-Si, C-C, C-O and C=O in an amino-coated glass were kept constant for each subsequent 
analysis, in order to identify any new functional groups added after surface modification with 
PEG. 
3.2.2 Static Water Contact Angle 
 
 Wettability measurements can provide a good understanding of surface properties, 
which can be determined from the measurement of contact angle of a pure liquid drop on that 
solid surface. When liquid is dropped onto a solid surface, it will spread over the surface 
depending on the surface properties. The angle formed between (as shown in Figure 3.5) 
solid surface and tangent of droplet is called the contact angle θ , which can be referred by 
the following Young's Dupre equation. The measurement of contact angle indicates the 
degree of wetting when a solid and liquid interact. Small contact angles (˂ 90°) correspond to 
high wettability, while large contact angles (˃ 90°) correspond to low wettability. 
 
                                                              γs = γL Cos θ + γsL                                                   (2.2) 
Where γs = solid surface energy, γL = liquid surface tension and γsL = solid and liquid surface 
tension. The contact angle (θ) is indicative of the wettability of the surface.  
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Figure 3.5. Schematic diagram of the contact angle 
and interfacial tensions at three phase boundaries. 
 
 In this work, the wettability of the amino-coated glass and LP-deposited surfaces 
before and after PEG grafting (of various coupling concentrations) was assessed by static 
water contact angle measurements, using a Ramé-Hart Inc., Model 100-00 115 goniometer. 
Three measurements were taken on each surface using Milli-Q water as probe liquid (2µL 
drop size), and experiments were repeated on three independent samples. The visual contact 
angle (VCA) Optima (AST Products, Billerica, MA) automated system was used to compare 
PEG, CMD and CS surfaces. A 2µL Milli-Q water (pH ≈ 6) drop was placed on each sample 
and the static contact angle measurements were performed on both sides of the drop within 5 
s. Three measurements were taken on each surface and experiments were repeated on three 
independent samples. 
 
3.3 QCM-D measurements 
 
3.3.1 QCM-D system 
 
The QCM-D that has been used for the assays in this work is the Q-Sense E4 model (Q-
Sense, Sweden). This system mainly consists of five parts (Figure 3.6): 
1. The sensor crystal: The quartz crystal sensors are usually available pre-coated with, for 
example, metals, polymers or SAMs. 
2. The flow module chamber: This is where the sensor crystal is mounted. This chamber 
provides a temperature-controlled environment for the crystal during the measurement. Four 
90 
flow modules can be arranged in parallel as shown in Figure 3.6, which allows the 
measurement of four different surfaces at a time. 
3. External peristaltic pump: This pump enables solution to be injected through Teflon 
tubes and regulates flow rate (up to 500µL/min). 
4. The electronics unit: This makes the QCM-D measurements possible and contains the 
temperature control system. 
5. The data acquisition software: Q-soft 301 (Q-Sense, Sweden) records frequency and 
dissipation changes simultaneously and the data analysis software, Q-tool (Q-Sense, 
Sweden), allows data interpretation and analysis. Q tools software helps to use Sauerbrey 
relation as well as to apply Voigt mathematic model that calculates the adsorbed mass and 
viscoleastic properties considering frequency and dissipation changes. The conditions used 
for the experiments and data analysis using Q tools are described in M & M section. 
 
 
Figure 3.6. Schematic picture of (A) complete setup of the QCM-D 
equipment (B) four flow modules chamber and their setup and (C) flow 
module with a crystal, dimensions and o-ring position. 
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3.3.1.1 Overtone sensitivity 
 
 This QCM-D system allows simultaneous measurements of the resonance frequencies 
and the dissipation shift at different overtones (fundamental, third, fifth, seventh and up to 
thirteenth; i.e., f=5 MHz, 15 MHz, 25 MHz and so on.). As shown in Figure 3.7, the 
penetration depth varies as a function of overtone number. The fundamental overtone is too 
sensitive to environmental fluctuation and a higher overtone number is related to a lower 
penetration/detection depth (see Figure 3.7 for penetration depth depending overtone 
numbers). Therefore these two overtones should be excluded for data analysis (for both 
Sauerbrey and Voigt models). Simultaneous measurement of multiple overtones is required 
to model viscoelastic properties and extract correct thickness applying the Voigt model. 
Moreover, considering different overtones enables providing information about the 
homogeneity of applied layers as the detection range out from the crystal surface decreases 
with increasing overtone number.  
 
 
Figure 3.7. Schematic shows the viscous penetration depth as 
function of the overtone number (Q-Sense reported data). 
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3.3.2 QCM-D measurements 
 
 QCM-D measurements were performed with a Q-sense E4 system (Q-Sense AB, 
Sweden). This technique was used for different purposes in this thesis: (i) To optimize PEG 
grafting on LP surface by comparing protein adsorption (for objective 1). (ii) To compare the 
low-fouling properties of PEG, CMD and CS surfaces (for objective 3). (iii) To optimize the 
combined immobilization of adhesive peptides (KQAGDV and RGD) and EGF and to follow 
cell adhesion on KQAGDV and RGD grafted surfaces (for objective 2). 
 
The Q-sense E4 system consists of four independent flow chambers, which allows measuring 
small masses for four different surfaces at a time. As detailed in the literature review section, 
this technique allows following of the changes in frequency (∆f) and energy dissipation (∆D) 
of an oscillating quartz crystal in response to mass changes on the crystal surface in real-time 
(Höök et al., 2002), as shown in Figure 3.8. The adsorbed mass of thin and non-dissipative 
layers can be calculated using the Sauerbrey relationship (∆m = C/n ∆f; where ∆f is linearly 
related to the adsorbed mass (∆m), n is the harmonic number and C is the mass sensitivity 
constant of the crystal) (Sauerbrey, 1959). In practice, most surface-adsorbed protein layers 
are hydrated, viscous, and cause significant energy dissipation. In such cases, the dissipation 
factor (D) can be considered, which is defined as the ratio of the energy dissipated during one 
period of oscillation and the energy stored in the oscillating system (D = E dissipated/2π E stored) 
(Voinova et al., 1999). In this study, depending on dissipation values, the adsorbed mass was 
calculated via the Sauerbrey equation (Sauerbrey, 1959) or by applying a viscoelastic, single-
layer Voigt model  implemented in the QCM software (Q tools, Q-sense AB, Sweden) 
(Voinova et al., 1999). The Voigt model was applied when dissipation shift was at least 5 % 
of the frequency shift of the respective surface (Höök et al., 2002). 
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Figure 3.8. Example of QCM-D data for simultaneous measurements of 
frequency (∆f) and (∆D) dissipation changes (for various over tones) during 
fibrinogen (0.5 mg/mL) adsorption on LP deposited surface. Arrows refer to 
injection (left) of fibrinogen and rinsing (right) with PBS solution. 
 
3.3.2.1 Protein adsorption studies to optimize star PEG coating for low-fouling 
properties 
 
 Gold-coated quartz crystals (5 MHz, Q-sense AB, Sweden) were coated with LP 
followed or not by star PEG grafting using PEG solutions of various concentrations (0.55, 
1.66, 5 and 15% w/v) as described in the sample preparation section. QCM-D assay was 
performed at 37°C using human fibrinogen (340 kDa) solution (0.5 mg/mL in PBS). Crystals 
were first exposed to PBS with a flow rate of 50 μL/min until a stable baseline was reached 
for frequency and dissipation. A fibrinogen solution was then flowed for 2 h followed by 
rinsing with PBS for 30 min. Protein adsorption on 4 different surfaces was compared each 
time by following changes in frequency (∆f) and dissipation (∆D) and each surface was 
tested at least three times. The Voigt viscoelastic modeling in QTools (Q tools, Q- sense AB, 
Sweden) was applied to estimate the adsorbed mass per surface unit by considering both 
frequency (∆f) and dissipation (∆D) shifts (Höök et al., 1998; Voinova et al., 1999). All the 
overtones except the first one were used to normalize the data and to estimate the adsorbed 
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mass of protein. It is important to note that the estimated mass included protein molecules in 
addition to water trapped in the layer. The following parameters were used for modeling the 
data as described by Weber et al. (Weber et al., 2007). The layer density was fixed at 1200 
kg/m3. Parameters fitted were i) layer viscosity between 0.001 and 0.01 kg/ms and ii) layer 
thickness between 10-10 and 10-7 m. 
 
 In addition, QCM-D was used to assess the stability of the PEG coating. To that 
purpose, 5% PEG grafted crystals were incubated in PBS (37°C, pH 7.4, 5% CO2) for 4 
weeks. Samples were then rinsed with Milli-Q water and dried with nitrogen gas. QCM-D 
assay was performed as described above to compare fibrinogen adsorption on LP, 5% PEG 
immersed for 1 day or for 4 weeks in PBS. This experiment was repeated three times. 
Between each experiment, gold crystals were extensively cleaned to remove LP and PEG for 
subsequent experiment. Crystals were cleaned by incubating them for 15 min in a solution 
containing Milli-Q water, ammonia and hydrogen peroxide (ratio of 5: 1: 1, 75 °C), followed 
by extensive rinsing with Milli-Q water. Then they were dried with nitrogen gas stream and 
exposed to UV and ozone for 10 min in an UV/ozone ProCleaner (Bioforce Nanosciences, 
Inc. Model ProCleaner 110), as reported in (Rodahl et al., 1997a). 
 
3.3.2.2 Comparing PEG, CMD and CS low-fouling properties 
 
 In this experiment, the gold-plated sensor surfaces were pre-coated with LP followed 
by PEG or CMD or CS. Protein adsorption kinetics were compared between these surfaces, 
as well as on a LP control surface. First, adsorption of human fibrinogen (0.5 mg/mL; 
340kDa) and BSA (0.2 mg/mL; 66kDa) were studied independently. Then the surfaces were 
subjected to FBS (10% v/v), which contains a wide range of proteins of various size and 
affinity. The adsorbed mass was calculated as described above. 
 
3.3.3  Combined immobilization 
 
 As mentioned earlier, the potential of combined immobilization of adhesive peptides 
(KQAGDV and RGD) and EGF to achieve confluent VSMC adhesion and growth on low-
95 
fouling surfaces was tested. In this section, the use of QCM-D to follow and analyze the 
immobilization peptides with/without coiled EGF is described. Gold-plated sensor surfaces 
were pre-coated with LP followed by PEG or CMD grafting, and followed by EMCH linker 
grafting as described in the peptide immobilization section. The linker-grafted surface can 
enable grafting of cysteine-tagged K coil and/or KQAGDV peptide via disulfide bonding 
(Trail et al., 1993), as shown in Figure 3.4. The sensor surfaces were inserted into the QCM-
D system equipped with 4 parallel flow modules to follow the serial immobilization of 
KQAGDV peptide, K coil and the tethering of E coil EGF in situ. Since the biomolecule 
solutions were prepared using PBS, the stable baseline for frequency and dissipation was first 
created using the same solution. For combined immobilization, as shown in Figure 3.9, 
KQAGDV peptide solution at various concentrations (38, 12.6, 4.2, 1.4 and 0.46 µM) was 
allowed to flow for 2 h and followed or not by injection of K coil (2 µM) solution. Then 
cysteine solution was flowed for 1 h to block possible unreacted sites of EMCH linker. 
Finally, E coil EGF solution (160 nM) was injected (1h) to tether E coil EGF onto K coil 
derivatized surfaces through coiled-coil interactions. For all experiments, at the end of each 
grafting step, surfaces were rinsed with PBS to remove unbound biomolecules and we waited 
until reaching the stable baseline before injecting another biomolecule solution. K coil and 
cysteine-only grafted surfaces were used as positive and negative controls, respectively. The 
frequency and dissipation changes due to the immobilization of biomolecules were recorded 
at each step. Since the dissipation values were very low, the grafted mass was calculated 
from frequency changes using the Sauerbrey equation. 
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Figure 3.9. Schematic diagram of serial immobilization of KQAGDV peptide, K coil, 
Cysteine and E coil EGF, with QCM-D. 
 
3.3.4 Measuring cell adhesion 
 
 QCM-D was also used to study VSMC adhesion kinetics in flow condition on various 
surfaces deposited on the gold sensors. Cells were routinely cultured in DMEM and used 
between passages 6 and 14. Cell suspension was prepared using DMEM (without serum) at a 
density of 1 × 105 cells/mL. For QCM-D experiments, first peptide grafting on a CMD 
surface was confirmed by following frequency changes (as described above) and cell 
suspension was then allowed to flow over the surfaces. Peptide-modified (LP + CMD + 
peptide) and unmodified LP surfaces were allowed to flow with the cell suspension at the 
flow rate of 50 µL/min. After 1 h adhesion, surfaces were rinsed with DMEM for 1 h (or 
until reaching a stable baseline) to remove weakly adhered cells. Cell adhesion was evaluated 
by recording changes in frequency and dissipation shifts. 
 
3.4 Protein adsorption studies by fluorescence measurements 
 
 Fluorescence measurements were performed using Texas Red conjugated BSA (66 
kDa; Sigma-Aldrich Canada Ltd., Oakville, ON, Canada) to confirm the results obtained with 
QCM-D and compare the coatings to pristine PET. Fluorescence measurements were used to 
demonstrate star PEG low-fouling properties as well as to compare BSA adsorption on PEG, 
CMD and CS surfaces. The fluorescence detection of adsorbed proteins was also used to 
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differentiate fouling and non-fouling patterns that were created using star PEG and LP 
coating on PET surfaces. 
 
3.4.1 Protein adsorption studies on PEG, CMD and CS surfaces  
 
 Each surface was covered with labeled BSA solution (0.2 mg/mL in PBS) for 2 h in 
static condition at room temperature (surfaces were protected from light exposure). The 
surfaces were washed thoroughly with PBS to remove unbound proteins, dried with a stream 
of nitrogen, and examined under a fluorescence microscope (Nikon Eclipse E600) at 10x 
magnification. The fluorescence intensity was assumed to be directly proportional to the 
amount of adsorbed albumin on the surface. The background auto-fluorescence was 
subtracted for each sample. 
 
3.4.2 Micro -patterning 
 
 In addition to developing low-fouling surfaces using star PEG coating, the ability of 
generating fouling and non-fouling micro-scale patterns was also investigated using LP and 
star PEG coating on PET surfaces. Micro-patterns were generated by placing electron 
microscopy grids (consisting of 184 µm wide parallel bars separated by 92 µm; Electron 
Microscopy Sciences, Hatfield, PA, USA; see Figure 3.10) over PET substrates before LP 
deposition. Then PEG grafting was performed by covalent binding and unbound PEG was 
removed by rinsing with PBS in an ultrasonic bath as explained above. Samples were then 
immersed in Albumin Texas Red conjugate (0.2 mg/mL in PBS) for 2 h at room temperature 
and surfaces were washed thoroughly with PBS to remove unbound protein. Finally, 
substrates were examined by fluorescence microscopy to differentiate the fouling and non-
fouling regions on PET surfaces. 
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Figure 3.10. Image of 
electron microscopy 
grids consisting of 184-
µm wide parallel bars 
separated by 92 µm. 
 
3.5 Platelet adhesion assays 
 
 Platelet adhesion and activation assays are typically used to evaluate the 
thrombogenicity of biomaterials. In this PhD, platelet adhesion assays were used first to 
estimate the anti-platelet property of star PEG and then to compare platelet adhesion on CS 
with PEG, CMD and bare PET surfaces. In both cases, platelet aggregation and morphology 
was also observed by scanning electron microscopy (SEM). Platelet adhesion in this study 
was evaluated by conducting perfusion tests using fresh human blood. This part of the study 
was approved by the human ethical committee of the Montreal Heart Institute. All subjects 
gave informed consent and were free from drugs interfering with platelet function for at least 
two weeks before blood sampling. Two different techniques were used to evaluate the 
amount of adhered platelets. First, radio-labeled platelets were used to demonstrate the anti-
platelet properties of star PEG, following a protocol previously used and validated by Merhi 
(Merhi, King et Guidoin, 1997). However, when comparing PEG, CMD and CS surfaces a 
different protocol was used, which was developed by H. Fadlallah (Master student at ETS) at 
Merhi's lab using direct immunostaining of platelets by FITC. This was chosen due to  the 
limitations of using radio-labeling at Merhi's lab, i.e. to reduce the cost and to allow double 
staining in the presence of endothelial cells. The perfusion system and platelet staining 
method are described in detail in the following paragraphs. 
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3.5.1 Perfusion system 
 
 All the perfusion assays were performed using plexiglas perfusion chambers that 
mimic the tube-like cylindrical shape of blood vessels (Diener et al., 2009; Merhi, King et 
Guidoin, 1997). The perfusion chambers were used to place the samples as shown in Figure 
3.11 (a & b), which allows direct exposure of the samples to a blood flow. For each perfusion 
assay, two chambers were connected in parallel and one sample placed in each chamber. The 
connection between the chambers and the peristaltic pump (Masterflex L/S 7518-10, Cole-
Parmer Inc.) has been made using non-toxic flexible surgical tubing (Tygon R-100, Fisher 
Scientific, Canada), and a thermostatically controlled water bath was used to maintain the 
perfusion system at 37° C, as shown in Figure 3.11 c. The perfusion time (15 min) and flow 
rate (40 mL/min) was fixed for blood flow. 
 
 The hemodynamic conditions inside the blood vessels lead to the development of 
shear stress, which is applied against the inner layer of vessel wall. Shear rate is the velocity 
gradient calculated across the diameter of a blood-flow channel, which is defined as the rate 
at which adjacent layers of fluid move with respect to each other. In physiological conditions, 
the shear stress at the arterial wall ranges between 10 and 70 dynes/cm2 (Papaioannou et 
Stefanadis, 2005). The shear rate or shear stress of perfusion in this study corresponds to 840 
s-1 or 29 dyn/cm2. This is calculated using Poiseuille’s law with the following approximation: 
the blood is an ideal Newtonian fluid, the blood flow is steady and laminar and the blood 
vessel is straight, cylindrical and inelastic (Papaioannou et Stefanadis, 2005). 
 
                                                            τ =  32. µ. Q/ π.d3                                                    (2.3) 
 
Where  = shear stress,  µ= viscosity of blood (3.5  10-3 Pa s), Q = mean volumetric flow 
rate (40 mL/min), d = chamber internal diameter (2mm).  
 
Therefore, τ = 32×3.5×10-3×0.66 / 0.025 = 29.4 dyne/cm2 and Shear rate ( ) =   = 840 s-1 
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Figure 3.11. Schematic picture of (a) perfusion chamber (b) sample holder 
and (c) perfusion system setup along with thermostatically controlled water 
bath. 
 
3.5.2 Platelet adhesion assay with radio-labeled platelets 
 
3.5.2.1 Platelet isolation and labeling 
 
 Platelet isolation and labeling as well as the perfusion experiments were conducted by 
following the previously developed method in Merhi's lab (Diener et al., 2009). A 60-mL 
sample of venous blood from each subject was anti-coagulated with 6 mL of D-Phenylalanyl-
L-prolyl-L-arginine chloromethyl ketone (PPACK; Calbiochem, QC, Canada) in saline (50 
nM final concentration) and a 30-mL sample with anticoagulant citrate dextrose (ACD, 
Baxter, Mississauga, Canada). PPACK was used in this study instead of heparin, because it is 
effective in preventing fibrin-  and surface- bound thrombin (Bernd, Jens et Maria, 2006). 
The ACD blood was used to isolate and radio-label platelets. Briefly, platelet-rich plasma 
(PRP) was isolated by centrifugation for 15 min at 1800 rpm. PRP was then centrifuged for 
10 min at 2200 rpm to separate platelets from platelet-poor plasma (PPP). The pellet of 
platelets was suspended with Hanks’ Balanced Salt Solution (HBSS; Sigma-Aldrich Canada 
Ltd., Oakville, ON, Canada) containing 0.5 µg/µL of prostaglandin E1 (PGE1; Sigma-
Aldrich Canada Ltd., Oakville, ON, Canada) and centrifuged for 10 min at 2200 rpm. The 
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platelet pellet was re-suspended with 2 mL of HBSS containing PGE1, and incubated with 
250 µCi of Indium111 Oxine (GE Healthcare Canada inc. Burlington, Ontario) for 15 min at 
room temperature, followed by centrifugation for 8 min at 2100 rpm. The supernatant was 
removed and the radio-labeled platelet pellet re-suspended in 10 mL of PPP and finally 
mixed with the 60 mL of the PPACK blood. Platelet count of each sample was measured 
using the Coulter Act Diff cell counter (Beckman Coulter, Canada). For reference, 10 µL of 
blood containing labeled platelets was measured using a gamma counter (Minaxi 5000, 
Packard Instruments). 
 
3.5.2.2 Platelet adhesion  
 
 Various samples (bare PET, LP-coated PET, and PEG-coated PET (prepared with 5% 
w/v PEG) were placed in the perfusion chambers that contained a window of 2 mm internal 
diameter x 10 mm long, permitting direct exposure of the samples to the blood. The samples 
within the perfusion chambers were directly exposed to the blood containing 111In labeled 
platelets for 15 min at a flow rate of 40 mL/min and shear rate of 853 s-1 (29 dyne/cm2), 
followed by rinsing with a buffered formalin solution for fixation. At the end of each 
experiment, the radioactivity on the exposed surfaces was measured using a gamma counter 
(Minaxi 5000, Packard Instruments). Platelet adhesion on each test surface was calculated 
from the known radioactivity of reference and platelet count in the blood in count per minute 
(cpm), using the following equation (Eq. 2.4). The experiment was repeated for each test 
surface using three different healthy blood donors. Results were also compared to intact (with 
endothelium) and injured (scrapped endothelium) arterial surfaces from pigs. 
 
          
 
3.5.3 Platelet adhesion assay using fluorescence staining 
 
 This technique is not required for platelet isolation prior to perfusion assay. A 60 mL 
sample of venous blood from each subject was anticoagulated with 6 mL of D-Phenylalanyl-
       (2.4) 
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L-prolyl-L-arginine chloromethyl ketone (PPACK) in saline (50 nM final concentration), as 
described above. The samples (bare PET, PET coated with LP +/- PEG, CMD and CS) were 
mounted in perfusion chambers and perfusion conducted for 15 min, as explained above. 
After perfusion, the surfaces were rinsed with saline for 10 s to remove weakly adhered 
platelets. Surfaces were then removed from the chambers and rinsed with PBS for three 
times. Platelets adhered to the surface were then stained with fluorescein isothiocyanate 
(FITC)-labeled anti-CD61 (DAKO, Burlington, Ontario, Canada), which is specific to CD61, 
a platelet membrane glycoprotein (Chou et al., 2003). The staining solution was prepared by 
dissolving FITC-labeled anti-CD61 (20 µg/mL) in 1% BSA. Each surface was covered with 
100 µL of this solution for 15 min, followed by three rinses with PBS to remove non-specific 
adsorption of the antibody. Finally, surfaces were fixed with 1% paraformaldhehyde for 25 
min and transferred to microscope slides with a mounting medium (DABCO, Fisher 
Scientific, Canada). Confocal microscopy images (Carl Zeiss LSM 510) were taken in the 
central zone of the exposed surface while areas out of the edges were excluded. The 
percentage of surface area covered by platelets was calculated using Image J software. 
 
3.5.4 Scanning electron microscopy 
 
 After platelet adhesion assay, each surface was observed by scanning electron 
microscopy (SEM) to confirm platelet adhesion and morphology to assess aggregation and 
activation. The specimens were dehydrated through a series of graded ethanol solutions 
(30%, 50%, 70%, 95% and 2x 100% v/v) and subjected to CO2 critical point drying (E3000, 
Polaron, Quorum Technologies). The dried specimens were sputter-coated with gold for 2 
min ( ~15 nm layer) and then observed using a Hitachi S-3600N (Hitachi High-Technologies, 
Canada) operating at an acceleration voltage of 5 kV under high vacuum. 
 
 A brief description about platelets and their morphology is provided here for 
understanding SEM images in the following sections. Platelets are the smallest corpuscular 
components of human blood with a diameter of 2-4 µm, which does not contain a nucleus 
(Harrison, 2005). The typical shape of adhered platelets is discoid (see Figure 3.12), but, 
upon activation, their shape changes to a spherical form with pseudopodia up to 5 µm long. 
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The adhesive proteins such as collagen, fibronectin, laminin, vitronectin, fibrinogen and von 
Willebrand factor (vWF) are known to promote platelet adhesion (Harrison, 2005). Platelets 
activation leads to actin polymerization, cytoskeleton reorganization and finally secretion of 
storage granules (calcium, vWF, ADP, P-selectin). The secretion of storage granules 
amplifies activation and aggregation, exposure of phosphatidylserins that enhance pro-
coagulant activity and contribute to thrombus stability (Harrison, 2005). 
 
 
Figure 3.12. Typical smooth discoid shape of platelets (left) and spherical 
shape of activated platelets (right) (Harrison, 2005). 
 
3.6 Cell culture experiments 
 
 Cell culture experiments were performed in various situations. Simple HUVEC 
adhesion and growth experiments were carried out to compare low-fouling properties of 
PEG, CMD and CS surfaces as well as to estimate HUVEC retention on various surfaces 
under blood flow. In order to confirm cell adhesion results obtained with QCM-D, VSMC 
adhesion assay was also performed in static condition to determine the KQAGDV or RGD 
bioactivity after grafting on a CMD surface. 
 
3.6.1 HUVEC adhesion and growth  
 
 Various surfaces (bare PET, PET coated with LP +/- CS, PEG and CMD; 1 cm2 each) 
were placed at the bottom of 24-well plates. Cloning cylinders (internal diameter= 0.8 cm; 
Corning, Lowell, MA, USA) were used to limit the area and to retain the films at the bottom 
of the wells. HUVECs (Lonza, Shawinigan, Canada) were routinely cultured in Lonza EGM-
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2 medium (containing growth factors and 2 % (v/v) FBS) and used between passages 2 and 
6. 
 For cell adhesion and growth assays, cells were suspended in an EGM-2 culture 
medium at a density of 0.75 × 105 cells/mL. A volume of 200 µL (15,000 cells) was 
deposited on each surface and cells were left to adhere for 4 h. The cloning cylinders were 
then removed and surfaces were washed with PBS (1x) to remove non-adherent cells. Cells 
were stained with a 0.75% (w/v) crystal violet solution (Sigma- Aldrich, Oakville, Canada) 
for 15 min and rinsed three times with Milli-Q water before drying at RT. For growth assays, 
after removal of the cloning cylinders, cells were left to grow for 2 d in complete medium at 
37 °C and 5% CO2 before being stained as described above. Three images per sample were 
captured by optical microscopy to evaluate cell density. A minimum of four samples was 
tested per condition and the experiment was repeated three times. 
 
 Focal adhesion assay: Focal contact formation was evaluated by immunostaining for 
vinculin and actin fibers after 24 h adhesion of HUVEC (15,000 cells/well) on the various 
surfaces (PET, LP, LP + CS and LP + CMD) in presence as well as in absence of serum in 
order to determine the advantage of using CS coating. To that purpose, substrates were rinsed 
with PBS, fixed with 4% paraformaldehyde for 10 min, permeabilized with 0.4% Triton X-
100 for 10 min and blocked 1 h with 2% BSA in PBS. Samples were then incubated 
overnight with a mouse anti-vinculin antibody (diluted 1:200 in PBS/2% BSA; MAB3574, 
Millipore, USA) at 4°C, followed by incubation with a secondary Goat Anti-Mouse IgG 
Alexa 546 (diluted 1:600 in PBS/2% BSA; Molecular probes, Invitrogen, Canada)) for 1 h at 
RT. To stain actin, samples were then incubated with Phalloidin-Alexa 488 (1:40 in PBS; 
Molecular probes, Invitrogen, Canada)) for 1 h, and finally counterstained for the nucleus 
with Hoechest 33258 (0.5μg/mL in PBS; Sigma-Aldrich Canada Ltd., Oakville, ON, Canada) 
which was added for the last 10 min of incubation. Samples were then mounted on glass 
slides using the DABCO mounting medium and images of stained samples were acquired 
using confocal microscopy (Olympus FV1000MPE). 
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3.6.2 VSMC adhesion assay on peptide grafted surfaces 
 
 To confirm results obtained with QCM-D, VSMC adhesion assay was performed in 
static condition. Various surfaces (bare PET, PET+LP, LP +CMD, LP +CMD + Peptide; 1 
cm2 each) were placed at the bottom of 24 well plates and cloning cylinders were used to 
limit the area and to retain the films at the bottom of the wells. Cells were suspended in 
DMEM (without serum) at a density of 0.75 × 105 cells/mL. A volume of 200 µL (15,000 
cells) was deposited on each surface and left to adhere for 4 h. The cloning cylinders were 
then removed and surfaces were washed with PBS (1x) to remove non-adherent cells. Cell 
staining procedure was followed as described above using a 0.75% (w/v) crystal violet 
solution. Three images per sample were captured by optical microscopy to observe cell 
adhesion and a minimum of four samples were tested per condition. 
3.7 Statistical Analysis 
 
 All the results are expressed as mean ± standard deviation. Statistical analysis was 
carried out using one-way ANOVA analysis followed by Tukey’s post-hoc analysis. The 
student's t test was used when comparing two groups and p < 0.05 was considered to be 
statistically significant. 
 

 CHAPTER 4 
 
 
RESULTS AND DISCUSSION 
 
 This section is divided into three different subsections, according to the three specific 
objectives. Results and discussion sections are presented separately for each specific 
objective. 
 
4.1 Develop a low-fouling and low-thrombogenic coating that can be applicable to 
 a wide variety of biomaterial surfaces. 
 
4.1.1 Rationale  
 
 The first objective of this thesis was to develop a low-fouling and low-thrombogenic 
coating using PEG that can be applicable to a wide variety of biomaterial surfaces and allows 
subsequent coupling of bioactive molecules. Indeed the current PEG coating methods lack 
versatility. The stable plasma polymerized coatings (LP) with very high primary amine 
density have been created, which can be deposited on a large variety of biomaterials. LP 
coatings allow the stable chemical coupling of desired molecules and therefore are able to 
reach high surface coverage. On the other hand, multi-arm PEG coating is known to offer 
higher grafting densities and better low-fouling properties compared to linear PEG due to its 
molecular architecture, long chain length and presence of several terminal groups (Hoffmann 
et al., 2006). 
 
 We hypothesize that together LP and star PEG could be an interesting and novel 
method for stable star PEG grafting, which can be applied to a large variety of biomaterials 
(polymers, ceramics, metals and semiconductors used in biomedical applications); it can also 
enable one to create various deposit geometries such as micro-patterns. In this part of the 
thesis, the ability of LP coating combined with star PEG to create protein and platelet-
repellent surfaces has been studied. To optimize this PEG grafting method, first covalent 
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coupling of star PEG on amino-coated glass substrates was assessed by static contact angle 
and XPS analysis (as a function of PEG coupling concentration), and then protein adsorption 
studies by QCM-D using LP coated substrates were carried out. Finally, the ability of PEG 
coatings to decrease protein adsorption and platelet adhesion on PET films was confirmed by 
fluorescence measurements and an in vitro perfusion platelet adhesion assay, respectively. 
 
4.1.2 Results 
 
4.1.2.1  Surface characterization 
 
 In order to confirm the presence of PEG, water contact angles were first measured on 
amino-coated glass before and after PEG coating (Figure 4.1). While amino-coated glass 
exhibited a relatively hydrophilic surface (54.9 ± 1.1°), the contact angle significantly 
decreased after star PEG grafting as a function of its coupling concentration. As can be seen 
in Figure 4.1, no significant difference was observed between 5 and 15%; very similar results 
were obtained for PEG grafting on LP deposited PET films. LP coatings, on their side, 
exhibited a contact angle of about 56.1 ± 0.6°. 
 
 
Figure 4.1. Static water contact angles on unmodified amino-coated glass 
(left) and LP (right), and after PEG coating at various coupling concentrations 
(0.55, 1.66, 5, and 15% w/v). Results are expressed as mean ± SD, n=9-12. 
*Significantly different from amino-coated glass and LP surfaces (P<0.001), 
# significantly different from 5% PEG (P<0.001). 
 
 XPS measurements further confirmed star PEG presence after the covalent coupling 
procedure on amino-coated glass surfaces. Survey scans were used to study changes in 
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elemental composition of modified and unmodified substrates. Table 4.1 shows the decrease 
of silicon (Si) and nitrogen (N) concentration, in parallel to the increase in carbon (C) on all 
PEG-modified surfaces, indicating the presence of PEG. However, in case of PEG 15%, we 
did not observe further increase in C or decrease in Si, which suggest that using PEG 15% 
may not help to further increase the grafting density. These results were further confirmed by 
high-resolution C1s and O1s scans. As shown in Figure 4.2, four different peaks were 
identified on the aminated glass control: the main two peaks (binding energies of 285 eV and 
284 eV) corresponded to carbon-carbon (C-C) and carbon-silicon (C-Si) bonding, 
respectively. The low intensity peak around 286.3 eV was attributed to a mixture of C-N and 
C-O bonds, for which binding energies are too close to be discriminated. This peak most 
likely came from the amination process used by the manufacturer since commercial amino-
coated glass substrates are generally produced by amino silylation using amino propyl 
triethoxy/methoxy silane. Therefore it is probable that this peak combines C-O (from 
triethoxy) and C-N (from C-NH2 end groups) groups. The other small intensity peak at a 
higher energy level (288.4 eV) was attributed to the presence of carboxyl groups resulting 
from surface contamination (Sofia Susan et Merrill Edward, 1997). High-resolution scans of 
all star PEG grafted surfaces presented a large increase of the peak around 286.5 eV, in 
agreement with the presence of C-O bond in PEG. As can be seen in Figure 4.2, the relative 
intensity of this peak increased with star PEG coupling concentration, hence highly 
suggesting that the density and/or thickness of PEG coating increased with PEG 
concentration. XPS analysis was also performed on PEG-coated LP surfaces. However due to 
the complexity of LP composition, in particular the presence of C-N bond, whose binding 
energy is close to that of C-O groups in PEG (Wagner, 1979), we were unable to reach a 
conclusion about C-O increase on these substrates. 
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Figure 4.2. XPS high-resolution C1s scans of amino-coated glass (a) before and (b-e) after 
star PEG grafting at various coupling concentrations (0.55, 1.66, 5, and 15% w/v). Note 
that the relative intensity of the C–O peak increased with the PEG coupling concentration; 
(f) Overlay spectra of 15% PEG-modified on unmodified amino-coated surface. 
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Table 4.1. Surface elemental concentration (in At. %) of C, 
O, Si and N, as determined by XPS on amino-coated glass 
and PEG-modified surfaces using various star PEG coupling 
concentrations. 
 
 
4.1.2.2  Protein adsorption studies 
 
 The non-fouling properties of our LP-PEG-coatings were first investigated by 
monitoring fibrinogen adsorption using QCM-D. Figure 4.3 presents an example of change in 
resonance frequency (∆f) and dissipation (∆D) when LP and PEG (5%) coated quartz crystals 
were exposed to a solution of fibrinogen (0.5 mg/mL). On LP surfaces, introduction of the 
fibrinogen solution led to rapid decrease of the resonance frequency, indicative of fibrinogen 
adsorption, while the related increase in dissipation indicated that the adsorbed protein layer 
was viscous. A subsequent rinse with PBS (pH 7.4) induced only slight changes, indicating 
that only a small amount of bound fibrinogen was dissociated when rinsing with buffer and 
most of the protein was irreversibly adsorbed (Höök et al., 2002). Δf and ΔD were much 
reduced on the PEG-modified surface.  
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Figure 4.3. QCM-D real-time change in resonance frequency (Δf) and dissipation 
(ΔD) related to modified (5% PEG) and unmodified LP surfaces upon exposure to 
fibrinogen solution (0.5 mg/mL; (1)) followed by rinsing with PBS (2). 
 
 Typical mass variation over time with the various PEG concentrations is presented in 
Figure 4.4, which is an example figure that presents data from one experiment, and the 
summarized data from several experiments were presented in Figure 4.5. As expected, 
fibrinogen adsorption decreased with rising PEG concentration, reaching a maximum 
reduction of 79 ± 11% for 5% w/v PEG solution. Increasing PEG concentration from 5 to 
15% did not result in a significant difference in subsequent fibrinogen adsorption (p=0.78). 
Finally, after 4 weeks’ immersion in PBS, the 5% PEG-coated surface still exhibited strong 
reduction of fibrinogen adsorption (89 ± 7%) compared to LP (Figure 4.6.). 
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Figure 4.4. Time-resolved effect of various PEG coupling 
concentrations on fibrinogen (0.5 mg/mL) adsorption. QCM-D 
data were analyzed according to the Voigt model. Time of 
fibrinogen injection (1) and rinsing with PBS (2) are indicated. 
This is an example figure that shows data from one experiment. 
 
 
 
Figure 4.5. Calculated mass of adsorbed fibrinogen 
(0.5mg/mL) on LP and after PEG grafting at various 
coupling concentrations. QCM-D data were analyzed using 
the Voigt model. Results are expressed as mean ± SD, n=4 
(* result expressed as a mean; n=2 only). 
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Figure 4.6. Example curves for fibrinogen (0.5 mg/mL) 
adsorption on LP and on PEG modified surfaces immersed in 
PBS over a period of 1 or 28 days. QCMD data were analyzed 
according to the Voigt model. Time of fibrinogen injection (1) 
and rinsing with PBS (2) are indicated. 
 
 In parallel, Texas-red conjugated albumin (66kDa, 0.2 mg/mL) adsorption in static 
condition was also investigated using fluorescence microscopy in order to allow comparison 
with PET surfaces (Figure 4.7). Since no significant difference had been observed by QCM-
D between 5 and 15% PEG conditions, only coatings obtained with in-solution 
concentrations of PEG up to 5% were compared to LP and to bare PET surfaces. While LP 
coating increased albumin adsorption compared to bare PET films, further PEG grafting 
strongly decreased protein adsorption. PEG coatings were even effective at low in-solution 
PEG concentrations and the amount of albumin adsorption decreased as PEG coupling 
concentrations were increased. Of interest, all PEG concentrations enabled decreasing 
albumin adsorption below PET control (P<0.001). On 5% PEG, fluorescence was decreased 
by 92% and 88% compared to LP and PET, respectively. 
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Figure 4.7. Fluorescence detection of adsorbed Texas red labeled 
albumin (0.2 mg/mL) on bare PET, LP alone and LP-PEG coated PET. 
Results are expressed as mean ± SD (n=12). Background was 
subtracted from each surface. *Significantly different from PET 
(P<0.001), # significantly different from LP+ 5% PEG (P<0.001). 
 
 Texas red conjugated albumin was also used to demonstrate the applicability of our 
LP deposition method to the generation non-fouling micro-patterns (Figure 4.8). While only 
a slight difference was observed between PET and PET+LP coated regions (Figure 4.8 a), 
subsequent PEG grafting led to non-fouling areas clearly distinct from bare PET regions that 
manifested strong adsorption (Figure 4.8 b).  
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Figure 4.8. Fluorescence microscopy images of LP micro-patterns on PET 
surfaces after exposure to albumin Texas red conjugate. Parallel pattern surface 
(a) without PEG grafting and (b) modified with PEG. 
 
4.1.2.3 Platelet adhesion 
 
 The levels of platelet adhesion on the various surfaces after 15 minutes of perfusion 
with whole blood containing radiolabeled platelets (see section 3.5.2) are presented in Figure 
4.9. As expected, LP coating on PET significantly increased platelet adhesion when 
compared to pristine PET (2060 x 103 versus 244 x103 platelets/cm2). These levels were, 
however, much lower than those corresponding to injured arterial tissues (15,195 x 103 
platelets/cm2). Of interest, PEG grafting (5% PEG solution) on LP drastically decreased LP 
surface thrombogenicity, reaching levels about 10 times lower than those determined for bare 
PET control surfaces (25 x 103 versus 244 x 103 platelets/cm2; p<0.001).  
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Figure 4.9. Platelet adhesion on an intact artery, injured artery, PET 
film, LP and 5% PEG- modified substrates. Results are expressed on a 
logarithmic scale, as mean ± SD (n=12). * significantly different from 
PET (P<0.001), # significantly different from LP + 5% PEG (P<0.001). 
 
 Direct observation of each individual surface using SEM (Figure 4.10) confirmed that 
platelet adhesion was almost abolished on PEG surfaces, since no platelets were observed on 
these surfaces. In contrast, a high level of platelet adhesion and aggregation was noticed after 
LP treatment and platelet morphology indicated that many of them were activated. Finally, 
although only a few platelets were identified on PET surfaces, their morphology 
corresponded to elongated pseudopodia and leading to platelet activation (Park, Mao et Park, 
1990), which has been reported to contribute to the recruitment of other platelets and blood 
cells such as leukocytes during long-term contact with blood. 
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Figure 4.10. SEM visualization of platelet adhesion on 
LP (a, b), PET (c, d) and LP + 5% PEG (e, f) grafted 
surfaces. 
 
4.1.3 Discussion 
 
 In this study, we have successfully grafted star PEG in a covalent fashion onto amino-
coated surfaces, as indicated by contact angle measurements and by XPS. The presence of 
surface-adsorbed PEG cannot be completely excluded, although unlikely because rinsing in 
the ultrasonic bath most probably removed loosely bound PEG from the surface. Increasing 
PEG concentration during coupling greatly increased its density of the final coating, up to 
15% PEG. While contact angle measurements showed no difference between 5 and 15% 
PEG, the relative intensity of the C-O peak was higher for 15% PEG. This suggests a higher 
density of the PEG coating that may in turn reduce protein adsorption, especially for small 
proteins such as albumin. However, owing to the high cost of star-shaped PEG and the 
modest improvement according to QCM-D assay when increasing concentration from 5 to 
119 
15%, we chose to evaluate the 5% PEG coating only, assuming that it would sufficiently 
reduce protein and platelet adhesion for the achievement of the other objectives of this thesis.  
 
 Fibrinogen and albumin were chosen for protein adsorption studies due to the fact 
that they are two major constituents of blood plasma. Fibrinogen (340 kDa), in particular, 
plays a key role in platelet adhesion and aggregation (Ratner Buddy, 2000). Albumin, a 
smaller protein (66 kDa), was also tested. 5% PEG coating strongly decreased protein 
adsorption compared to LP surfaces, fibrinogen adsorption was reduced by 79% and albumin 
by 92%, as deduced from QCM-D and fluorescence measurements, respectively. The slight 
discrepancy between QCM-D and fluorescent labeling results may be attributable to an 
overestimation of wet mass adsorption by QCM-D, in addition to inherent differences 
between dynamic (QCM-D) and static (fluorescence) assays for protein adsorption. Indeed, it 
has already been reported that QCM-D leads to 1.4 to 4-fold overestimation of adsorbed 
mass when compared to labeling or optical methods, depending on the type of protein 
(Weber, Wendel et Kohn, 2005b). However, protein adsorption could not be completely 
abrogated, even at high PEG coupling concentration. This result is most likely due to protein 
adsorption occurring at open spaces between the star PEG molecules (Sofia Susan et Merrill 
Edward, 1997), a process that can be favored by protein conformation changes initiated by 
steric constraints (Huang et al., 2011). Studies have also shown that protein adsorption 
decreases as PEG chain length and density increase (Gombotz et al., 1991; Groll et Moeller, 
2010; Zhu et al., 2001). Hence, increasing PEG molecular weight and concentration may 
further decrease or completely inhibit protein adsorption with our amine-rich deposited 
polymer. Other teams showed that even more complete protein repellency can be achieved 
with PEG-containing copolymers (bulk modification) (Weber et al., 2007). However, these 
particular cases are very different from the method that we propose here, since the latter is 
much more versatile and can be translated to any type of surface without modifying the bulk 
properties of biomaterials. 
 
 Another interesting feature of the present method is its use to create fouling / non-
fouling micro-patterns, as shown by experiments with electron microscopy grids (Figure 4.8). 
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Finally, the present PEG grafting method was demonstrated to exhibit excellent stability, as 
evidenced by strong reduction of fibrinogen adsorption over periods close to one month. 
Interestingly, results suggest that PEG is even more protein-resistant after 4 weeks of 
incubation in PBS than after 1 day in PBS. The reason for this observation is unclear and 
further investigation would be needed using complementary surface analysis techniques such 
as XPS and ellipsometry dry thickness measurements at different incubation times to better 
assess PEG stability on the surfaces. 
 
 The low level of fibrinogen adsorption on PEG surfaces can be directly related to 
their ability to prevent platelet adhesion (Zhang, Desai et Ferrari, 1998). This was confirmed 
with our perfusion model using fresh human blood, which mimics physiological conditions. 
This perfusion model is believed to better estimate the non-thrombogenic potential of PEG-
grafted surfaces compared to platelet adhesion tests performed under static condition because 
it better mimics the hemodynamic conditions inside the blood vessels (Dimitrievska et al., 
2011) as the contact of platelets with a given surface is a dynamic process that involves 
adhesion, activation, secretion and spreading. The relatively high level of platelet adhesion 
after LP treatment and its morphology by SEM indicate that LP attracts blood elements such 
as proteins and platelets. PEG grafted surface led to negligible number of platelet adhesion, 
as determined in our platelet adhesion assay and further confirmed by SEM observations. 
 
 The star PEG grafting method developed here is versatile and was shown to possess 
good stability in PBS, but how long PEG coated implants would consistently exhibit protein 
resistance and prevent thrombosis in vivo needs further investigation since PEG long-term 
stability and efficiency to prevent thrombus formation in vivo has shown to be limited (Akbar 
et al., 2011; Hubbell, 1993). As will be discussed later, the sole use of low-fouling coatings 
to prevent thrombus formation has been shown to exhibit disappointing results, due to the 
lack of active process to inhibit coagulation. Other methods proposed in the literature will be 
described in the section 1.3.2, but the sole completely long-term anti-thrombogenic surface 
that is known so far is a stable confluent endothelium lining. This could be achieved by 
immobilizing peptide and/or growth factor on star PEG or other low-fouling polymers to 
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promote confluent cell adhesion and growth. Indeed PEG derivatives have been shown to be 
interesting potential molecular linker/spacers for such bioactive molecules. Moreover, due to 
the steric constraints, either one or two terminal groups of star PEG are grafted to the surface, 
while the remaining groups do not participate in amide coupling and emanate outside of the 
surface. Hence, these terminal groups will be available for subsequent coupling of 
biomolecules. More importantly, star PEG increases the bioactivity of immobilized 
biomolecules and helps to achieve optimal interactions with the cells. 
 
4.2 Develop a bioactive coating with the combination of peptide and GF on low-
 fouling background. 
 
4.2.1 Rationale  
 
 We just showed that low-fouling PEG surfaces that strongly decrease protein 
adsorption and platelet adhesion can be created on any kind of biomaterial surface using 
nitrogen-rich plasma polymers (LP). Such low-fouling surfaces are believed to have several 
advantages in developing bioactive coatings. 
• They prevent non-specific protein adsorption and platelet adhesion, but their terminal 
groups allow the immobilization of bioactive molecules to generate specific 
interactions with cells. 
• They could enhance the bioactivity of immobilized biomolecules by offering 
conformational flexibility and motility.  
 The second aim of this thesis was to generate bioactive surfaces on low-fouling 
backgrounds and demonstrate their advantages for promoting optimal cell interactions. For 
several reasons, the bioactive coatings developed during this part of the thesis were created 
not to generate an EC layer on VG but for another clinical application, i.e. to improve VSMC 
adhesion and growth around stent-grafts (see section 1.1.3 in the literature review). Thus the 
peptides and EGF were chosen for their adhesive properties and proliferative and anti-
apoptotic properties on VSMC, respectively. Based on the literature review, adhesive 
peptides such as RGD or KQAGDV could help to improve VSMC adhesion (Bellis, 2011; 
Dong et al., 2012a; Mann et al., 2001; Sabra et Vermette, 2011), while EGF immoblization 
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on biomaterials was shown to enhance VSMC survival and proliferation (Charbonneau et al., 
2011; Lequoy et al., 2014). However, it was observed that EGF immobilization alone is not 
sufficient to achieve confluent cell growth on low-fouling backgrounds (Klenkler et al., 
2008; Lequoy et al., 2014). Therefore we hypothesize that combined immobilization of 
integrin-binding peptide and growth factor (EGF) could lead to positive synergistic effects 
and help to achieve optimal cell interactions on low-fouling background. 
 
 In this project we combined the immobilization of KQAGDV/RGD peptide and EGF 
on PEG or CMD surfaces. To that end we take advantage of coiled-coil immobilization 
(Boucher et al., 2008b), which enables oriented immobilization of EGF. Since we aimed to 
develop a versatile method which could be applied on any biomaterial surface, LP films were 
first deposited and then used to graft a low-fouling polymer followed by peptide and EGF 
tethering. A secondary objective of this part of the PhD thesis was to demonstrate the ability 
of QCM-D to follow and optimize the sequential grafting of peptides and EGF on the 
surface. First, two different linkers (EMCH and PDPH) and two low-fouling substrates (PEG 
and CMD) were tested to choose the most appropriate ones. Then the peptide coupling 
solution concentration was varied while keeping that of EGF constant. The frequency and 
dissipation shifts were recorded for each immobilization step. The adsorbed mass was 
calculated using the Sauerbrey equation, since the dissipation values were too low to be 
considered for the Voigt model. Finally, the impact of the adhesive peptides on cells was 
evaluated by performing cell culture experiments in flow as well as in static conditions. 
 
4.2.2 Results 
 
4.2.2.1 Choosing a linker 
 
 EMCH and PDPH linkers were pre-coated on CMD surfaces and their efficiency for 
immobilization was verified by comparing K coil followed by E coil EGF immobilization in 
situ using QCM-D. Frequency shifts were observed as shown in Figure 4.11. A K coil 
solution injection on an EMCH-modified surface yielded a significantly higher frequency 
shift compared to that of a PDPH-modified surface. Subsequent E coil injection on these 
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surfaces further confirmed that EMCH allows more EGF recruitment than a PDPH surface. It 
is important to note that E coil EGF immobilization occurred only through coiled-coil 
interaction, since the unreacted EMCH sites were blocked with cysteine after K coil 
immobilization. These observations suggest that an EMCH linker is a better choice for 
further steps. 
 
 
Figure 4.11. QCM-D frequency shift due to K coil, cysteine and E coil 
EGF serial injections on EMCH and PDPH modified CMD surfaces. 
Arrows refer to the PBS rinsing. 
 
4.2.2.2 PEG vs. CMD 
 
 PEG and CMD are both known to reduce non-specific protein adsorption and both 
contained carboxyl groups that allow subsequent protein/peptide grafting. However, the 
concentration of these carboxylic groups may vary between PEG and CMD. It was thus 
important to assess possible differences in K coil/EGF immobilization between two surfaces. 
Since an EMCH linker allowed better K coil/EGF grafting, it was used to compare PEG and 
CMD surfaces. A significant frequency shift was observed on both PEG and CMD surfaces 
after K coil immobilization, but the frequency shift was slightly higher on the CMD surface, 
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as shown in Figure 4.12. This difference was very significant after E coil EGF injection, 
which indicates that CMD allows higher levels of immobilization than PEG. Cysteine only 
grafted PEG and CMD surfaces neither allow immobilization of K coil nor subsequent E coil 
EGF recruitment (top two curves in Figure 4.12), which indicates that the reactive sites had 
reacted with cysteine and non-specific adsorption of K coil and E coil EGF is completely 
prevented on these surfaces. These observations also indicate that K coil is grafted only 
though the EMCH linker and accessible for coiled-coil immobilization of E coil EGF. CMD 
was chosen for future steps, since it allowed better immobilization. 
 
 
Figure 4.12. QCM-D frequency shift due to K coil, cysteine and E coil EGF 
serial injections on EMCH activated PEG and CMD surfaces. PEG + 
Cysteine and CMD + cysteine control surfaces corresponds to surface where 
K coil had not been immobilized. Arrows refer to the PBS rinsing. 
 
4.2.2.3 Combined immobilization of KQAGDV peptide and growth factor 
 
 Figure 4.13 presents one typical QCM-D result corresponding to the injections of 
various concentrations of peptide (0.15, 0.46 and 38 µM) on an EMCH + CMD surface, 
followed by K coil and E coil EGF injections. As expected, the frequency shifts increased 
with peptide concentrations and the highest frequency shift was observed for 38 µM. K coil, 
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cysteine (to block available sites), and E coil-EGF injections led to a further decrease in 
frequency. 
 
 
Figure 4.13. QCM-D frequency changes due to immobilization of various 
concentrations of KQAGDV and serial immobilization of K coil, Cysteine and E 
coil EGF on CMD surfaces. Arrows refer to PBS rinsing. 
 
 Experiments were repeated at least three times for each condition. Figure 4.14 
summarizes the mean mass changes due to peptide, K coil and EGF immobilization. An 
increase in peptide grafted mass was observed from 0.15 µM to 38 µM input concentrations. 
Subsequent K coil grafting mass was influenced by the initial peptide grafted mass, with a 
clear increase in K coil and E coil grafted mass as the initial peptide grafting mass decreases. 
However, this trend was not observed for data corresponding to 0.46 and 0.15 µM peptide 
concentration . This can be at least partly explained by the limitation of using QCM-D, which 
allows comparison of only four surfaces at a time. The resulting variability of results from 
one experiment to another may explain why there is no clear trend at such low peptide 
concentration. Overall, these results indicate that E coil EGF mass can be increased by 
decreasing peptide concentration and vice versa. This is due to the fact that both molecules 
use the sample functional groups for immobilization, so that surfaces with low peptide 
concentration have more available sites for K coil immobilization. More generally, results 
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show that it is possible to capture both the peptide and growth factor at different ratios using 
CMD surfaces. 
 
 
Figure 4.14. Mass increase corresponding to KQAGDV, K coil grafting 
and E coil EGF recruitment on CMD surfaces (previously modified 
with EMCH linker), as a function of KQADGV concentration that had 
been initially injected (n=3-6). Cys only surface corresponds to 
negative control surface, on which reactive sites are blocked with 
cysteine. 
 
4.2.2.4 Following VSMC adhesion using QCM-D 
 
 The effect of bioactive coating on cells was studied by QCM-D and cell adhesion 
tests. First, a preliminary experiment was performed to verify the feasibility of using the 
QCM-D technique for the detection of cell adhesion. VSMC adhesion (in a serum-free 
medium) was studied on LP, PEG and CMD surfaces in flow condition by following 
frequency and dissipation changes. PEG and CMD surfaces were known to be low-fouling, 
whereas the LP surface was known to exhibit fouling properties. As shown in Figure 4.15, 
there was a strong decrease in resonance frequency on the LP-coated gold electrode. This is 
believed to be essentially due to the VSMC adhesion, since the cells are suspended in 
DMEM (a serum-free medium) and a baseline was created using the same medium prior to 
VSMC injection. In strong contrast, neither frequency nor dissipation changes were 
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significant for PEG and CMD surfaces, which is indicative of prevention of VSMC adhesion 
on these surfaces. Interestingly, frequency change on LP was accompanied with a strong 
increase in dissipation. Rinsing with DMEM was started after 1 h to remove non-adherent 
cells and this was continued for 3 h to observe the behavior of frequency and dissipation 
shifts. After 1.5 h, a sudden increase in dissipation shift (from 3 to 6) was observed and 
reached a stable line after 2 h. This observation is similar to the results obtained in another 
study when measuring fibroblast cell adhesion on a collagen-modified surface using QCM-D 
(Tymchenko et al., 2012). According to Tymchenko et al studies, the increase in dissipation 
shift could be due to cell spreading on the surface. 
 
 
Figure 4.15. The frequency (left panel) and dissipation (right panel) changes due to 
VSMC adhesion on LP, PEG and CMD. Arrows refer to the injection of VSMCs 
(left) and DMEM rinsing (right). 
 
 In the next experiment, the ability of a peptide grafted surface to promote cell 
adhesion was evaluated using QCM-D by comparing bare CMD surfaces, CMD grafted with 
peptides (38 uM) and an LP surface as positive control. Once again VSMC adhesion was 
investigated in a serum-free medium (DMEM) to minimize the influence of non-specific 
protein adsorption during the experiment. Before injecting cell suspension, peptide 
immobilization on the EMCH + CMD surface was confirmed by following the frequency 
changes, which were similar to those presented in Figure 4.13 (for 38 uM). 
 
 In the following step, VSMC adhesion on these surfaces was compared with that on 
the LP surface, as shown in Figure 4.16. QCM-D behavior demonstrated similar trends to 
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those in Figure 4.15 despite some discrepancies. Thus a significant frequency shift was found 
for the LP surface after VMSC injection, with an almost stable baseline reached after 1 h 
adhesion. The decrease in frequency shift was observed on this surface after rinsing with 
DMEM, which is probably indicative of detachment of weakly adhered cells. Also as 
expected, (Figure 4.16), the frequency shift was much lower on the CMD surface than on LP. 
Yet, surprisingly, no improvement in VSMC adhesion was observed on the peptide grafted 
CMD surface, the frequency shift (and dissipation) being nearly similar to that of the bare 
CMD surface. The same trends were observed when using an RGD grafted CMD surface 
(Figure 4.17). Overall, these results indicate that peptide grafting on a CMD surface did not 
improve VSMC adhesion, as confirmed later in a conventional cell culture assay (see section 
4.2.2.5). 
 
 The unconventional shape of the dissipation shift curve after VSMC injection on LP 
surfaces (Figure 4.16, right panel) is also worth mentioning. The rapid increase in dissipation 
is an indication of immediate cell adhesion on the LP surface, but it then decreased and was 
further decreased after rinsing with DMEM. No stable baseline could be observed even after 
3 h. It is difficult to interprete the shape of these curves. According to published scientific 
reports (Tymchenko et al., 2012) and dissipation curves in Figure 4.15, the dissipation 
slightly decreases when cells start spreading on a surface. However, in this case it is not clear 
whether cells are spreading on the LP surface or detaching from it. Another possible 
explanation is that these changes are due to degradation or detachment of the LP underlaying 
coating. We have observed in the lab that, while this coating is generally stable, some 
degradation may appear and change the composition and therefore the stability of this 
coating.  
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Figure 4.16. The frequency (left) and dissipation (right) changes due to 
VSMC adhesion on LP, CMD and CMD + KQAGDV surfaces. 
 
 
Figure 4.17. The frequency changes due to RGD (38 µM) grafting (first arrow) 
on CMD + EMCH and CMD surfaces (left). VSMC adhesion on LP, CMD and 
CMD + RGD surfaces (right). 
 
4.2.2.5 VSMC adhesion in static condition 
 
 VSMC adhesion in static condition was performed to verify peptide influence on cell 
adhesion under various conditions. First, a VSMC adhesion assay was performed in the 
presence of serum using amino-coated 96 well plates. This experiment did not allow us to 
differentiate the cell adhesion between peptide-modified (various concentrations) and 
unmodified PEG/CMD or amino-coated surfaces, which might be due to the influence of 
serum. It was therefore decided to use a serum-free medium to evaluate peptide influence on 
promoting VSMC adhesion in the following experiment. In a serum-free medium, both PEG 
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and CMD were able to prevent VSMC adhesion. However, peptide immobilization (on PEG 
or CMD) did not show any improvement in VSMC adhesion. Finally, in order to confirm the 
results obtained with QCM-D, complementary VSMC adhesion assays were performed in 
static condition using LP-deposited PET films as a substrate for low-fouling and peptide 
grafting. The results were similar to those observed using QCM-D (Figure 4.18). Either 
KQAGDV or RGD grafting on CMD surfaces did not improve VSMC adhesion. The 
summarized results are presented in the Table 4.2. 
 
 
Figure 4.18. VSMC density observed (after 4 h adhesion in serum-free medium) 
by crystal violet staining on KQAGDV peptide modified and unmodified LP, 
CMD and EMCH surfaces. Scale bar corresponds to 200 µm. 
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Table 4.2. Summarized observations of various experiments (at least 4 samples tested for 
each condition) performed to investigate the influence of immobilized peptides on VSMC 
adhesion. 
Experiments Observations 
1) VSMC adhesion (20,000 cells/well) assay on 
various surfaces in complete medium using 
amino coated 96 well plates. 
• KQAGDV modified (0.15-12 µM) and 
unmodified PEG, CMD (70 kDa) and 
CMD (500 kDa) surfaces  
• EMCH linker, cysteine grafted surfaces 
and bare amino-coated wells 
2) Experiment was repeated using different cell 
seeding densities (5,000 - 15,000 cells/well) on 
peptide modified and unmodified PEG and CMD 
(70 KDa) surfaces. 
•  No difference in VSMC adhesion was 
observed on KQAGDV modified (0.46-
12.6µM) and unmodified surfaces, including 
EMCH linker and control (cysteine grafted) 
surfaces . 
•  PEG and CMD (70kDa) surfaces were not 
effective in preventing VSMC adhesion in 
complete medium 
•  However, VSMC adhesion was completely 
prevented by CMD (500 KDa). Surprisingly, 
peptide immobilization on this did not show 
any improvement in cell adhesion. 
•  Same trends were observed when using 
different cell seeding densities. 
1) VSMC adhesion assay (15,000 cells/well) on 
various surfaces in serum free medium and 0.5% 
FBS, using amino-coated 96 well plates. 
Experiment repeated 2 times. 
• KQAGDV modified (1.4 and 12 µM) and 
unmodified PEG and CMD (70 kDa) 
surfaces. 
EMCH linker, cysteine grafted surfaces and bare 
amino-coated wells 
•  VSMC adhesion was not improved on peptide 
modified surfaces. 
• PEG and CMD (70kDa) surfaces were able to 
prevent VSMC adhesion. Very few cells were 
adhered on these surfaces. 
•  Significantly higher cell adhesion was 
observed on PCP as well as amino-coated 
positive control surfaces  
1) VSMC adhesion (15,000 cells/well) assay in 
serum free medium on various surfaces using LP 
deposited PET films.  
• LP + CMD + EMCH + KQAGDV (38 
µM)  
• LP + CMD+ EMCH , LP + CMD + 
EMCH + Cysteine, CMD, LP , PET and 
PCP. 
2) VSMC adhesion assay was repeated using 
RGD peptide 
• LP + CMD + EMCH + RGD (38 µM) 
and LP + CMD + EMCH + KQAGDV 
(38 µM) 
• LP + CMD+ EMCH, LP + CMD + 
EMCH + Cysteine, CMD, LP, PET and 
PCP. 
•  VSMC adhesion did not improved either on 
KQAGDV or RGD peptide immobilized CMD 
surfaces  
•   Significantly higher cell adhesion was 
observed on LP and PCP surfaces, whereas 
CMD surface prevented VSMC adhesion. 
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4.2.3 Discussion  
 
 In this study, we hypothesized that the combination of peptides and growth factor 
could help overcome the lack of cell adhesion on low-fouling backgrounds and thus take 
advantage of these low-fouling backgrounds to obtain better bioactivity of the growth factor 
or observed synergistic effect of peptide and GF. Frequency changes, measured by the QCM-
D technique, were used to optimize the combined immobilization method. Although the 
calculated mass value using this technique is a wet mass and cannot be used to calculate the 
amount of peptide or GF used, it gives an idea of the total amount of mass on the surface and 
allows comparison between different surfaces. We confirm here that the QCM-D technique 
enables detection of mass changes despite the fact that peptide mass is only a few hundred 
Daltons and detection can occur even at very low peptide concentrations. It is worth noting 
that the limit of detection for a QCM-D sensor is about 0.9 ng/cm2 for a frequency resolution 
of 0.1 Hz, for a response time of 1 s (Biolin, 2014; Ogi et al., 2009). 
 
 This study was performed on CMD because it offers several advantages: 1) we have 
observed that CMD coatings present low-fouling properties that are as good as or even better 
than PEG (see objective 3), 2) it is less expensive than PEG and 3) most importantly it 
allowed a higher grafting mass of peptide and growth factor compared to that observed on 
star PEG during preliminary experiments. Since a CMD surface prevented non-specific 
adsorption of E coil EGF (Lequoy et al., 2014), and since the unreacted sites of EMCH on 
the CMD surface were already blocked with cysteine, the mass accumulation (after E coil 
EGF injection) is solely due to coiled-coil interactions between K coil and E coil EGF. It was 
previously demonstrated that such a coiled-coil system offers stable, bioactive and oriented 
immobilization of EGF (Boucher et al., 2008a). Although QCM-D data did not allow 
quantitative analysis, the mass changes due to sequential immobilization of peptide, K coil 
and E coil EGF confirms the presence of both the peptide and E coil EGF on the CMD 
surface. However, peptide immobilization on CMD, even at the highest coupling 
concentration tested here (38 µM), did not improve VSMC adhesion. Cell adhesion assay 
results, performed under flow (QCM-D) and static (conventional cell culture) conditions, 
showed no improvement in VSMC adhesion. Yet, in general, several studies reported 
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improved cell attachment on peptide-functionalized surfaces (Groll et al., 2005b; Hubbell, 
Massia et Drumheller, 1992; Ito, Kajihara et Imanishi, 1991; Kämmerer et al., 2011; Li et al., 
2008; Massia et Stark, 2001; Tugulu et al., 2007).  
 
 In the present study, the lack of improvement in cell adhesion on peptide-modified 
surfaces could be explained by several reasons that can be divided mainly into three 
categories: (i) the impact of peptide immobilization method and experimental conditions (ii) 
the impact of peptide surface concentration and (iii) the influence of peptide conformation 
and accessibility to the receptor. The possible reasons will be discussed in the following 
section. 
 
(i) Impact of peptide immobilization method and experimental conditions 
 
 The use of a spacer for peptide immobilization allows peptide to stand out from the 
surface and freely extend outward from it, and therefore helps to reach the integrin-binding 
site on the cell. However, whether a spacer is needed or not is still not clear, as some studies 
also developed peptide-modified surfaces without using any spacers to investigate their 
interaction with cells and to enhance cell adhesion (Dee, Andersen et Bizios, 1998; Dee, 
Anderson et Bizios, 1999; Mann et West, 2002). Most systems are, however, using some 
form of soft polymeric matrix (e.g. hydrogels, brushes and SAMs) as a background for 
peptide immobilization to minimize non-specific protein adsorption and thus at least to offer 
some flexibility and motility (Petersen, Gattermayer et Biesalski, 2011). 
  
 Some studies have successfully used low-fouling polymers (such as PEG and 
Dextran) for peptide immobilization and thus to enhance cell adhesion (Groll et al., 2005b; 
Sabra et Vermette, 2011; Tugulu et al., 2007). However, it is difficult to compare results 
emanating from a small number of studies because several parameters such as the 
immobilization method, the type of substrate, the type of polymer and its molecular weight, 
the type of peptide and conditions used for the cell culture experiment can greatly influence 
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the outcomes of the studies. Nonetheless, we did a comparison here with the studies that are 
closely related to our work. 
 
 Both Sabra et al. and Massia et al. used dextran or CMD (70 kDa) for the 
immobilization of RGD and cyclic RGD peptides, respectively. (Massia et Stark, 2001; Sabra 
et Vermette, 2011). They both showed an increase in endothelial cell adhesion compared to 
an unmodified dextran surface. Although these studies used the same polymer as we did in 
our study, there are two main differences. Firstly, the peptide immobilization method is 
different, where RGD was immobilized on CMD or dextran through its N-terminus (without 
using a cross-linker). In our study KQAGDV/RGD peptide was immobilized using an 
EMCH cross-linker, which allows disulfide bonding between thiol groups (present on 
cysteine molecule of CGG-KQAGDV) and maleimide groups (present on EMCH cross-
linker). Normally this would not be a problem, but some studies indicated that the optimal 
spacer length should be around 3-4 nm, as further increase in spacer length was shown to 
impede cell adhesion (Beer, Springer et Coller, 1992). This might be due to the increasing 
entropy of longer flexible spacer chains, which opposes strong binding with integrin 
receptors (Mammen, Choi et Whitesides, 1998; Wong et al., 1997). In our case the length of 
PEG and CMD is already in the range of 10-20 nm and the use of an EMCH linker can add a 
further 1.3 nm to the length of these polymers. Although this increase is not considerably 
high, the overall spacer length is much higher than optimal spacer length (3-4 nm), as 
suggested in (Beer, Springer et Coller, 1992). Thus, in future studies it would be worth 
verifying cell response by immobilizing peptide through its N-terminus without using a 
linker or using shorter spacer lengths. 
 
 Secondly, the conditions used for cell culture experiments are different in our study 
compared to other studies. Sabra et al., Massia et al. and others (Groll et al., 2005b; Tugulu et 
al., 2007; Wang et al., 2011b) performed cell adhesion assays in the presence of serum in 
order to show the improvement of cell adhesion on RGD-immobilized CMD or dextran 
surfaces. Wang et al. performed similar experiments to test the RGD impact on cell adhesion 
when it is immobilized on PEG-based materials. In this study, cell viability results (after 1 
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day) showed no significant difference in cell attachment when they tested various coatings on 
Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) films (PHBV, PHBV + NH2, PHBV 
+ PEG and PHBV + PEG + RGD). We observed a similar trend when we tested VSMC 
response (in the presence of serum) on KQAGDV-modified and unmodified PEG or CMD 
surfaces. Another important observation from Wang's studies is that after 3 days, some 
improvement in cell attachment on a PHBV + PEG + RGD surface compared to bare PHBV 
were noted, but cell adhesion on a PHBV + PEG surface was as good as a PHBV + PEG + 
RGD surface. It was concluded that the maleimide groups were responsible for good cell 
attachment on a PHBV + PEG surface. However, this was not true in our case when we 
tested cell adhesion on an EMCH-activated CMD (see Figure 4.18) or a PEG surface. The 
adsorption of serum proteins seems to be responsible for the variable results reported by 
Wang and colleagues.  
 
 Generally speaking, the influence of adhesive peptide on cell adhesion should be 
verified in the absence of serum, otherwise it is difficult to know whether the increase in cell 
response is due to immobilized peptide itself or through the combined effect of peptide and 
adsorbed proteins (Shin, Jo et Mikos, 2003). Recent results suggest a possible synergy 
between immobilized peptides and proteins. Thus the presence of a PHSRN sequence in the 
fibronectin-III domain of fibronectin can act synergistically with RGD to increase α5β1 
binding, and therefore it enhances cell adhesion and spreading (Benoit et Anseth, 2005; 
Ebara et al., 2008; Nakaoka et al., 2013). In our case we did not observe any difference in 
terms of VSMC adhesion in the presence of serum when we tested peptide-modified and 
unmodified surfaces (PEG/CMD or amine-displaying surfaces). Therefore we performed 
further experiments in the absence of serum in order to investigate the impact of peptide. 
However, unfortunately, peptide-modified PEG or CMD surfaces did not show improved 
VSMC adhesion. 
 
(ii) Peptide surface concentration  
 
 Peptide density can play a key role in promoting cell adhesion. Cell adhesion as a 
function of peptide density showed a sigmoidal increase (Danilov et Juliano, 1989; Jeschke et 
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al., 2002; Kantlehner et al., 2000; Neff, Tresco et Caldwell, 1999). Some studies also 
reported a required minimum peptide concentration to enhance cell adhesion, spreading and 
focal contact formation (Drumheller, P. D. and Hubbell, J. A. 1994, Hubbell, J. A., Massia, 
S. P. et al. 1992, Massia, S. P. and Hubbell, J. A. 1991). The required minimum peptide 
density was indicated as 12 fmol/cm2 for cell-spreading and 66 fmol/cm2 for focal contact 
formation when using a PEG spacer (Drumheller, Elbert et Hubbell, 1994). However, cell 
attachment and spreading depend not only on peptide density but also on the 
hydrophilic/hydrophobic nature of the substrate/material. Moreover, it is not possible to 
generalize the impact of density to all peptides, because different peptides have different 
integrin-binding affinity and selectivity. Finally, high peptide density also has drawbacks 
since it was shown to impede cell migration and proliferation (Mann et West, 2002). 
 
 Although we were not able to compare our QCM-D data with these peptide densities, 
the input peptide concentrations used in the present work are comparable to several other 
studies (Patel et al., 2007; Sabra et Vermette, 2011; Wang et al., 2011b). Very low E coil 
EGF grafting was observed at the highest peptide input concentration (38 µM), which 
indicates that the surface was almost completely occupied by the peptide. Therefore, we do 
not believe that further increase in peptide concentration would improve cell adhesion. 
Moreover, this could make it impossible for combined immobilization of peptide and GF, 
which was the ultimate goal of this study. The absence of direct measurement of peptide 
density is, however, the main limitation of this study. Ideally, it should be performed by 
ELISA or by quantification of immobilized peptides using radio-labeled peptides. 
 
(iii) Peptide conformation and accessibility 
 
 The objective of this study was to promote VSMC-specific adhesion and growth on a 
low-fouling background. To meet this requirement KQAGDV peptide was chosen, which is 
known to mediate VSMC-specific adhesion through α2bβ3 integrin (Dong et al., 2012b; 
Mann et West, 2002). Since the poor results with KQAGDV could be explained by the 
absence of bioactivity on the peptide on rat VSMC, other experiments were also performed 
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with RGD for comparison purposes. RGD peptide is known to promote adhesion of several 
cell types through several different integrins (α3β1; α5β1; α8β1; αIIbβ3; αvβ1; αvβ3; αvβ5; 
αvβ6; αvβ8, α2β1 and α4β1) (Hersel, Dahmen et Kessler, 2003; Ruoslahti, 1996). Since low-
fouling backgrounds offer some flexibility and mobility, these peptides are supposed to be 
accessible to integrin receptors present on cells. However, a lack of improvement in cell 
adhesion was observed. One possible reason might be an inaccessibility of the peptide to 
integrin receptors. Some ligands on PEG and CMD may not be accessible to cell receptors, 
and accessible ligands may not be sufficient for strong cell adhesion and spreading. 
 
 Some studies indicated that the presentation of ligands in a way that allows or triggers 
integrin clustering could enhance cell interactions with the surface (Irvine et al., 2001; 
Maheshwari et al., 2000). Studies by Maheshwari and colleagues reported enhanced 
fibroblast cell adhesion, spreading and focal contact formation when RGD was presented in 
clusters (9 RGD/star PEG molecule) versus individual format. In our case, star PEG has 4 
arms, and at least 2 arms are available for peptide immobilization (see Figure 3.2 and Figure 
3.3). In the case of CMD, we are unsure of the number of side chains per molecule, but it 
might have a higher density of carboxyl terminal groups than star PEG, as suggested by the 
higher amount of peptide grafting and EGF recruitment on CMD versus star PEG (Figure 
4.12). Nevertheless, this may be insufficient to form clusters. In our case, both PEG and 
CMD are branched polymers and they would have promoted integrin clustering and therefore 
VSMC adhesion, as showed in Maheshwari et al.’s work. However, this did not occur when 
using both PEG and CMD polymers. Possible reasons for lack of cell adhesion in our case 
might be due to two reasons: (i) With regard to CMD, although it has several branches, the 
chain conformation may not be same as star PEG. The side chains or arms in star-shaped 
molecules always emanate towards the surface (see Figure 3.3) due to the steric hindrance 
effect of the core of the PEG molecule; (ii) In the case of our star PEG, the number of side 
chain groups or arms (only 4 arms per molecule as explained above) per molecule may not be 
sufficient to form integrin clustering, which could be further verified using star PEG 
molecules that have at least nine arms. 
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 Conformation of the peptide is another important concern. It has been recognized that 
the specificity and binding ability of small peptide sequences are limited compared to ECM 
proteins (Kantlehner et al., 2000; Pierschbacher et Ruoslahti, 1984), since ECM proteins 
have multiple binding sites for cell adhesion receptors or integrin receptors. RGD peptide in 
looped conformation was shown to be more effective towards cell adhesion receptors 
compared to linear peptide, because looped confirmation closely mimics the natural structure 
of fibronectin and offers several binding sites for integrin binding (Kämmerer et al., 2011; 
Kantlehner et al., 2000; Verrier et al., 2002; Zhu et al., 2009). Moreover, since looped 
structures are large in size compared to linear peptide, there are chances to overcome the 
influence of the steric hindrance effect of low-fouling surfaces. 
 
 Overall, this study enabled us to investigate the possibilities for combined 
immobilization of peptide and GF on non-fouling surfaces. QCM-D data allowed us to 
follow the changes in mass resulting from combined immobilization. These results indicated 
that it is possible to modulate EGF immobilization by varying peptide input concentrations. 
However, this system did not allow us to compare the peptide surface concentration with 
other studies. Several other surface characterization techniques (XPS, FTIR, contact angle 
etc.) and direct or indirect quantification methods (BCA assay, ELISA, UV detection and 
radio-labeling etc) are available to determine peptide densities (Hersel, Dahmen et Kessler, 
2003). Most systems used radio-labeled peptides for quantification of immobilized peptide 
and it was believed to be more reliable than other techniques. In our case it was difficult to 
use such a technique due to the inaccessibility and unavailability of these radio-labeled 
peptides. Most research teams did not perform complementary studies to confirm the 
presence of immobilized peptide, relying instead on cell culture experiments to show the 
impact of peptide on cell response. In our case, the QCM-D technique allowed to follow 
peptide immobilization in real time and confirmed the presence of the peptide, but the 
absence of improvement in cell adhesion did not allow us to prove the concept. We did not 
verify cell adhesion on peptide- and EGF-immobilized surfaces for two reasons: (i) our aim 
was to promote initial cell adhesion with the help of peptide and then to promote cell growth 
with the help of growth factor; (ii) we observed poor VSMC growth on EGF-immobilized 
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CMD surfaces in recent studies in our lab (Lequoy et al., 2014). Therefore, we anticipate that 
the presence of EGF may not benefit improvement of cell proliferation response on low-
fouling backgrounds. In future studies, the cell response could be verified by changing 
several parameters such as peptide conformation, spacer length, immobilization method and 
combination with other peptide sequences such as PHSRN. At the same time, other 
hydrophilic polymers can be foreseen that would exhibit favorable properties for promoting 
cell adhesion (with or without the need for peptide/GF immobilization) while preventing 
protein adsorption. Overall, the strategy of improving cell adhesion by peptide 
immobilization on low-fouling surfaces is not as good as we expected and seen in the 
literature. Most probably, the combination of the steric hindrance effect and the hydrophilic 
nature of low-fouling polymers is strongly opposing cell adhesion. However, this could be 
further verified by changing several parameters as discussed above. 
 
4.3 Evaluate the advantages and limitations of using CS coating for vascular 
 grafts 
 
4.3.1 Rationale 
 
 Section 4.2 highlighted the limitation of using peptide grafting on low-fouling 
surfaces to promote cell adhesion. Recently, chondroitin sulfate (CS)-based surfaces have 
been developed in our laboratory to tether growth factors (GF) in a random (Charbonneau et 
al., 2011; Charbonneau et al., 2012; Lequoy et al., 2014) or oriented fashion. (Lequoy et al., 
2014). This polymer presented a huge advantage when we compared VSMC behavior on CS 
and CMD surfaces on which EGF had been grafted. We hypothesize that this is mainly due 
to CS cell pro-adhesive properties despite good protein resistance. Moreover, sulfated 
polysaccharides can improve hemocompatibility by means of electrostatic repulsion towards 
negatively charged blood components (Keuren et al., 2003). This suggests that CS could 
combine several advantages as a coating on vascular implants. Therefore in this part of 
thesis, we investigated the advantages and limitations of CS for the creation of low-fouling 
and non-thrombogenic surfaces by comparing CS to well-known low-fouling polymers, i.e. 
multi-arm PEG and CMD. 
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 In order to achieve this objective, LP coatings (Ruiz et al., 2010; Truica-Marasescu et 
al., 2008) were used once again for covalent coupling of the three (PEG, CMD and CS) 
carboxyl-functionalized polymers. The low-fouling properties were first assessed by 
following adsorption of fibrinogen, bovine serum albumin (BSA) and fetal bovine serum 
(FBS) in real time using QCM-D and further confirmed using labeled BSA in static 
incubation. The functionalized surfaces were also evaluated for their ability to promote 
endothelial cell adhesion, retention and growth in vitro. Finally, platelet adhesion during 
blood perfusion was also assessed on bare and endothelial cell grown surfaces. 
 
4.3.2 Results 
 
4.3.2.1  Physical characterization of coatings 
 
 The chemical grafting protocols for PEG have been already optimized, as presented 
in section 3.1. PEG grafting was confirmed with an XPS survey and high resolution scans of 
C1s and O1s. In addition, CMD and CS grafting on aminated surfaces had been recently 
optimized to maximize surface density. These surfaces were characterized using various 
techniques such as XPS, Tof-SIMS and ellipsometry dry thickness measurements, as detailed 
in previous publications (Charbonneau et al., 2011; Liberelle et al., 2010). In brief, XPS 
analysis confirmed the presence of sulphur (0.3%) indicative of CS on the surface, 
(Charbonneau et al., 2012) while Tof-SIMS demonstrated its uniform distribution on the 
surface (Charbonneau et al., 2011). The dry thickness of the CS layer was estimated by 
ellipsometry to be around 0.8 nm (n≥5) and slightly higher for CMD (about 1.3 nm; n=5) 
(Liberelle et al., 2010). In both cases, the surface was almost completely covered since 
adsorption of a 6 kDa molecule (epidermal growth factor) was reduced by 93% according to 
ELISA measurement, as published by Lequoy et al. (Lequoy et al., 2014).  
 
In this part of the thesis, optimized protocols were applied to LP-coated PET and amino-
coated glass substrates to prepare PEG, CMD and CS coatings. Contact angle measurements 
were performed to rapidly confirm chemical grafting and compare the three surfaces. As 
shown in Figure 4.19, all modified surfaces (PEG, CMD and CS) exhibited contact angles 
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significantly lower than those observed on LP (62 ± 1°) or PET (66 ± 3°) surfaces, the lowest 
contact angle corresponding to CMD (40 ± 2°). The same trend was observed when grafting 
these polymers on aminated glass surfaces (see Figure 4.20). 
 
 
Figure 4.19. Static water contact angle 
measurements of unmodified LP and LP coated 
with PEG, CMD and CS (mean ± SD; n = 10-12); 
* p < 0.0001 vs. LP. 
 
 
Figure 4.20. Static water contact angle 
measurements of unmodified and modified 
amino-coated glass surfaces with PEG, CMD and 
CS (mean ± SD; n = 7). 
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4.3.2.2 Protein adsorption 
 
 Low-fouling properties of PEG-, CMD- and CS-coated LP surfaces were assayed by 
QCM-D, and compared to those of LP. First, fibrinogen injections were performed on the 
different surfaces. Examples of frequency and dissipation curves obtained for LP and CMD 
coatings are presented in Figure 4.21. Fibrinogen adsorption occurred rapidly on LP surfaces, 
yielding a significant negative frequency shift (Figure 4.21 a) and positive dissipation shift 
(Figure 4.21 b). As expected, these shifts were largely reduced on CMD-coated surfaces, 
indicating almost complete prevention of protein adsorption. 
 
 
Figure 4.21. QCM-D frequency (Δf, panel a) and dissipation (ΔD, panel b) 
versus time for fibrinogen (0.5 mg/mL) adsorption on a CMD modified and an 
LP surface. The arrows refer to the injection of the protein solution (left) and 
PBS rinsing (right). 
 
 Similar adsorption assays were performed for each surface using BSA and FBS. In 
each case, frequency and dissipation values were used to calculate the mass of adsorbed 
material (Figure 4.22). The average reduction of adsorbed mass on PEG, CMD and CS 
compared to LP surfaces is presented in Table 4.3. LP surfaces induced a large amount of 
fibrinogen adsorption that was almost suppressed by CMD (98%) and PEG (90%) coatings, 
as expected. Interestingly, results for CS-coated surfaces were comparable to those of PEG 
(87%). In the case of BSA, PEG and CMD also exhibited very good resistance to adsorption, 
while CS was somewhat less efficient (72% compared to 85% and 84% for PEG and CMD, 
respectively; Table 4.3 and Figure 4.22 a). The small number of samples that were assayed 
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did not permit conclusions to be drawn on the significance of these differences. Finally, when 
FBS was injected (Figure 4.22 b), the same trend was observed (Figure 4.22 and Table 4.3). 
 
 
Figure 4.22. The adsorption and desorption kinetics of BSA (a) and 10% (w/v) FBS 
(b) on PEG, CMD and CS modified and unmodified LP surfaces. Arrows indicate the 
start of the protein (left) and PBS (right) injections. 
 
Table 4.3. Mean percentage reduction of protein-adsorbed mass compared to LP 
surface, based on QCM-D results (mean ± SD; n = 3-5). 
Coating % Reduction of 
fibrinogen  
% Reduction of 
BSA 
% Reduction of FBS 
(10% v/v) 
PEG 90 ± 3 85 ± 2.5 88 ± 5 
CMD   98 ± 0.1 84 ± 3.6 89 ± 5 
CS 87 ± 9 72 ± 4.2 66 ± 9 
 
 For validation purposes, under static conditions, BSA adsorption on various surfaces 
was also directly evaluated using fluorescent-labeled albumin. Results (Figure 4.23) were in 
excellent agreement with those obtained by QCM-D. The reductions of BSA adsorption 
mediated by PEG and CMD coatings (85 ± 3% and 84 ± 4% reduction, respectively) was 
significantly (p < 0.0001) better than that mediated by CS coating (71 ± 4%). The difference 
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was also significant compared to bare PET surface (p < 0.0001), with a reduction of 81 ± 4 
%, 80 ± 3% and 64 ± 8 % on PEG, CMD and CS, respectively. 
 
 
Figure 4.23. Fluorescence intensity of adsorbed Texas Red labeled 
albumin (0.2 mg/mL) on PEG-, 2 CMD- and CS-modified and 
unmodified LP surfaces, as well as on bare PET control (mean ± 3 SD; n 
= 8-12); * p < 0.0001 vs. PET; # p < 0.0001 vs. CS. 
 
4.3.2.3  Cell adhesion and growth 
 
HUVEC adhesion and growth was investigated on PEG, CMD and CS surfaces and 
compared to growth on LP, bare PET and polystyrene culture plates (PCP) (Figure 4.25). 
HUVEC adhesion and growth were excellent on LP and PCP positive control, but relatively 
poor on PET as already observed in previous studies (Gigout et al., 2011). Grafting of PEG 
and CMD to the surfaces led to even lower adhesion and no growth. Cells displayed a round 
shape and spreading was limited (see Figure 4.24). These observations are consistent with 
previous investigations with low-fouling polymer surfaces (Desai et Hubbell, 1991; Zhang, 
Desai et Ferrari, 1998). In stark contrast, cells adhered well on CS and showed rapid growth 
similar to that observed on LP and PCP surfaces. 
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Figure 4.24. Typical images of crystal violet staining after 2 day HUVEC 
growth on each surface (scale bar = 200 µm). 
 
 
Figure 4.25. HUVEC density after 4h (adhesion) and 2 days 
(growth) (mean ± SD ; n = 12); * p < 0.0001. 
 
 The presence of HUVEC focal adhesion after 24h on CS was confirmed by actin and 
vinculin immunostaining, as shown in Figure 4.26. HUVECs on CS and LP surfaces 
exhibited a spread morphology, with well defined actin fibers (in green) throughout the 
cytoplasm and termini clustered at vinculin rich sites (red color spots mainly at the edges). 
These observations are indicative of integrin-mediated anchorage on CS and LP surfaces and 
suggest strong cell attachment and adequate signaling for cell growth and survival. On bare 
PET, fewer cells were observed. Some exhibited a rounded morphology (data not shown) 
while others were spread but exhibited only a few stress fibers and the actin cytoskeleton did 
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not appear to be well organized. Only rare focal adhesion points could be observed. Finally, 
as expected, very few cells were observed after 24h on CMD and they generally presented a 
rounded morphology, without any focal contact formation. Absence of spreading and focal 
adhesion of HUVEC on CMD suggests that there is a strong risk of cell detachment and cell 
death and correlates well with the very low cell number after 2 days of growth in Figure 4.25. 
 
 
Figure 4.26. Immunostaining of vinculin (red), actin (green), and the nucleus 
(blue) after 24 h of HUVEC adhesion on PET, LP, LP-CS and LP-CMD 
surfaces. 
 
4.3.2.4 Platelet adhesion  
 
Since the hemocompatibility of the surface is particularly important for vascular graft 
application, platelet adhesion was assayed on our different coatings using the previously 
described device and protocols developed at Dr. Merhi's laboratory (Merhi, King et Guidoin, 
1997). Figure 4.27 presents the average percentages of LP, PET, PEG, CMD and CS surfaces 
covered by platelets after whole blood perfusion for 15 min. Representative images from 
confocal microscopy after platelet labeling using CD61/FITC labeling and from SEM for LP, 
PET and CS are shown in Figure 4.28. The platelets adhered on LP surfaces, appeared as 
activated and changed in shape with pseudopod extrusions. The LP surface also became 
prone to platelet-platelet interaction and aggregation, most likely due to the positively 
charged amine groups present in aqueous media. Although platelet adhesion on PET was 
significantly lower than on the LP surface, the adhesion on PET surfaces varied considerably 
from one experiment to another, probably due to the variability in platelet reactivity between 
different blood donors. However, on PET surfaces, platelets presented filopodia typical of an 
activated phenotype (Figure 4.28 c). In contrast, platelet adhesion was almost abolished on 
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PEG, CMD and CS surfaces. Interestingly, CS grafted surfaces were as efficient as PEG and 
CMD surfaces in resisting platelet adhesion as no significant difference was observed 
between these three surfaces.  
 
 
Figure 4.27. Percentage of surface area covered 
by platelets after perfusion with whole blood for 
15 min (mean ± SD; n = 5-9); * p < 0.0001 vs. 
LP; # p < 0.0001 vs. PET. 
 
 
Figure 4.28. Representative images of SEM (a, c, e) and confocal microscopy 
(b, d, f, g, h: labeling with CD 61/FITC) for platelet adhesion on LP (a, b), PET 
(c, d), CS (e, f), PEG (g) and CMD (h) surfaces after perfusion with whole 
blood. 
 
 Since CS surfaces exhibited very low platelet adhesion and favorable HUVEC 
growth, they appeared as promising surfaces for creating a complete endothelial layer on a 
non-thrombogenic underlayer. To that purpose, HUVEC must present a non-thrombogenic 
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phenotype and must be resistant to the shear induced by blood flow. As a first assessment of 
these properties, cells grown for 7 days on the various surfaces were subjected to blood flow 
for 15 min. HUVEC density and platelet adhesion were measured.  
 
 Figure 4.29 presents the results of Fadlallah's work, showing the HUVEC density on 
each type of surface that had been submitted or not to blood flow, thus enabling estimation of 
HUVEC retention. Despite relatively similar initial HUVEC densities on all three surfaces 
(PET, LP, CS), cell density on PET was shown to decrease dramatically during perfusion, 
with only 25% retention on the surface. In contrast, cells strongly adhered on LP and CS, on 
which cell densities before and after perfusion were not significantly different. 
  
 With respect to platelet adhesion on HUVEC-grown surfaces, platelet adhesion on CS 
was very low, both on HUVEC-grown and bare CS surfaces (Figure 4.30). On HUVEC-
grown LP surfaces, the presence of numerous cells significantly reduced platelet adhesion 
compared to LP alone (p < 0.0001). However, platelet adhesion was still visible in regions 
(of green color) where no cells were present (Figure 4.30 b), which might be either due to the 
lack of complete coverage after 7 days of growth or to cell detachment during perfusion. 
Altogether, even with HUVEC, LP surfaces tended to be more thrombogenic than CS 
surfaces, though the difference was not statistically significant (p = 0.16; n=7). 
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Figure 4.29. Cell density on the different surfaces (bare PET and LP +/-CS 
coating) not perfused (-Perfusion) and after perfusion (+Perfusion) of whole 
blood (mean ± SD; n = 7); * p < 0.0001 vs. all other surfaces. Confocal 
microscopy images (right side) of HUVEC growth (7 d; labeled with 
CellVue Maroon (in blue color)) on PET, before and after 15 min of 
perfusion. Data adapted from Fadlallah's thesis (Fadlallah, 2013). 
 
 
Figure 4.30. (a) Percentage of LP and CS surfaces covered by platelets after 
perfusion with whole blood in the absence (-HUVEC) and presence (+HUVEC) 
of previously seeded HUVEC (mean ± SD; n = 7; * p < 0.0001 vs. other 
surfaces). (b) Representative images of HUVECs and platelets on LP and CS 
surfaces after perfusion (HUVEC membranes colored with CellVue® Maroon 
(blue) and platelets stained with anti-CD61/FITC antibody (green). Scale bar 
corresponds to 200 µm. Data adapted from Fadlallah's thesis (Fadlallah, 2013). 
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4.3.3 Discussion 
 
 The aim of this part of the thesis was to study whether CS could be an interesting 
alternative to PEG or CMD as an underlayer for vascular implants, to be used alone or 
combined with GF immobilization. Therefore the low-fouling and cell-adhesive properties of 
CS were compared with well-known low-fouling polymers such as PEG and CMD, as well 
as with an LP coating and pristine PET as controls. CS was as efficient as PEG and CMD in 
limiting fibrinogen adsorption, a key protein in the cascade leading to thrombus formation 
(Ratner Buddy, 2000). However, CS was less effective than PEG and CMD in limiting the 
adsorption of albumin and FBS (containing hormones, ECM proteins (collagen, fibrinogen, 
fibronectin, etc.) and growth factors). In a previous study, it was demonstrated that CS 
surfaces prevented EGF non-specific adsorption as efficiently as CMD (Lequoy et al., 2014). 
In contrast, CS has also been reported to interact strongly with fibroblast growth factor and 
heparin-binding growth factors (Deepa et al., 2002; Freeman, Kedem et Cohen, 2008). 
Altogether, these observations strongly suggest that CS presents selective protein resistance. 
QCM-D enables study of the adsorption kinetics of proteins from complex mixtures, but it 
allows neither identification of the adsorbed proteins nor determination of whether these 
proteins are denatured once adsorbed. This could be further investigated by conducting 
competitive protein adsorption studies (Hlady, Buijs et Jennissen, 1999) using serum 
containing the mixture of several different fluorescent labeled proteins and GFs. This will 
help to identify which proteins are selectively recruited by CS and thus gain a better 
understanding of its mode of action. 
 
 Interestingly, although protein adsorption was not completely abrogated on CS 
surfaces, platelet adhesion was almost abolished and comparable to that observed on PEG 
and CMD surfaces. The perfusion assay in this work mimicked physiological conditions 
(Papaioannou et Stefanadis, 2005), and therefore it is believed to give a better estimate of the 
anti-platelet property of our surfaces as compared to static assays because the shear stress 
induced by blood flow causes qualitative and quantitative differences in adhesion (Engbers et 
al., 1987). Moreover, platelets have a relatively low density and do not settle easily in static 
conditions. One limitation of our platelet adhesion test is the short perfusion time (15 min), 
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which was chosen due to the limited lifetime of the anticoagulant as well as to allow 
comparison of several surfaces with blood from the same donor. However, 15 min perfusion 
was sufficient to observe a significant decrease in platelet adhesion on PEG, CMD and CS 
surfaces as compared to PET. Almost no platelets were observed on both HUVEC grown and 
bare CS and none were activated. This suggests that HUVEC growth on CS exhibited a non-
thrombogenic phenotype. However, further studies would be required to confirm this point, 
including the assay of released pro- and anti-thrombogenic molecules by cells (Thébaud et 
al., 2010) and of longer perfusion times. These observations are consistent with some 
previous results (Keuren et al., 2003) and are probably due to the electrostatic repulsion of 
the negative charges on sulfated CS, and the additive effect of highly hydrophilic properties 
of CS surfaces. Indeed, platelet adhesion and complement system activation are known to 
decrease with increasing surface hydrophilicity (Rodrigues et al., 2006). 
 
 Overall, resistance to fibrinogen adsorption and the absence of platelet adhesion on 
CS suggest that it can prevent thrombus formation. Vascular grafts fail due to several 
reasons, but the most prevalent is occlusion due to blood coagulation. Therefore, additional 
studies such as using a whole blood kinetic clotting time method (Motlagh et al., 2006) or 
plasma coagulation tests based on turbidity measurements (Sask et al., 2011) and 
measurement of thrombin generation in flowing blood (Keuren et al., 2003) could be 
performed to confirm the blood compatibility of CS.  
 
 More importantly, in stark contrast to PEG and CMD, CS was shown to support and 
promote endothelial cell adhesion and growth leading to the formation of a complete and 
flow-resistant endothelium, whereas most cells detached from the PET surface during 
perfusion. Focal adhesion points and strong cell attachment suggest integrin-mediated 
anchorage on CS surfaces. CS probably promotes the adsorption of some proteins and/or 
growth factors present in the culture medium (containing 2% FBS) that are favorable to 
HUVEC adhesion and proliferation. Since CS has negatively charged sulfate groups, it may 
preferentially interact with proteins that have basic amino acids (Lys and Arg) whose 
positive charges presumably interact with the negatively charged sulfates and carboxylates of 
the GAG chains (Esko et linhardt, 2009). The cell-adhesive proteins and (fibronectin (Fn), 
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laminin (Ln) and Vitronectin ) (Faucheux et al., 2006; Sottile, 2004; Underwood, Steele et 
Dalton, 1993) and GFs, particularly VEGF and FGF-2 (Byzova et al., 2000; Koenig, 
Gambillara et Grainger, 2003a), possess binding domains for endothelial cells. Of these 
proteins, vitronectin is a positively charged protein at physiological pH conditions, and it 
seems CS interacts with this protein to promote EC adhesion. The role of adsorbed proteins is 
the performance of CS coating are demonstrated by the fact that previous work in our lab 
showed that CS by itself did not exhibit proliferative properties (Charbonneau et al., 2012). 
Moreover, during focal adhesion assays, we observed much lower cell adhesion when cells 
were incubated on the CS surface in a serum-free medium.  
 
 Despite the fact that other factors could explain the difference in results between CS 
and CMD or PEG coatings (density, length of free mobile chains and compliance of the 
coating), we believe that these differences are mostly due to CS composition. Other studies 
also showed that sulfated GAG-modified surfaces were able to promote EC adhesion in the 
presence of FBS (but not in the absence of FBS) due to the interaction of selective FBS 
proteins and/or growth factors with negatively charged sulfate groups (Wang et Luo, 2013). 
Indeed, heparin-binding proteins and GF were shown to bind to sulfated HA and sulfated 
alginate but not to HA or alginate (Freeman, Kedem et Cohen, 2008).  
 
 Moreover, CS shares structural similarities with heparin, which is well known for its 
anticoagulant activity. Both are sulfated polysaccharides with repeating units of uronate and 
hexasomine saccharides (Kjellen et Lindahl, 1991). Their net negative charge due to the 
presence of sulfate groups allows them to interact with a large number of proteins and basic 
molecules through ionic and hydrogen bonding interactions (Kidane et al., 1999; Li et Henry, 
2011a). In terms of anti-coagulant effect, heparin has an advantage since it binds specifically 
to the enzyme inhibitor antithrombin III (AT), which inactivates thrombin. On the other 
hand, CS is more effective in preventing protein adsorption (including fibrinogen) and 
platelet adhesion (Keuren et al., 2003). Keuren et al. also concluded that CS leads to almost 
as little thrombin generation as heparin, thanks to its higher protein-repelling property. 
Moreover, CS has the advantage of exhibiting an anti-apoptotic effect on vascular cells, 
including endothelial cells and mesenchymal stem cells (Raymond et al., 2004). This anti-
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apoptotic activity is conserved when CS is grafted by covalent coupling on biomaterial 
surfaces (Charbonneau et al., 2011). Furthermore, the hydrophilic and low-fouling properties 
of CS are believed to be important to ensuring good access and presentation of GF to the 
cells (Lequoy et al., 2014). Overall, the results from this part of the work suggest that CS as a 
sublayer favors selective low-fouling properties, which lead to low thrombogenicity 
combined with cell adhesive properties. 
 

 CHAPTER 5 
 
 
GENERAL DISCUSSION 
General discussion, limitations and perspectives 
 
  Cardiovascular diseases are the leading cause of mortality and morbidity in the aging 
population and they are expected to increase in the future. There is an urgent clinical need for 
improved vascular implants, mainly vascular grafts and vascular stents, that will promote 
desirable blood-biomaterial interactions with a high patency. The current vascular grafts 
made of polyethylene terephthalate (PET) and polytetrafluoroethylene (PTFE) have failed 
due to two main reasons: (i) when in contact with blood, implants are subject to the risks of 
coagulation and thrombosis, which are especially problematic when using small-diameter 
vascular grafts (<6mm); (ii) the lack of favorable surface properties to induce 
endothelialization in vivo on the lumen of vascular grafts; and similarly for stent grafts, the 
lack of vascular smooth muscle cell growth that promotes healing and SG incorporation into 
the surrounding vessel wall. Therefore, recent research efforts have aimed to develop surface 
physical, chemical and biological modification methods to improve the patency of vascular 
implants. Several attempts were already made to develop surface modification methods to 
minimize surface thrombogenicity and promote desirable cell interactions, as described in the 
literature review section.  
 
 Currently there is a strong trend toward using low-fouling surfaces for bioactive 
coatings, thanks to their advantages (prevent non-specific protein adsorption and interactions 
with cells, as described in the literature review section). However, based on the literature 
review, we realized that two major issues need to be resolved: (i) the current bioactive 
coating methods fail to find a good compromise between preventing protein adsorption and 
promoting desirable cell adhesive properties. Moreover, (ii) most techniques lack versatility, 
which compromises their commercial use since the coating process must be optimized for 
each new material and application. 
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 Therefore, in this PhD thesis we proposed developing an innovative and versatile 
bioactive coating for vascular grafts and stent grafts that can induce desired cell interactions 
while preventing protein adsorption and platelet adhesion. This proposal has been divided 
into three different steps: (i) Develop a versatile PEG coating method to offer low-fouling 
and non-thrombogenic properties. (ii) Subsequently immobilize adhesive peptides (here 
KQAGDV or RGD) and growth factor (here EGF) to create a bioactive coating which 
promotes specific and optimal cell interactions. (iii) Evaluate the potential of CS as a 
possible ideal compromise between low-fouling and cell-adhesive properties, in comparison 
with conventional low-fouling coatings, for developing biocompatible vascular implants.  
 
A versatile PEG low-fouling coating 
 
 The primary aim of this thesis was to develop a versatile low-fouling coating, using 
PEG and LP plasma polymer, for further grafting of biomolecules in order to create bioactive 
coatings. Protein-resistant coatings such as those made of polyethylene glycol (PEG) have 
already been extensively investigated, since they can reduce platelet adhesion and the risk of 
thrombus formation (Kidane et al., 1999; Li et Henry, 2011b). PEG low-fouling properties 
are attributed to steric repulsion and a highly hydrated surface layer (Hoffmann et al., 2006; 
Kidane et al., 1999; Ratner Buddy, 2000; Zhang, Desai et Ferrari, 1998). Several strategies 
previously used for PEG immobilization on biomaterial surfaces include simple direct 
adsorption (Davis et Illum, 1988), radiation and chemical cross-linking approaches (Graham 
et McNeill, 1984), and self-assembled monolayers (Yang, Galloway et Yu, 1999). Simple 
adsorption is flexible and convenient, but its efficacy is limited by the tendency of PEG to 
elute off the surface (Gombotz et al., 1991). Stable PEG coatings generated by direct 
covalent chemical coupling to substrates have already been reported (Demming et al., 2011). 
However, this approach is far from being versatile since it relies on the availability of 
compatible functional groups on both PEG and the host surface, as well as on their respective 
surface densities. 
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 The main originality of the first part of this thesis consists in the versatility of the star 
PEG low-fouling coating, which was created by exploiting LP coatings. This versatile PEG 
coating method is applicable to a wide variety of biomaterials used for vascular implants and 
other biomedical and bio-analytical applications. This part of the work was published in the 
journal BioMed Research International (Thalla et al., 2012). 
 
 Star-shaped (multi-arm) PEG was used in this study for two reasons: (i) star PEG’s 
molecular architecture and long chain length enable a higher grafting density than linear PEG 
(Groll et Moeller, 2010; Kuhl et Griffith-Cima, 1996; Sofia Susan et Merrill Edward, 1997) 
and therefore a highly protein-resistant surface can be created. Indeed, for similar chain 
lengths and molecular weights, star-shaped polymer brush variants have been demonstrated 
to possess higher density and greater steric repulsive forces against adsorbing proteins when 
compared to linear PEGs (Satulovsky, Carignano et Szleifer, 2000). (ii) Star PEG offers a 
high density of functional groups that allow subsequent grafting of selected biomolecules 
designed to further tailor surface properties (Groll et Moeller, 2010; Kuhl et Griffith-Cima, 
1996).  
 
 As expected, protein adsorption studies carried out in this project showed that the 
efficiency of the star PEG low-fouling coating increased as a function of its coupling 
concentration. XPS analysis (of survey and high-resolution scans) and contact angle 
measurement results also indicate an increase in PEG surface concentration as a function of 
its coupling concentration. However, complete prevention of protein adsorption was not 
achieved and led to some cell adhesion in the presence of serum (as seen later during the 
second part of this study). To better understand the reasons for this result, other surface 
characterization methods such as ellipsometry dry thickness measurements, ToF-SIMS and 
AFM techniques could be performed to study grafting densities and coating uniformity. The 
main limitation of this part of the study was a lack of studies comparing grafting densities 
and low-fouling properties using different molecular weights of star PEG, which could have 
helped to achieve a complete low-fouling surface. We did not perform these studies for 
several reasons: (i) Although protein adsorption was not prevented by 100% on star PEG, 
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platelet adhesion was almost completely abolished on 5% PEG-coated surface. We believed 
that it would be sufficient to create a versatile non-thrombogenic surface. (ii) Our ultimate 
goal was to tether biomolecules to promote confluent cell adhesion and growth on a low-
fouling underlayer. We believed that this star PEG coating method would be enough to create 
such a surface, since it has at least two or three available functional groups per star molecule 
for further coupling. (iii) Finally, the star PEG grafting method is not economical, which is 
also encouraged us to look for other alternatives for bioactive coatings in the next steps. 
Recommendation 1: Since the current PEG grafting did not prevent complete protein 
adsorption, in future work the low-fouling properties of star PEGs could be investigated by 
changing several parameters such as PEG molecular weight, number of arms, chain length 
and grafting conditions on surface density, uniformity and thickness.  
 
 Alone, this star PEG coating exhibits low-fouling and anti-platelet adhesion 
properties, which suggests that this surface could be non-thrombogenic. However, most in 
vivo studies of PEG-modified implants have been unsuccessful in limiting blood clot 
formation (Akbar et al., 2011; Hubbell, 1993; Nojiri et al., 1990a). This is in part due to the 
poor stability of PEG coatings and might be due to the fact the PEG layers limit only 
individual platelet adhesion but not platelet aggregates that might form in blood away from 
the material surface (Park et al., 2000). Although PEGylated surfaces showed prolonged 
circulation profiles in the vasculature (Moghimi, Hunter et Andresen, 2012), they can still 
trigger complement activation through all three known pathways (Andersen et al., 2013a). 
Some studies also showed that PEG is effective in preventing protein adsorption when using 
10% serum, but  it is not effective when using full serum or 100% plasma (Zhang et Horbett, 
2009; Zhang et al., 2008b). Moreover, unlike anticoagulants such as heparin and hirudin, 
PEG is not able to inhibit thrombin generation. The star PEG grafted in this study presented 
stable low-fouling properties for up to one month in PBS, but this is clearly insufficient to 
demonstrate its long-term stability in vivo. 
 
 Dextran-based coatings were developed as an alternative to PEG coatings since their 
low-fouling properties were demonstrated to be as good as PEG (Dubois, Gaudreault et 
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Vermette, 2009; Massia, Stark et Letbetter, 2000). However, they face the same stability 
issues as PEG. More generally, approaches involving only low-fouling surfaces are limited 
due to the absence of active mechanisms to prevent coagulation and induce thrombolysis. 
Several authors thus used low-fouling surfaces to further immobilize anti-thrombogenic 
molecules such as heparin, hirudin, or other direct thrombin inhibitors (Akbar et al., 2011; 
Gorbet et Sefton, 2004) to create active anti-thrombogenic surfaces. We will not further 
discuss these approaches in detail here since it is outside the scope of the present thesis. 
Moreover, despite interesting results, the long-term durability of these approaches is also a 
concern and the only demonstrated long-term anti-thrombogenic surface to date is a stable 
complete endothelial layer. Low-fouling coatings can be used to create such bioactive 
surfaces by subsequent immobilization of biomolecules. 
 
Bioactive coating on low-fouling backgrounds 
 
 The second objective of this thesis was to co-immobilize adhesive peptides and 
growth factor on low-fouling backgrounds and demonstrate their benefit. Due to the 
availability of the coil-coil technique only for EGF (which has quite limited benefit on 
endothelial cells), we decided to focus this part of the study on the combination of adhesive 
peptides and growth factor to promote VSMC adhesion and growth for SG application. 
Immobilization of adhesive peptide could promote initial cell attachment on low-fouling 
surfaces while growth factor could further support cell growth and survival, and therefore 
enable achievement of a confluent cell layer. The literature demonstrates that integrin and 
growth factor receptors share common signaling pathways within the focal adhesion complex 
(Plopper et al., 1995) and the mutual activation of both the receptors through their association 
results in signaling synergism and reciprocal potentiation (see literature review section 1.5.4 
for more details) (Comoglio, Boccaccio et Trusolino, 2003; Yamada et Even-Ram, 2002). 
According to some recent studies, enhanced cell migration and proliferation was observed 
when a variety of growth factors (such as EGF (Gobin et West, 2003b) and FGF (DeLong, 
Moon et West, 2005; Kolodziej et al., 2011)) co-immobilized with RGD-like peptides on 
PEG hydrogels. Therefore, combined immobilization of peptide and growth factors not only 
offers an additive effect but also possible synergistic effects, and thus there is great interest in 
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surfaces which combine both biomolecules. The optimization of cell-surface interaction, 
however, requires optimization of the ratio of both molecules. Here, the same linker was used 
to graft peptides and growth factor (through the coiled-coil immobilization technique) in 
order to modulate the relative density of these two biomolecules on the surface and study 
their influence on cells.  
 In this study, both CMD and PEG were used as an underlayer for combined 
immobilization, but the probable higher density of carboxyl functional groups of CMD 
enabled higher peptide mass on CMD compared to PEG-modified surfaces. We first 
demonstrated that the QCM-D technique can be used to follow changes in mass due to 
immobilization of biomolecules in real time and then confirmed the presence of peptide and 
growth factor on low-fouling surfaces. This technique has several advantages as it allows: i) 
using label-free biomolecules, ii) following reaction kinetics of biomolecules at the surface, 
iii) using flow conditions and iv) using a very low concentration of biomolecules (in the rage 
of nM concentrations) with the mass sensitivity of 0.9ng/cm2. The QCM-D technique also 
enabled us to follow changes in frequency due to cell adhesion on different types of surfaces. 
However, there were some limitations when using this technique:  
 
• It did not allow for quantitative analysis to compare peptide surface concentration 
with other studies. In addition, the conformation of grafted peptide and its availability 
to the cells could not be confirmed, which may explain the poor results in terms of 
cell adhesion. Moreover, the Q-sense E4 system did not allow us to compare more 
than four surfaces at a time, which makes it difficult to interpret and compare data 
from one set of experiments to another when using several different concentrations. 
• Reproducing the results for cell adhesion experiments seemed to be difficult because 
the changes in resonant frequency are related not only to changes in mass but also to 
changes in the fractional surface coverage by the cells (Lord et al., 2006; Modin et al., 
2006; Wegener et al., 2000). Another limitation was the difficulty in understanding 
the behavior of dissipation changes during cell adhesion and spreading on the surface. 
The relationship between cell attachment and energy dissipation has not been fully 
understood, and several authors have expressed different opinions. Rodahl and 
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colleagues reported that the changes in energy dissipation are due to the liquid 
trapped between the cell and the surface, in the cell membrane, and in the interior of 
each cell (Rodahl et al., 1997b), whereas Marx and coworkers suggested that the 
dissipation arises due to the remodeling of actin filaments (Marx et al., 2005) and 
Wegner et al. suggested that it is related to changes in the ECM, the actin 
cytoskeleton and the cell-substrate separation distance (Wegener et al., 2000). 
• In addition, we were not able to draw conclusions about dissipation and frequency 
changes for cell experiments in the presence of serum. The reasons were unclear, but 
we suspect that the complex reactions and conformational changes due to the 
adsorption of serum proteins make it difficult to understand the trends in frequency 
and dissipation changes. 
 Unexpectedly, peptide immobilization on the CMD surface did not improve cell 
attachment and did not allow us to achieve the objective. These disappointing results 
contradict several other studies (Massia et Stark, 2001; Sabra et Vermette, 2011). Several 
factors influence prevention of cell adhesion when using low-fouling backgrounds, as 
discussed in section 4.2.3. However, we suspect two main reasons for these unfavorable 
results. The non-adhesive nature and strong low-fouling effect of CMD could be one reason, 
because previous studies and recent studies in our lab observed poor cell growth on EGF-
tethered PEG (Klenkler et al., 2008) or CMD surfaces (Lequoy et al., 2014). Our QCM-D 
results confirmed the presence of peptide, but a lack of improvement in cell adhesion was 
observed. Therefore, the other possible reason could be inaccessibility of immobilized 
peptide to cell adhesion receptors. 
 
Recommendation 2: Peptide surface concentration may be verified using other methods 
such as ELISA or quantification of immobilized peptides using radio-labeled peptides. Deep 
understanding of peptide influence on cell response when it is immobilized on low-fouling 
surfaces would be required. This could be further investigated by changing several 
parameters such as peptide confirmation, spacer length, peptide immobilization method and 
combination with other peptide sequences such as PHSRN.  
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 Due to the lack of cell adhesion on the peptide modified PEG or CMD surfaces, it 
was not possible to draw a conclusion about the possible increase in bioactivity of 
biomolecules when grafted on a low-fouling background or on the possible additive effect or 
synergy between adhesive peptides and EGF. More generally, our results and the careful 
critical review of the literature on biomolecule grafting on low-fouling backgrounds 
emphasize the difficulty of achieving good cell coverage on such surfaces, probably due to 
the steric hindrance of the non-fouling background (Klenkler et al., 2005).  
 
 Since the creation of bioactive coating using conventional low-fouling polymers such 
as PEG and CMD and thereby promoting confluent cell adhesion did not work in our case, 
we moved on to next step to find an alternative polymer that would offer favorable properties 
for endothelialization on vascular graft materials. Several strategies have already been 
proposed to increase endothelial cell adhesion and retention on the lumen of vascular grafts, 
particularly through the use of RGD peptides. Although these studies in general, with or 
without using low-fouling polymers, showed enhanced cell adhesion and resistance to shear 
stress in vitro (Rémy et al., 2012; Tugulu et al., 2007), their in vivo efficiency still remains 
uncertain. Indeed, some studies have reported enhanced tissue response (Ferris et al., 1999; 
Li et al., 2003) while others showed no benefit (Petrie et al., 2008; Schliephake et al., 2002). 
These mitigated results may be explained by the difficulty in finding a compromise between 
(i) preventing non-specific protein adsorption when RGD peptides are grafted on fouling 
surfaces directly; and (ii) achieving sufficient RGD peptide density when using a non-fouling 
underlayer (Bellis, 2011). Moreover, native ECM proteins are known to stimulate a more 
robust integrin signaling than the isolated RGD domain and can engage multiple ligands at 
different time-points (Williams, 2008). However, as mentioned earlier, they increase not only 
endothelial cell adhesion but also the risk of thrombosis through the recruitment of platelets. 
 
Is CS coating an ideal compromise between low-fouling and pro- cell adhesive 
properties? 
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 The final objective of this thesis was therefore to study the possible advantages and 
limitations of using CS coating for developing vascular grafts. CS coating was already shown 
to enhance resistance to apoptosis in vascular cells (Raymond et al., 2004), prevent EGF non-
specific adsorption (Lequoy et al., 2014) and improve hemocompatibility by means of 
electrostatic repulsion towards negatively charged blood components (Keuren et al., 2003). 
These interesting properties of CS coatings motivated us to evaluate its low-fouling and low-
thrombogenic properties by comparing it with well-known low-fouling polymers such as 
PEG and CMD. 
 
 Again, the use of nitrogen-rich plasma polymerized thin film coatings (LP) (Ruiz et 
al., 2010; Truica-Marasescu et al., 2008) enabled us to create and achieve good surface 
coverage of PEG, CMD and CS. The low-fouling potential of PEG and CMD compares well 
with those reported in the literature. Unsworth and colleagues reported an 80% reduction of 
fibrinogen adsorption on surfaces with high PEG chain density (Unsworth, Sheardown et 
Brash, 2005), where PEG had been grafted on a gold surface through the chemisorption 
method. Indeed, our CMD coating almost completely prevented fibrinogen adsorption (98% 
reduction) , whereas PEG coating reduced it by 90%. The reduction of albumin adsorption on 
both PEG and CMD (~ 85%) assessed by fluorescence is comparable to the results obtained 
by covalent coupling of PEG on silicone surfaces (Chen et al., 2005a).  
 
 Interestingly, CS low-fouling properties towards fibrinogen adsorption and platelet 
adhesion were as efficient as PEG and CMD, but less effective in preventing BSA and FBS 
adsorption. Therefore, it is believed that selective protein adsorption is responsible for good 
HUVEC adhesion and growth on CS surfaces. However, it is not clear which specific 
proteins and GFs are involved in promoting HUVEC adhesion and growth, and this could be 
further investigated.  
 
 The low-platelet adhesion on CS can be explained in large part by its chemical 
structure and composition, as detailed previously. In a way, the CS coating is a biomimetic 
approach to prevent platelet adhesion. Indeed, native endothelium exerts its antithrombogenic 
activity by expressing proteoglycans (such as heparin sulfate proteoglycons (HSPGs), 
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chondroitin sulfate (CS) and hyaluronic acid/hyaluronan (HA)), which serve as cofactors for 
antithrombin-III (AT-III) to facilitate thrombin inhibition. Moreover, these macromolecules 
in glycocalyx, including CS, are negatively charged, which effectively retains water and 
forms a lubrication layer on the EC surface and can resist platelet adhesion (Hashi et al., 
2007).  
The originality of this part of the work is to highlight the selective low-fouling properties of 
CS and to demonstrate for the first time the ability of CS coating to promote confluent 
endothelium while preventing fibrinogen and platelet adhesion, thus minimizing the risks of 
thrombosis and occlusion in vascular grafts. This part of the work was published in the 
journal Biomacromolecules (Thalla et al., 2014). 
 
 In comparison with CS coating, coatings with cell-adhesive proteins such as 
fibronectin, collagen or laminin (Assmann et al., 2013; De Visscher et al., 2012; Kapadia, 
Popowich et Kibbe, 2008; Parikh et Edelman, 2000; Wissink et al., 2000b) were also shown 
to enhance endothelial cell adhesion and growth, but they increase the risk of thrombosis 
through the recruitment of platelets. This same risk applies to LP coating, which has been 
shown previously to strongly improve endothelial cell adhesion and retention (Gigout et al., 
2011), but was found here to be highly thrombogenic. A thrombogenic underlayer is not 
recommended for vascular grafts as it could lead to thrombosis if cells detach from the 
surface under blood flow.  
 
 The high resistance to flow-induced shear stress observed on CS coatings is also 
important since the in vitro pre-seeding of VG by ECs or EPCs has shown success 
(Bordenave et al., 2005; Deutsch et al., 1999), but is known to be limited by poor cell 
adhesion and retention under blood flow (Feugier et al., 2005). Early attempts to seed 
autologous ECs on ePTFE/PET-based vascular grafts showed that the majority of ECs are 
lost within 24 h after exposure to physiological shear stress (Herring et al., 1994; 
Walluscheck et al., 1996) and has led to poor clinical outcomes. Long-term outcomes of EC-
seeded implants depend on the type of seeding protocol as well as the synthetic material 
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used. Therefore, surface coating must favor strong EC attachment and bear fluid shear stress 
for a long period.  
 
 Thus, the main advantage of using CS coating over other low-fouling polymers is that 
CS promotes strong endothelial cell attachment and growth while preventing protein 
adsorption and platelet adhesion and activation. Research in our lab has also shown that CS 
allows GF immobilization (via the coil-coil technique) with an excellent adhesion and 
proliferation effect on VSMC (Lequoy et al., 2014). CS may therefore be an ideal 
compromise for promoting endothelialization of vascular and stent and grafts. Yet CS 
promotes not only HUVEC but also VSMC adhesion (Charbonneau et al., 2012) and is 
therefore more suitable as a coating for cell pre-seeding on vascular implants.  
 
 This part of the study is limited by a lack of information regarding CS anticoagulant 
properties and long-term anti-platelet properties. This could be further investigated by 
comparing it with other anticoagulants such as heparin. However, the long-term 
hemocompatibility of CS coating is of less concern once the CS coating is covered by 
confluent endothelium, since endothelium acts as an active anti-thrombogenic surface. 
Further work could also be done to ensure that EC present their normal anti-thrombogenic on 
CS surface and do not enhance inflammation. Since endothelial cells contribute to the 
inflammatory process through the expression of adhesion molecules (platelet endothelial cell 
adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1(ICAM-1), Integrin 
avb3; vascular cell adhesion molecule-1 (VCAM-1), E-selectin, P-selectin and L-selectin), it 
would be important to examine whether their expression is modified by the interaction with 
our coating. For example, ammonia plasma treated PET and PTFE surfaces shown to 
improve EC adhesion and growth but also slightly up regulated expression of  adhesion 
molecules (Pu et al., 2002a). However, on the other hand, a number of studies noted that the 
effect of underlying substrate on EC function is insignificant when cell confluence is reached 
(Kottke-Marchant, Veenstra et Marchant, 1996; McGuigan et Sefton, 2007; Wissink et al., 
2001; Wissink et al., 2000a). All of these aspects could be further verified using our CS 
coatings.  
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Recommendation 3: CS interactions with several heparin-binding proteins and growth 
factors could be investigated and compared with heparin coating in order to understand the 
molecular mechanism by which CS governs cell adhesion. To demonstrate whether CS has 
additional advantages over heparin coating, CS long-term stability, anti-clotting and 
thrombin generation properties could be investigated and compared with heparin coatings. 
These studies could also be extended to HUVEC-grown CS surfaces. Some studies 
highlighted neointima formation due to heparin coatings; this can be verified on CS coatings 
since it has structural similarities to heparin. 
 
 CONCLUSION 
 
The long-term goal of this PhD thesis was to develop bioactive coatings on vascular 
biomaterials to either promote a stable endothelium to limit vascular graft occlusion or to 
favor VSMC growth to promote healing around endovascular stent grafts. Extensive research 
has previously been conducted on improving surface properties for the development of 
vascular implants, however the current coating methods lack versatility and failed to promote 
optimal cell interactions with the biomaterial surface. The coating methods presented in this 
thesis are versatile and transferable to a wide variety of biomaterials used in designing 
vascular implants. To allow such versatility, we took advantage of stable nitrogen-rich 
plasma polymerized thin film coatings (LP) that can be deposited on any biomaterial surface.  
 
The primary aim of this project was to create a low-fouling and low-thrombogenic 
underlayer for bioactive coatings. The PEG-coated surfaces were not completely protein-
repellent and could be further optimized. However, platelet adhesion study suggests that star 
PEG-modified surfaces may prevent thrombus formation. Subsequent immobilization of 
peptide (KQAGDV or RGD) on low-fouling polymers (PEG and CMD) did not show 
improvement of VSMC adhesion and therefore did not allow us to prove the concept of 
bioactive coating. However, this part of the work showed the potential of the QCM-D 
technique as a tool to follow and optimize grafting on surfaces and opened new avenues for 
developing bioactive coatings on low-fouling backgrounds using a combination of peptide 
and growth factors. Further studies would be required to understand the mechanisms 
involved in poor cell adhesion on peptide-immobilized low-fouling surfaces. The 
disappointing results obtained with low-fouling surfaces, also partly due to methodological 
problems, emphasize the limitations of this approach due to the difficult compromise to be 
found between the prevention of protein adsorption and the promotion of cell attachments on 
the surface.  
 
Based on previous results obtained in the lab, we proposed CS as a potential candidate for 
finding this compromise and designing a non-thrombogenic coating. The final objective of 
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this thesis was to develop a coating that would promote a stable endothelium while 
preventing protein adsorption and platelet adhesion. In this context, the properties of CS 
coatings were compared with other low-fouling polymers such as PEG and CMD. This study 
demonstrates the advantages of CS as an underlayer with selective low-fouling properties 
that result in low fibrinogen adsorption and platelet adhesion combined with HUVEC 
adhesive properties. CS thus exhibits very favorable properties as a coating for vascular 
implants. Alone or combined with other biomolecules such as growth factors, it may promote 
formation of a complete and stable endothelium, and therefore prevent graft occlusion. 
Further studies are however required to assess CS stability, long-term non-thrombogenic 
properties, and the molecular mechanisms by which CS governs cell adhesion. Although 
there are some issues that still need to be clarified and optimization of coating methods is 
required, the multidisciplinary work presented in this thesis and our promising results are 
essential to the development of vascular implants. 
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